https://glance.eyesoneyecare.com/ daily 1.0 https://glance.eyesoneyecare.com/stories/?organizations=SpyGlass+Pharma%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Olleyes weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=The+Vision+Council weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bruno+Vision+Care weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Genentech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Syncona+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sun+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Cognition+Therapeutics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Optometric+Association weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=NovaSight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visionix weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Fera+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Carrot weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Myopia+Profile weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyebiotech+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocubio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Famy+Life+Sciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AimMax+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Beyeonics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Research+to+Prevent+Blindness weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VIEW+Optometry weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Be+My+Eyes weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OcuSciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Celularity%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AntlerA+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Virtual+Vision+Health weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ascendis+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Cloudbreak+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vista+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Qlaris+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=HCP+Cureblindness+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocuvex+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Intelligent+Retinal+Imaging+Systems weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dopavision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eclipse+Life+Sciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Brill+Engines weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Rinsada weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Horizon+Surgical+Systems weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Celanese weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RetiSpec weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Atsena+Therapeutics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=UNITY+Biotechnology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Character+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CSI+Dry+Eye+Innovations weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sun+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Newton weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=WAVE+Eye+Care weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=eSight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Grifols weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Kuria+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Senju+Pharmaceutical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visionary+Medical+Education weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nidek weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Modulight+Corporation weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CASExGLOBAL weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyedaptic weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=National+Eye+Institute weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Association+for+Pediatric+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Cellusion+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Baxter+International weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Outlook+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=National++Federation+of+Opticianry+Schools weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Mu+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lensar weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Voiant weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Luxa+Biotechnology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Neurolens weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ASRS weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Astellas weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Orbis+International weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Glaucoma+Research+Foundation weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=TearRestore weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Belite+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aviceda+Therapeutics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Emmetrope+Ophthalmics+(Emmecell) weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Skyline+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=FELIQS weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Innovent+Biologics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Merck weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Th%C3%A9a+Open+Innovation weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Allegro+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Shifamed weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Amber+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=PlenOptika weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Formosa+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aura+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oculogenex%2C+Inc.+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Seonix+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Graybug+Vision%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Abeona+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visibly weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ViaLase weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BELKIN+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Brightstar+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sling+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Amring+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Biocon+Biologics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocumetra weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iVeena+Delivery+Systems weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Atia+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ace+Vision+Group weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ollin+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LSL+Pharma+Group weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OCULUS%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=International+Agency+for+the+Prevention+of+Blindness+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visus+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Samsung+Bioepis+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Rain+Eye+Drops weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visionary+Optics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Alembic+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Novoxel+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VisiRose weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optometry+Divas weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EzriCare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Johnson+%26+Johnson weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ModMed weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RegenxBio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Medicel+AG weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OKYO+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Barti weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Celltrion%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nicox weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sightpath+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Allotex weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=InflammX+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ray+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SalioGen+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sight+Sciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optos weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Hubble+Contacts weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Frontera+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eluminex+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Apellis+Pharmaceuticals+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nacuity+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Neuralink weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dyno+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Naegis+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Scope+Health+Inc.+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ARVO weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Altris+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iOR+Partners weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LumiThera weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Kodiak+Sciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Alumis weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aegis+Venture weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Biogen weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=PulseSight+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RetinaLyze weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyeganics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Verana+Health weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Regeneron weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Palatin+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Beacon+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oculogyx weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Exonate weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Moria+Surgical+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SGN+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Novaliq weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Precise+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visible+Genomics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VirtuaLens weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Amgen weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Chiesi+Group weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OliX+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nordic+Pharmra weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lilly+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eversight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Unither+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BRIM+Biotechnology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dr.+Contact+Lens weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Adverum+Biotechnologies+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Immunogen weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Myra+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AMETEK%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Heidelberg+Engineering+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ViGeneron weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RareSight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ophthalmic+World+Leaders+(OWL) weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Amaros weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Opticians+Association+of+America weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=HuidaGene+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Cassini+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sandoz weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Microsurgical+Technologies+(MST) weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=20%2F20Now+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Amneal+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RetinAI weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VeonGen+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nanoscope+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Alimera weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Phoenix-Micron weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Yuyu+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Coave+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=World+Council+of+Optometry weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Samsara+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Azalea+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Apple weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=HealthyCell weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=New+World+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Avulux weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CoFi%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tenpoint+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ivantis%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OASIS+Medical+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Mireca+Medicines weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LambdaVision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visiox+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Academy+of+Ophthalmology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Topcon+Healthcare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Mediwhale weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Inflammasome+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VivaVision+Biotech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Blinkjoy+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ProQR+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lumata+Health weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EyeYon+Medical+Ltd. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=InfantSee weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Endogena+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Zhongmou+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EyeCheq weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tear+Film+%26+Ocular+Surface+Society+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pykus+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optometry+Giving+Sight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Galimedix+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Boehringer+Ingelheim weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Global+Pharma+Healthcare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VSP+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OcuTrx+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Latinos+En+Optometry weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Long+Grove+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=DifGen+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Mount+Sinai+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pantheon+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Opthea+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Euclid+Vision+Corporation weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Medical+Association weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EyeMD+EMR weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Caeregen+Theapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Rayner weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Prevent+Blindness weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyefficient weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EyeCool+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Meivertor weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BlueRock+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Advancing+Eyecare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Provectus+Biopharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eye2Gene weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=FDC+Limited+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Olympic+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=4D+Molecular+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Art+Optical+Contact+Lens%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OrCam+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=The+Contact+Lens+Institute weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Neurophth+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ASCRS weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=PolyActiva weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vantage+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OCuSOFT weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Avisi+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Byers+Eye+Institute weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pandorum+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyefinity weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LKC+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pine+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AAVantgarde+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Norlase weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eschenbach+Optik+of+America weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Balance+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bayer+AG weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Foundation+Fighting+Blindness weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Annexion+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Novartis weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AcuFocus weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BioTissue weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Opus+Genetics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BioAge+Labs weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Coherus+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lineage+Cell+Therapeutics%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Glaucoma+Society+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SignaBlok weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bionic+Vision+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Neolight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+College+of+Eye+Technicians+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=C.+Light+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Viatris weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CorNeat+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=FundamentalVR+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Radius+XR+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lighthouse+Guild weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=NextGen+Healthcare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BVI weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Academy+of+Optometry+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AI+Optics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optomed+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Zenni+Optical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oertli+Instrumente weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Evoq+Technologies+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SightGlass+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BioStem+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=American+Association+for+Pediatric+Ophthalmology+and+Strabismus weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Iridex weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Marco+Lombart weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Spark+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sanofi+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LUVO+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vital+Tears weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Shamir+Optical+Industry weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oxular+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BeeKeeper+AI weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyenuk weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VEO+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sagent+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EyePoint+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tourmaline+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=TheiaNova weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=InMode weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Orasis+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Caplin+Steriles+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Epion+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iSTAR+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AesculaTech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=FGH+Science weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Allovir%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AbbVie weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RxSight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=HanAll+Biopharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Alkeus+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EMC+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visioneering+Technologies+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optivate weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Azura+Ophthalmics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Trefoil+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ripple+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Horizon+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tukera+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Avista+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Kiora+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=M%26S+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Laboratoires+Th%C3%A9a weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=+Allysta+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ONL+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Spryte+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lumibird+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RightEye weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Glaukos weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oxurion+NV weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Osheru weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=DigitalOptometrics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=North+American+Neuro-Ophthalmology+Society weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=STAAR+Surgical+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dr.+Reddy%27s+Laboratories weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Elios+Vision+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CLIARA+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OpZira+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Arctic+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=UnitedHealthcare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=STAAR+Surgical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Accusite+Surgical+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=jCyte weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Meridian+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aramis+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Surface+Ophthalmics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Brill+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Centre+for+Ocular+Research+and+Education weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=NewSight+Reality weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Quantel+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=TECLens weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyexora weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Humonix+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Skye+Bioscience weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocugen weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Visant+Medical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Forge+Biologics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=GenSight+Biologics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bausch+%2B+Lomb+enVista weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=MYZE weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Neurotech+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Delsam+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pixium+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Smartlens%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Alcon%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=KALA+BIO weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lumenis weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oyster+Point+Pharma%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Domp%C3%A9 weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tarsus+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iCare+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Reichert+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vision+Source weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=EssilorLuxottica weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Heru weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Johnson+%26+Johnson+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Allergan%2C+an+AbbVie+company weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RevolutionEHR weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LasikPlus weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Carl+Zeiss+Meditec weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyes+On+Eyecare weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VISION+EXPO weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Johnson+%26+Johnson+Surgical+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SynergEyes weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ASOA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ziemer+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Formycon+AG weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ImprimisRx weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iHealthScreen+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Oculis weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bausch+%2B+Lomb weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Virtual+Field weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocutech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=BostonSight weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyecare+Partners weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OcuTerra+Therapeutics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=MediPrint+Ophthalmics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ora%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=NovaBay+Pharmaceuticals+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=IbisVision+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Clinical+AI weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Optase weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Apotex+Corp. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aldeyra+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bascom+Palmer+Eye+Institute weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lenz+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RevitalVision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eiyan+Lens weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pangaea+Data weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Selagine weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Coburn+Technologies+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Melt+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Centricity+Vision+Inc.+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Drug+Farm weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SightLife+International+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nona+Biosciences weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Acelyrin%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sonoma+Pharmaceuticals+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=GoCheck+Kids weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=RevOpsis+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OpenAI weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Bruder+Healthcare.+A+Hilco+Vision+Company. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nanodropper weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aerie+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Eyenovia weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Thea+Pharma%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=LighTopTech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Haag-Streit+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Hyperion+DeFi%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=VSY+Biotechnology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Focus+Vitamins weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Clearside+Biomedical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Meibum+Scientific weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Pharmedica weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Gland+Pharma+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Global+Myopia+Awareness+Coalition+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ForSight+Robotics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lumenis+Be weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=iuvo+Bioscience weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=OnPoint+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tracey+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Salvat+Laboratories weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Akorn+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Stuart+Therapeutics+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Toku%2C+Inc. weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Regener-Eyes weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Santen+Pharmaceutical weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Aurion+Biotech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Glenmark+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Zhaoke+Ophthalmology+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AsclepiX+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SpliceBio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Sydnexis+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vantage+Surgical+Solutions+ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ArtiKode+Intelligence weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Therini+Bio weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Avant+Technologies weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Invirsa weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Complement+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocuphire+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Mylan+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=HelpMeSee weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Apellis+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Kalaris+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=DryEye+Rescue weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ZEISS+Medical+Technology weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=DORC weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Iantrek+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Nova+Eye+Medical+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Notal+Vision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dry+Eye+Institute weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ciliatech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Tern+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Keeler+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=CooperVision weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Konan+Medical+USA weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ainnova+Tech weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ascidian+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Vyluma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Octane+OC weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=SeaBeLife++ weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=ANI+Pharmaceuticals weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Telios+Pharma weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Interventional+Mindset weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Deep+Optics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Gore weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=identifeye+HEALTH weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Ocular+Therapeutix weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Lupin+Limited weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Hoya+Vision+Care weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Capsida+Biotherapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Dry+Eye+Society+of+the+Americas weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=TearOptix weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Gentex weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Luminopia weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Rebion weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Northwell+Health weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=DefEYE%2C+Inc weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Viridian+Therapeutics weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=Harrow weekly 0.75 https://glance.eyesoneyecare.com/stories/?organizations=AEYE+Health weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Business weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Research weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Pipeline weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Products weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Legal weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Archives weekly 0.75 https://glance.eyesoneyecare.com/stories/?category=Events weekly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-16/settlement-paves-way-for-us-commercialization-of-eylea-biosimilar/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-20/lampalizumab-injections-lead-to-low-iop-risk-for-ga/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-28/fda-has-approved-evo-visian-icl/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-07/eyebiotech-limited-introduces-first-retinal-disease-candidate/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-06/rare-rgcs-may-lead-to-new-color-perception-insights/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-21/topcon-purchases-toku-inc/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-26/fda-grants-aao-funding-for-pediatric-cataract-surgery-research/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-04-02/study-high-intensity-exercise-critical-for-reducing-dr/ 2026-04-02T19:15:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-13/study-identifies-inducing-factors-for-angle-closure-glaucoma/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-27/postop-iop-when-should-you-measure/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-01/akorn-pharma-recalls-70-drugs-from-the-us-market/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-29/smartlens-raises-usd5-2-million-to-advance-milens-fda-clearance-and-launch/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-27/treat-uveitis-without-steroids-weekly-glance/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-05/nicox-reports-analysis-of-phase-3-data-on-iop-lowering-glaucoma-therapy/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-23/fda-clears-expansion-of-eyenuk-s-ai-system-for-dr-detection/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-23/new-data-on-dr-progression-in-native-americans/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-30/advancing-eyecare-purchases-eyefficient-ophthalmic-supplier/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-10/coburn-technologies-debuts-the-huvitz-hvs-1-vision-screener/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-05/ortho-k-preferred-method-myopia-management-physically-active/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-12/azalea-vision-raises-usd9m-to-support-development-of-intelligent-ocular-tech-platform/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-25/researchers-develop-eye-aging-clock-for-ocular-disease-treatment/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-25/leadership-watch-polyactiva-b-l-and-wills-eye-make-strategic-changes/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-08/alcon-unveils-precision7-one-week-replacement-contact-lens/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-04-02/new-hampshire-governor-rejects-od-laser-legislation/ 2026-04-02T21:05:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-11/look-latest-launches-weekly-glance/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-19/a-new-treatment-for-ossn-is-on-the-rise/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-20/iantrek-reports-favorable-2-year-data-on-uveoscleral-outflow-technology-for-glaucoma/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-04/fda-clears-zhongmou-therapeutics-ind-for-rp-optogenetic-gene-therapy/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-05/tfos-releases-dews-iii-diagnostic-methodology-report/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-17/ai-better-detecting-retinopathy-than-ophthalmologist/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-27/eric-donnenfeld-md-joins-nordic-group-as-chair-of-medical-advisory-board/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-02/identifeye-health-launches-ai-based-retinal-screening-platform/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-27/active-lifestyle-among-hyperopia-patients-lowers-depression-risk/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-14/rare-tooth-in-eye-surgery-restores-vision-in-the-blind/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-18/vitamin-d-deficiency-tied-to-increased-risk-for-rvo/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-17/future-of-optometry-is-increasingly-women-report-finds/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-07/heidelberg-and-eye2gene-partner-on-ai-ophthalmic-diagnostics-for-ird/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-09/bausch-lomb-reports-national-dry-eye-data-launches-awareness-tool/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-29/misleading-labeling-identified-in-multifocal-contact-lenses/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-12/rki-drops-may-protect-endothelial-cells-post-cataract-surgery/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-21/pediatric-study-supports-multifocal-contact-lens-method-for-slowing-myopia/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-17/barti-introduces-ai-transcription-tech-for-optometrists/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-16/study-suggests-toddlers-eye-movements-predict-their-metamemory/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-28/otc-allergy-eye-drop-options-weekly-glance/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-12/beacon-therapeutics-doses-first-patient-in-vista-xlrp-gene-therapy-trial/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-01/maximeyes-ehr-integrates-with-aao-iris-registry/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-02/abbvie-and-capisda-to-develop-gene-therapies-for-eye-diseases/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-09/annexon-releases-phase-2-and-3-clinical-developments-for-ga-therapeutic/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-13/eyecool-reports-favorable-safety-data-on-cosp-investigational-device/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-08/bausch-lomb-s-zenlens-echo-scleral-lens-launches-in-the-us/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-20/lumenis-optiplus-delivers-clinically-significant-results-for-ded/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-18/alcon-launches-total30-multifocal-for-astigmatism-toric-contact-lens/ 2026-02-18T19:10:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-21/the-myopia-collective-selects-over-60-ods-to-lead-us-myopia-control-efforts/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/two-year-data-reported-for-gather2-study-on-izervay/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-16/fda-extends-reproxalap-s-pdufa-to-march-2026/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-19/new-data-reveals-practice-behaviors-for-retaining-new-and-long-term-cl-wearers/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-17/octane-ophthalmology-tech-forum-highlights-ai-and-personalized-medicine/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-07/apple-is-developing-adjustable-ophthalmic-lenses/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-06/study-links-gout-patients-with-increased-amd-risk-and-progression/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-15/lumithera-reports-24-month-data-from-lightsite-iii-trial-for-dry-amd/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-18/could-optic-disc-hemorrhage-impact-glaucoma-progression/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-18/customizable-artificial-tears-may-soon-be-a-reality/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-24/bausch-lomb-launches-new-surgical-planning-software/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-09/prevent-blindness-to-host-world-sight-day-event-on-capitol-hill/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-02/bausch-lomb-launches-new-digital-ordering-marketplace/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-07/cms-lowers-cut-to-2024-medicare-reimbursement-rates/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-25/hope-dry-amd-patients-weekly-glance/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-13/horizon-performs-world-s-first-robotic-assisted-cataract-surgery/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-08/mediprint-ophthalmics-begins-phase-2b-study-drug-eluting-lens/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-23/study-dementia-may-be-tied-to-declining-visual-function/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-16/ocutrx-launches-oculenz-ar-headset-for-advanced-macular-degeneration/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-16/the-vision-council-reports-us-consumers-prescription-purchase-choices/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-30/dc-bill-seeks-to-add-controlled-substances-to-od-scope-of-practice/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-29/eyepoint-doses-first-patient-in-global-phase-3-wet-amd-trial-of-duravyu/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-26/3d-mini-corneas-show-promise-as-new-tool-for-corneal-diseases/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-15/extended-mask-wear-linked-with-worsening-dry-eye-in-healthcare-workers/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-10/spyglass-pharma-secures-usd90m-in-financing-for-chronic-ophthalmic-disease-drug-delivery-platform/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-23/altris-ai-launches-new-app-for-direct-oct-syncing/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-12/glp-1-use-may-lower-long-term-dme-dr-risk/ 2026-01-12T22:21:20Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-27/ocugen-doses-first-patient-in-phase-3-rp-gene-therapy-trial/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-21/luminopia-ranks-among-best-inventions-of-2023/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-11/optometry-divas-to-host-celebratory-10-year-anniversary-events/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-09/efficacy-of-nsaids-post-cataract-surgery-may-surpass-corticosteroids-alone/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-14/nanoscope-secures-us-patent-for-mco-optogenetic-tech-platform/ 2026-01-14T13:55:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-18/fda-approval-dr-screening-tool-weekly-glance/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-30/outer-retina-plays-key-role-in-amd-progression/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-16/nicox-releases-favorable-phase-3b-data-on-iop-lowering-glaucoma-therapeutic/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-16/fda-approves-anda-for-generic-ketorolac-tromethamine-ophthalmic-solution-0-5/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-02/inaugural-dry-eye-forum-kicks-off-summer-series/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-19/fda-grants-tentative-approval-for-lupin-s-lumify-generic/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-17/fda-clears-cloudbreak-pharma-s-ind-for-phase-2-presbyopia-drop-trials/ 2026-02-17T12:33:10Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-29/researchers-identify-protein-for-optic-nerve-regeneration/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-13/eyes-on-eyecare-announces-the-launch-of-courses/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-16/fda-approves-difgen-s-fml-0-1-complex-generic-for-ocular-inflammation/ 2026-02-17T21:12:45Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-28/grifols-and-hhs-partner-on-preclinical-testing-of-osig-drops-for-mustard-gas-eye-injury/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/focusing-in-surgical-innovation-highlights-at-aao/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-22/which-form-of-glaucoma-testing-do-patients-prefer/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-25/registration-open-for-eyes-on-2026/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-09/harrow-acquires-u-s-rights-to-clobetasol-propionate-for-postop-inflammation-and-pain/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-31/new-aoa-report-exposes-nationwide-consequences-of-unmanaged-screen-time/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-11/eyepoint-pharmaceuticals-names-new-ceo/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-16/sagent-launches-travoprost-0-004-generic-for-iop-reduction/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-24/medical-coverage-rates-makes-a-difference-in-pdr-diagnosis/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-15/decreased-corneal-sensitivity-may-be-indicative-of-pdr/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-10/luxa-biotechnology-releases-fih-data-on-rpe-cell-therapy-for-dry-amd/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-28/loteprednol-etabonate-tobramycin-ocular-inflammatory-diseases/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-01/fda-approves-lenz-therapeutics-vizz-for-presbyopia/ 2026-01-07T22:54:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-11/tfos-dews-iii-report-supports-use-of-lacrifill-canalicular-gel/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-13/pivotal-study-supports-b-l-s-teneo-laser-for-myopic-lasik-surgery/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-03/retinal-perspective-from-aao-day-1/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-15/are-uveitis-patients-at-an-increased-risk-for-complications-post-cataract-surgery/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-19/dry-eye-institute-to-host-immersive-education-retreat-in-dublin/ 2026-03-19T18:58:40Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-23/new-qlosi-safety-data-supports-drop-as-pupil-selective-for-presbyopia/ 2026-01-28T12:09:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-06/eyemd-emr-s-patient-engagement-system-targets-workflow-efficiency/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-28/eyes-on-eyecare-now-accepting-pitches-for-2024-optometry-innovation-awards/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-25/ocuvex-resubmits-fda-crl-for-brimonidine-tartrate-0-35-nda/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-11/4dmt-completes-enrollment-for-phase-3-wet-amd-gene-therapy-trial/ 2026-02-11T11:59:30Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-25/eye2gene-study-supports-ai-analysis-of-spectralis-platform-for-irds/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-01/assessing-impact-of-photobiomodulation-on-amd-patients/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-31/eye-color-changing-surgeries-spark-aao-warning/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-25/ted-may-cause-reduced-stromal-corneal-thickness/ 2026-03-25T19:12:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-18/fuch-s-dystrophy-may-be-accelerated-among-certain-patient-demographics/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-20/phase-4-data-presents-early-patient-reported-outcomes-of-miebo/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-19/visual-impairment-older-adults-more-common-than-you-think/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-17/alcon-unveils-lensx-onaxis-technology-for-astigmatism-management/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-12/glaukos-launches-enrollment-next-gen-corneal-cxl-trial-keratoconus/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-25/alcon-earns-fda-clearance-for-vitreoretinal-and-cataract-surgery-systems/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-10/fda-agrees-to-atsena-s-regulatory-pathway-for-xlrs-gene-therapy/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-11/bausch-lomb-to-launch-infuse-for-astigmatism-sihy-lenses-in-the-us/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-13/mediprint-ophthalmics-completes-phase-2-study-on-drug-eluting-contact-lens/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-24/neurotech-pharma-earns-bla-priority-review-for-mactel-cell-therapy/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-29/hope-for-pediatric-color-blindness-weekly-glance/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-16/u-s-house-committee-to-investigate-ftc-regulation-of-vision-insurance-market/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-18/severe-vision-impairment-anxiety-depression-weekly-glance/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-25/bausch-lomb-launches-stablevisc-ovd-totalvisc-viscoelastic-system-in-us/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-12/researchers-identify-pediatric-autism-via-ai-and-retinal-abnormalities/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-10/glaucoma-aes-may-be-connected-to-pediatric-cataract-surgery/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-02/csi-dry-eye-innovations-unveils-new-branding-and-software-patent/ 2026-02-03T18:52:58Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-29/harrow-partners-with-cencora-to-launch-product-accessibility-program/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-27/icare-to-release-updated-version-of-maia-microperimeter/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-01/onpoint-vision-s-ide-app-for-iopcl-magnifier-earns-fda-approval/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-15/cloudbreak-advances-vascularized-pinguecula-eye-drop-to-phase-3-trials/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-18/fda-approves-expanded-label-of-iluvien-for-chronic-posterior-uveitis/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-05/endogena-therapeutics-concludes-dose-escalation-stage-in-rp-trial/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-02/optometry-excluded-in-new-dc-scope-of-practice-legislation/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-02/eyecheq-adds-new-exec-in-mission-to-target-early-diagnosis-of-blinding-diseases/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-11/vialase-and-moran-eye-center-launch-glaucoma-research-partnership/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-06/keratoconus-eye-drop-regenerates-lost-collagen-in-the-eye/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-18/kansas-passes-optometry-scope-of-expansion-bill-for-laser-procedures/ 2026-03-18T10:57:33Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-16/nona-biosciences-and-kodak-sciences-to-advance-antibody-therapies-for-ophthalmic-diseases/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-21/fda-sends-warning-letters-to-three-eye-drop-manufacturers/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-15/enrollment-completed-for-ocular-therapeutix-s-helios-trial-in-dr/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-05/florida-governor-vetoes-not-a-doctor-bill/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-26/new-report-reveals-us-eye-care-practice-performance-is-decreasing/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-17/vision-risks-asprp-aesthetic-skin-treatments-weekly-glance/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-01/study-finds-comparable-data-for-olleyes-visuall-vrp-in-sap-for-pediatrics/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-01/opus-genetics-vega-3-presbyopia-trial-meets-endpoints-for-phentolamine-0-75/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-03/normal-tension-glaucoma-risk-alzheimers-disease-weekly-glance/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-02/vialase-secures-usd40m-in-financing-to-advance-glaucoma-femtosecond-laser/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-03/vyzulta-for-poag-shows-surprising-effect-on-retinal-vessel-density/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-11/optase-s-allegro-eye-drops-target-seasonal-allergy-relief/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-15/ibisvision-launches-online-patient-prescription-checker/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-25/alcon-launches-systane-pro-pf-drops-for-dry-eye/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-11/long-term-visual-outcomes-support-remote-amd-monitoring/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-30/genentech-reports-phase-4-vabysmo-data-among-underrepresented-dme-patients/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-17/zeiss-releases-updated-smartlife-young-lenses-for-kids/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-16/type-patient-convert-dry-wet-amd-weekly-glance/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-22/aapos-names-vp-as-next-president/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-19/icare-and-mediwhale-partner-on-ai-based-cvd-retinal-imaging/ 2026-02-19T12:16:14Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-16/foundation-fighting-blindness-launches-gyrate-atrophy-natural-history-study/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-17/is-ded-actually-linked-to-sedentary-behavior/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-26/ani-pharmaceuticals-to-purchase-alimera-sciences/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-07/comparison-study-finds-similar-positive-profiles-iyuzeh-xalatan/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-04/new-north-dakota-bill-establishes-optometric-telemedicine-guidelines/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-28/lumibird-launched-latest-tango-reflex-lasers/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-10/clearside-biomedical-reports-phase-3-plans-for-scs-wet-amd-therapy/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-02/aldeyra-s-adx-2191-nda-receives-fda-priority-review/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-07/laboratoires-thea-purchases-proqr-therapeutics-ird-rna-therapies/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-01/data-is-the-future-of-ophthalmic-patient-care-industry-leaders-say/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-27/fda-grants-aflibercept-priority-review-for-retinal-diseases/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-26/zeiss-launches-first-hand-held-ultrasound-free-lens-removal-device/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-30/arvo-names-2023-2024-president-elect/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-03/defeye-and-celularity-partner-to-advance-ophthalmic-biologics-portfolios/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-07/yuyu-pharma-releases-topline-data-from-phase-1-2-ded-trial/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-03/aurion-doses-first-canadian-patient-in-allogeneic-cell-therapy-trial-for-ced/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-12/assessing-the-significance-of-the-iris-registry-wide-scale-migs-study/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-12/eyes-on-eyecare-acquires-interventional-mindset-educational-series/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-02/is-there-a-link-between-outer-retinal-thinning-and-brain-health-in-amd/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-18/harrow-launches-vevye-accessibility-program-for-patients/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-13/enrollment-concludes-in-phase-3-reproxalap-trial-for-ded/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-18/glaucoma-research-foundation-awards-usd2-5m-in-grants/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-15/hanall-biopharma-kicks-off-phase-3-ded-trial-on-topical-anti-inflammatory/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-15/harrow-launches-initiative-for-expanded-access-price-cuts-of-branded-products/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-08/nextgen-healthcare-introduces-ai-based-ambient-listening-tech/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-08/eyes-on-eyecare-announces-second-annual-optometry-innovation-awards/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-11/omnibus-model-identifies-framework-for-effective-myopia-management/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-20/fda-inspection-of-regener-eyes-manufacturing-facility-unveils-significant-violations/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-30/fda-grants-rare-pediatric-disease-designation-to-stargardt-gene-therapy/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-20/which-iol-is-more-effective-for-near-vision-correction/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-28/opus-genetics-receives-fast-track-designation-reports-phase-3-updates-for-phentolamine-solution/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-24/scientists-design-ar-system-for-3d-printed-smart-contact-lens/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-11/new-data-reinforces-xiidra-s-eye-dryness-relief-among-cl-wearers/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-27/study-finds-ace2-in-gut-reduces-diabetic-blindness-risk/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-02/extension-study-reinforces-syfovre-long-term-efficacy-for-ga/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-06/fda-approves-fdc-limited-s-pilocarpine-hcl-ophthalmic-solution/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-19/iuvo-biosciences-purchases-promedica-international/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-23/coherus-is-selling-off-its-ophthalmology-franchise-to-sandoz/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-20/which-slt-technique-proves-more-effective/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-27/vista-ophthalmics-and-mst-to-launch-global-partnership/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-03/add-cover-hoya-introduces-visupro-all-day-and-flex-lenses-for-young-presbyopes-hoya-introduces-visupro-all-day-and-flex-lenses-for-young-presbyopes/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-02/regener-eyes-ends-recall-of-remaining-older-product-inventory/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-21/ocugen-s-ocu400-receives-fda-rmat-designation-for-rp/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-17/first-patient-dosed-phase-1b-study-retinitis-pigmentosa/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-31/real-world-data-reveals-comparable-findings-against-tube-vs-trab-study/ 2026-01-07T22:54:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-04/eschenbach-optik-launches-blue-light-readers-with-anti-fog-tech/ 2026-03-05T17:45:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-05/reducing-chronic-inflammation-minimizes-amd-linked-vision-loss/ 2026-02-05T20:17:35Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-19 /a-look-at-2023-ophthalmic-commercial-launches / 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-24/referral-rates-impact-perception-of-low-vision-services/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-20/study-identifies-key-vitamin-supplementation-for-ncp/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-04/harrow-relaunches-triesence-to-the-us-market/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-22/analysis-tracks-gender-distribution-across-ophthalmology/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-07/opus-genetics-acquires-rights-iveric-bio-gene-therapy-candidates/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-12/gore-launches-silicone-free-syringe-plunger-for-prefilled-syringes/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-01/shamir-introduces-drive-intelligence-lens-technology/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-25/new-fda-policy-shifts-to-single-pivotal-trial-standard-for-ndas/ 2026-03-02T12:24:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-25/real-world-luminopia-data-supports-pediatric-amblyopia-improvement/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-09/eyepoint-fails-to-meet-primary-goal-in-phase-2-npdr-trial/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-12/fda-oks-okyo-pharma-s-ind-for-neuropathic-corneal-pain-candidate/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-07/researchers-identify-impact-of-serotonin-on-visual-information-process/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-06/second-annual-dry-eye-pathways-series-kicks-off-this-weekend/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-26/new-findings-link-cardiovascular-disease-to-poag/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-06/topcon-launches-ai-based-ocular-digital-health-platform/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-24/eyes-on-dry-eye-spotlights-next-gen-treatments-and-hot-topics/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-17/glp-1-drug-users-twice-as-likely-to-develop-namd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-16/reichert-s-tono-vera-tonometer-launches-in-the-us/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-24/taping-down-mask-help-weekly-glance/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-29/two-year-data-released-on-pds-with-ranibizumab-for-wet-amd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-14/fda-grants-fast-track-designation-to-epion-s-epismart-epithelium-on-cxl-system/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-15/fda-grants-rmat-designation-to-atsena-s-xlrs-gene-therapy/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-31/fda-clears-ascidian-s-ind-for-therapeutic-targeting-genetic-cause-of-stargardt/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-18/fda-green-lights-myra-vision-s-ide-study-for-glaucoma/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-02/fda-clears-ind-for-atsena-s-xlrs-gene-therapy-candidate/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-28/binocular-vision-therapy-followed-by-sleep-may-aid-amblyopia/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-25/fda-accepts-snda-of-phentolamine-0-75-for-presbyopia/ 2026-02-25T19:40:26Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-08/eyes-on-dry-eye-exceeds-industry-expectations/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-08/fda-issues-new-hpcps-labeling-guidance-for-manufacturers/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-18/survey-finds-us-adults-value-vision-care-but-are-not-taking-advantage-of-benefits/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-13/mediprint-ophthalmics-releases-data-from-sight-2-phase-2-trial-for-glaucoma/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-29/ophthalmology-tech-forum-to-highlight-latest-trends-and-advancements/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-15/stuart-therapeutics-initiates-phase-3-ded-trial/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-09/fda-clears-epithelial-thickness-module-for-heidelberg-imaging-platform/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-13/alcon-reaches-settlement-agreement-with-johnson-and-johnson/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-26/versea-ophthalmics-launches-novel-quantitative-poc-testing-platform-for-osd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-16/potential-glaucoma-prevention-benefits-linked-to-nitrate-use/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-15/public-support-needed-for-landmark-pediatric-vision-and-eye-health-legislation/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-28/lineage-phase-2a-study-genentech-ga-secondary-amd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-06/updated-reciprocal-tariffs-to-take-effect-this-week/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-17/eyes-on-myopia-draws-nearly-3-000-attendees-in-inaugural-event/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-02/will-vision-care-clinics-be-affected-by-walmart-s-health-center-closings/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-04/haag-streit-introduces-ophthalmoscope-rop-simulator/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-16/eyebio-doses-first-patients-in-phase-1b-2-trial-for-wet-amd-dme/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-24/researchers-identify-new-phenotype-for-amd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-06/ascrs-launches-at-iol-focused-educational-initiative/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-27/algorithm-predicts-amd-progression-with-near-perfect-accuracy/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-24/aoa-opens-registration-for-optometry-s-meeting-2024 / 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-17/new-ama-policy-targets-diversity-in-clinical-trials-and-research/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-17/identifying-the-keys-to-glaucoma-prevention/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-12/tenpoint-and-visus-therapeutics-merge-with-plans-for-ophthalmic-therapeutic-advancements/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-11/smart-contact-lens-features-eye-tracking-and-radio-frequency/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-21/jcyte-doses-first-patients-rp-allogeneic-cell-therapy-trial/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-23/apellis-reports-update-on-retinal-vasculitis-cases-with-syfovre-treatment-for-geographic-atrophy/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-07/investigators-identify-new-primary-treatment-for-advanced-glaucoma/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-06/regeneron-reportedly-purchases-british-biotech-oxular/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-20/study-proposes-turmeric-supplements-reduce-amd-risk/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-03/positive-topline-results-reported-in-optogenetic-therapy-trial-for-rp/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-08/tenpoint-submits-nda-for-brimochol-pf-for-presbyopia/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-06/bausch-lomb-buys-blink-eye-drops-from-johnson-and-johnson-vision/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-02/new-presbyopia-drops-weekly-glance/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-24/apellis-publishes-phase-3-post-hoc-analyses-on-syfovre-for-ga/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-18/researchers-identify-high-risk-patients-prone-to-iol-dislocation/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-25/cli-releases-new-investigative-report-on-consumers-contact-lens-digital-searches/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-21/clearside-biomedical-names-retinal-industry-veteran-as-cmo/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-03/zeptolink-iol-positioning-system-earns-fda-clearance/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-27/fda-clears-4dmt-s-ind-for-genetic-ga-treatment/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-13/prevent-blindness-unveils-interactive-children-s-vision-health-map/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-20/visionix-usa-launches-new-topography-module-with-optovue-solix-oct-octa/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-04/corneal-sweep-test-weekly-glance/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-01/happy-new-year-2025/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-22/ftc-to-host-public-workshop-on-proposed-eyeglass-rule-changes/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-19/avista-and-forge-biologics-partner-to-advance-xlrs-gene-therapy/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-27/conflicting-evidence-surrounds-astigmatism-s-role-in-myopia/ 2026-01-27T22:09:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-23/tearrestore-launches-onedrop-for-daily-dry-eye-care/ 2026-02-26T11:23:05Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-24/bvi-medical-and-neurotech-name-new-ccos/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-15/ophthalmology-tech-forum-explores-next-frontier-in-retina-diagnostics-and-treatment/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-25 /oct-a-for-pediatric-diabetes-may-be-a-game-changer/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-16/haag-streit-usa-to-debut-new-slit-lamp-and-digital-phoropter/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-26/genentech-reports-vabysmo-superiority-for-retinal-drying-versus-aflibercept-for-wet-amd-dme/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-04/glaukos-idose-tr-intracameral-launches-the-us/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-23/mixed-reality-glasses-may-restore-partial-vision-loss-in-stroke-patients/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-10/new-hampshire-laws-allows-ods-to-administer-vaccines/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-31/visioneering-technology-names-new-ceo/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-14/could-reticular-pseudodrusen-increase-the-risk-for-stroke/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-26/nanoscope-reports-positive-data-from-restore-trial-on-optogenetic-therapy-for-rp/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-17/aura-biosciences-reports-positive-end-of-study-phase-2-data-for-choroidal-melanoma/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-13/dual-gip-glp-1-ra-shows-superior-efficacy-in-lowering-poag-oht-risk/ 2026-02-13T16:59:00Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-21/ai-chatbots-and-virtual-assistants-are-offering-advanced-capabilities/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-06/lumenis-launches-optiplus-radio-frequency-device-for-ded/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-06/vitamin-d-may-benefit-pediatric-keratoconus-progression/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-04/what-are-the-risk-factors-for-microshunt-implanation-in-glaucoma-patients/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-06/bascom-palmer-receives-moonshot-project-award-to-support-whole-eye-transplant/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-27/metformin-use-associated-with-decreased-risk-of-dry-amd/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-01/thea-introduces-new-iyuzeh-patient-resources/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-12/whats-new-glaucoma-world-weekly-glance/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-05/bausch-lomb-launches-infuse-multifocal-sihy-contact-lenses-in-us/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-10/fda-clears-ind-for-zhaoke-ophthalmology-s-csa-ophthalmic-gel/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-27/nanodropper-s-eyedrop-adaptor-is-heading-to-space/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-28/oculus-and-luvo-partner-to-launch-new-ipl-rf-devices/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-28/fda-issues-scope-health-warning-letter-over-optase-ophthalmic-products/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-16/fda-reportedly-clears-moria-surgical-s-corneal-storage-solution/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-26/ray-therapeutics-secures-usd100-million-in-funding-for-optogenetic-gene-therapy-programs/ 2026-01-07T22:55:04Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-12/connection-between-dietary-nitrate-intake-low-amd-risk/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-09/what-factors-impact-visual-acuity-in-intermediate-amd/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-10/clearside-biomedical-reports-phase-2b-analyses-of-cls-ax-for-wet-amd/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-15/fda-approves-glaukos-idose-tr-intracameral-implant/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-24/vabysmo-provides-long-term-durability-in-dme-extension-study/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-24/fda-issues-warning-against-use-of-two-msm-eye-drops/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-21/keratoconus-may-be-more-prevalent-than-previously-thought/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-25/corneal-transplant-recipients-may-be-herpesvirus-positive/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-29/elios-vision-concludes-enrollment-in-pivotal-trial-of-implant-free-tech-for-glaucoma-in-combo-with-cataract-surgery/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-10/phase-2-data-of-tthx1114-shows-promise-for-improving-post-dso-visual-recovery-rate/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-06/glaukos-completes-enrollment-of-phase-3-corneal-cxl-trial-for-keratoconus/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-30/latinos-en-optometry-unveils-new-branding/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-16/cognition-therapeutics-ind-for-geographic-atrophy-earns-fda-ok/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-14/atsena-receives-fda-fast-track-designation-for-xlrs-gene-therapy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-02/alcon-launches-clareon-panoptix-pro-iol-in-the-us/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-20/aaoptometry-to-host-regional-retina-summit-in-indianapolis/ 2026-04-03T11:35:05Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-29/fda-approves-tenpoint-s-yuvezzi-as-first-dual-agent-presbyopia-drop/ 2026-02-04T19:47:45Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-17/vsy-biotechnology-receives-us-patent-for-spectacle-free-cataract-technology/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-27/which-is-better-for-dr-diagnosis-annual-or-biennial-screenings/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-07/fda-grants-orphan-drug-designation-to-aavantgarde-s-stargardt-gene-therapy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-28/newton-s-sequel-lenses-now-available-through-vsp/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-18/check-vision-home-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-16/hpmc-injections-for-hypotony-show-vision-restoration-potential/ 2026-01-16T21:08:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-09/leadership-watch-vital-tears-brightstar-form-joint-medical-advisory-board/ 2026-03-17T16:16:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-08/headache-relief-linked-to-neurolens-patients-study-finds/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-04/fda-grants-ind-clearance-for-bluerock-s-primary-photoreceptor-disease-cell-therapy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-17/the-dry-eye-society-of-the-americas-launches-as-new-nonprofit/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-01/novel-3d-printing-technique-for-artificial-eyeballs-offers-faster-alternative/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-28/ftc-adds-final-compliance-targeted-updates-to-eyeglass-rule/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-14/new-ird-genetic-testing-maps-mutations-to-improve-diagnoses/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-13/oertli-releases-updated-os-4-surgical-platform/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-20/debate-back-omega-3s-dry-eye-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-28/survey-women-optometrists-report-higher-burnout-and-stress/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-17/how-impactful-is-light-color-on-our-internal-clock/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-10/another-way-treat-amblyopia-besides-patching-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-15/fda-clears-heidelberg-engineering-s-spectralis-flex-module-for-ophthalmic-imaging/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-11/formosa-to-ship-clobetasol-propionate-to-us-for-commercialization/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-14/breathing-technique-may-reduce-stress-iop-in-glaucoma/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-08/beacon-therapeutic-raises-usd170m-for-xlrp-gene-therapy-development/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-11/rinsada-s-irrigating-eyelid-retractor-targets-ocular-surface-restoration/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-21/aoa-survey-finds-ods-favored-to-perform-yag-capsulotomy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-23/retinal-markers-may-detect-parkinson-s-years-in-advance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-07/vital-tears-names-joseph-tauber-md-as-chief-medical-officer/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-29/fda-amends-spa-for-ocular-therapeutix-phase-3-wet-amd-trial/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-21/fda-approves-eylea-hd-for-vision-threatening-retinal-diseases/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-01/apple-s-myopia-focused-health-feature-is-now-available/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-04/case-report-a-rare-occurrence-of-caruncle-and-conjunctival-argyrosis/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-05/fda-grants-fast-track-designation-to-okyo-pharma-s-ncp-therapeutic/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-11/positive-topline-phase-2-data-pced-treatment/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-19/closing-2022-fda-approval-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-12/new-research-investigates-uveoscleral-outflow-technology-for-oag/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-17/four-year-data-supports-prima-subretinal-implant-in-ga-patients/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-06/north-america-projected-to-dominate-ophthalmic-drug-market/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/aaopt-launches-first-issue-of-clinical-insightsin-eyecare/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-03/fda-grants-breakthrough-therapy-designation-to-nacuity-s-rp-tablets/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-21/high-myopia-early-glaucoma-causing-vf-defect-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-16/nanoscope-plans-for-phase-3-trial-on-stargardt-macular-degeneration/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-05/neurolens-introduces-new-vr-based-binocular-measurement-device/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-25/complement-therapeutics-begins-patient-dosing-in-ga-gene-therapy-trial/ 2026-03-25T20:09:45Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-30/smartphone-based-vr-therapy-may-benefit-amblyopia-patients/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-07/iris-registry-based-data-predicts-significant-iop-response/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-31/ai-optics-receives-fda-510-k-clearance-for-handheld-retinal-imaging-system/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-19/pandorum-technologies-secures-usd11m-to-advance-corneal-regenerative-therapy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-29/hoya-vision-care-introduces-anti-reflective-lens-coating-technology/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-31/bausch-lomb-launches-seena-ophthalmic-diagnostic-system/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-09/lenz-and-thea-partner-on-canadian-commercialization-of-presbyopia-eye-drop/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-18/asrs-reports-safety-concerns-over-apellis-syfovre/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-21/aao-validates-teleretinal-screening-for-effective-dr-detection/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-19/vision-expo-east-is-moving-to-orlando/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-17/samsara-vision-reports-6-month-postop-data-on-sing-imt-for-amd/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-31/eyenovia-and-sgn-nanopharma-partner-on-nanoparticle-platform-based-cyclosporine-for-dry-eye/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-28/foundation-fighting-blindness-partners-with-bluerock-therapeutics-on-ird-study/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-01/bausch-lomb-unveils-2025-state-of-dry-eye-survey-results/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-06/vision-expo-2026-to-debut-new-programming-and-optical-advancements/ 2026-03-06T11:55:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-13/study-identifies-eye-surgeon-shortage-in-rural-us/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-30/visible-genomics-amd-genetic-tests-target-early-disease-detection/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-01/why-do-patients-congenital-blindness-visual-processing-activity-brain/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-05/caffeine-reduce-myopia-progression-children-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-05/single-vision-lens-approach-targets-myopia-management/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-21/consuming-more-calcium-may-decrease-amd-risk/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-25/fda-grants-rmat-designation-to-veongen-s-stargardt-therapy/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-16/pine-pharmaceuticals-issues-voluntary-recall-of-ocular-products/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-19/aoa-foundation-and-perc-alliance-reveal-recipients-of-inaugural-golden-opportunity-award/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-04/warby-parker-fined-usd1-5m-over-hipaa-violations-after-cyber-attacks/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-10/assessing-the-efficacy-of-trabeculectomy-for-neovascular-glaucoma/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-15/could-dr-screenings-benefit-cvd-detection/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-25/how-common-fuchs-corneal-dystrophy-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-22/benefits-strab-surgery-weekly-glance/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-11/cassini-launches-market-s-first-digital-cataract-surgery-suite/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-07/misight-1-day-lens-7-year-data-supports-long-term-myopia-control/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-25/investors-and-key-therapeutic-areas-are-determining-the-state-of-the-ophthalmic-market/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-01/viatris-launches-ryzumvi-in-the-united-states/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-13/fda-accepts-ocuphire-nda-for-nyxol-to-treat-rm/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-25/amazon-launches-online-subscription-service-generic-drugs/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-16/high-myopes-face-increased-pco-risk-with-hydrophilic-iols/ 2026-03-16T20:20:08Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-01/target-enrollment-achieved-in-trial-for-rp-associated-with-usher-syndrome/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-25/zeiss-earns-fda-approval-for-ct-lucia-621p-monofocal-iol/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-23/tanfanercept-fails-ded-phase-3-trial-primary-endpoints/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-25/unity-biotechnology-s-dme-candidate-shows-positive-phase-2-study-results/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-11/bausch-lomb-purchases-elios-vision/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-05/does-yag-capsulotomy-increase-dr-risk/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-21/focus-vitamins-launches-pf-artificial-tears-for-dry-eye/ 2026-01-21T20:09:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-30/genentech-releases-72-week-data-on-vabysmo-for-rvo/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-25/sight-sciences-debuts-omni-edge-surgical-system/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-07/kols-eye-the-future-of-genetic-engineering-and-cell-transplantation/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-04/study-supports-reduced-dosing-for-doxycycline-alternative-in-mgd/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-02/aoa-inducts-new-leadership-during-2025-optometry-s-meeting/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-23/could-white-blood-cells-be-a-dme-biomarker/ 2026-01-07T22:55:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-14/lenz-therapeutics-submits-nda-for-presbyopia-eye-drop/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-28/fda-approves-alembic-s-difluprednate-0-05-generic/ 2026-01-29T16:52:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-29/air-pollution-exposure-may-lead-to-increased-risk-for-cataract-development/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-22/leadership-watch-j-and-j-and-rebion-appoint-new-executives/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-08/scope-introduces-optase-hylo-forte-dry-eye-drops/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-15/meta-reportedly-buys-minority-stake-in-essilorluxottica/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-29/topcon-names-former-genentech-exec-as-chief-medical-officer/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-22/aoa-debriefs-on-optometric-legislative-and-advocacy-updates/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-24/fda-approves-new-eylea-hd-indication-expanded-dosing-intervals/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-07/negative-dry-eye-symptoms-linked-to-silicone-hydrogel-lenses/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-19/could-insulin-eye-drops-provide-corneal-healing/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-09/leadership-watch-staar-surgical-names-co-ceos-acet-adds-to-board/ 2026-02-09T12:42:38Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-26/cms-grants-triesence-transitional-pass-through-reimbursement-status/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-23/positive-topline-data-reported-in-phase-3-dme-trial-of-ocs-01-eye-drops/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-27/eyes-on-eyecare-launches-inaugural-eyes-on-myopia-event/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-24/national-eyecare-organizations-launch-campaign-against-nei-consolidation/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-09/eyes-on-eyecare-debuts-first-in-person-meeting/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-12/novel-research-supports-ai-led-screenings-for-dr/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-14/fda-clears-huidagene-s-ind-for-crispr-rna-editing-namd-therapy/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-15/high-altitude-exposure-may-actually-benefit-dr/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-07/new-research-identifies-additional-dr-signs-in-the-retina/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-12/lots-of-amd-news-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-09/tarsus-releases-new-phase-2-data-on-tp-03-for-mgd/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-18/ocular-therapeutix-reports-positive-phase-3-sol-1-superiority-data-for-wet-amd/ 2026-02-18T12:33:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-03/new-world-medical-debuts-new-ahmed-clearpath-glaucoma-device/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-26/analysis-finds-follow-up-for-pvd-has-a-critical-window-of-time/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-05/alcon-to-acquire-staar-surgical/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-31/consider-accepted-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-15/ded-patients-may-be-more-prone-to-psychiatric-conditions/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-28/exercise-help-dry-eye-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-13/zeiss-launches-collaborative-care-digital-app-for-flexible-ecp-coordination/ 2026-03-13T10:56:05Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-02/avisi-raises-usd10-7m-to-advance-study-on-visiplate-glaucoma-device/ 2026-03-02T20:06:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-20/iridex-launches-next-gen-pascal-laser-with-micropulse-to-us-market/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-27/court-sides-with-regeneron-eylea-patent-case-against-novartis/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-11/cornea-and-contact-lens-skills-symposium-kicks-off-this-september/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-08/generic-brimonidine-ophthalmic-solution-launches-for-iop-reduction/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-31/babys-eyes-stay-blue-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-08/fda-approves-gland-pharma-s-otc-extra-strength-pataday-generic/ 2026-01-20T17:01:44Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-23/ai-system-found-to-match-and-surpass-human-ophthalmologists/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-04/avulux-migraine-glasses-added-to-federal-pediatric-medical-device-accelerator/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-28/fda-declines-bla-approval-for-regeneron-s-high-dose-aflibercept/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-29/harrow-officially-acquires-triesence-nda/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-14/correlating-chalazion-vitamin-a-deficiency-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-11/novabay-to-commercialize-amniotic-tissue-allograft-as-avenova-allograft/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-17/lupin-launches-lotemax-generic-suspension-in-the-us/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-03/ocular-anesthetic-fda-approval-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-29/eyecare-companies-offering-support-to-la-wildfire-victims/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/vti-presents-1-year-data-on-naturalvue-mf-1-day-for-pediatric-myopia-control/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-28/apv-launches-free-vision-screening-training/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-26/dual-action-drug-targets-dme-and-amd/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-18/topical-vs-soft-steroid-drops-which-is-more-effective-for-post-cataract-inflammation/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-22/fda-determines-aldeyra-s-adx-2191-nda-submission-lacks-substantial-evidence-of-effectiveness/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-20/eyes-on-eyecare-ceo-honored-as-mm-m-s-top-40-under-40/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-18/vialase-reports-24-month-data-on-first-in-human-study-for-flight/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-24/researchers-identify-severe-glaucoma-via-lamina-cribrosa-pores/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-13/optic-neuritis-is-on-the-rise-among-specific-patient-demographics/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-06/amsler-grid-test-effectiveness-wet-amd-under-question/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-24/ags-2026-highlights-best-practices-for-surgery-and-new-evidence-based-innovations/ 2026-02-24T17:10:05Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-06/national-keratoconus-foundation-raises-awareness-ahead-of-world-kc-day/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-20/atsena-releases-favorable-lighthouse-trial-data-on-xlrs-gene-therapy/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-07/chromatic-myopic-blurs-may-be-a-new-myopic-control-therapy/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-14/gensight-biologics-releases-3-year-follow-up-data-on-lumevoq-for-lhon/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-05/eyes-on-2025-showcases-the-industry-s-upcoming-innovations/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-07/viatris-seals-deal-two-ophthalmic-acquisitions/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-23/regenxbio-reports-positive-phase-2-bilateral-wet-amd-data/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-15/visionix-usa-introduces-latest-customized-lens-edging-technology/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-15 /amazon-receives-fda-warning-for-selling-7-unapproved-eye-drops/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-29/nordic-pharma-launches-authorized-generic-of-maxitrol/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-28/viatris-appoints-new-ceo/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-10/sightpath-medical-now-owns-lasik-provider-pennvista/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-18/is-thermal-pulsation-effective-for-mgd-in-dry-eye/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-16/phase-4-data-on-cequa-indicates-significant-ded-improvements/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-03/eyepoint-begins-dosing-in-phase-3-dme-trials-for-duravyu/ 2026-03-03T12:17:17Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-24/updated-eyeglass-rule-officially-takes-effect/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-02/topical-ivermectin-exhibits-positive-safety-profile-for-demodex-blepharitis/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-19/positive-24-month-data-reported-in-phase-3-study-of-izervay-for-ga/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-31/women-with-osteoporosis-more-prone-to-amd-development/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-10/texas-court-blocks-vision-plan-law-limiting-vbms/ 2026-03-10T18:45:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-02/association-pseudotumor-cerebri-tetracycline-antibiotics-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-17/fda-issues-third-crl-to-aldeyra-rejecting-reproxalap-nda/ 2026-03-19T18:14:49Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-21/ai-based-systems-target-amd-screening-progression/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-27/how-does-social-media-impact-academic-performance-of-ophthalmic-research/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-03/cataract-surgery-reimbursement-costs-might-be-undervalued-for-some-patients/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-08/allysta-completes-enrollment-phase-2b-3-oasis-1-trial-aly688-ded/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-23/fda-grants-orphan-drug-designation-to-bluerock-s-rp-cell-therapy/ 2026-01-23T12:24:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-27/ocular-therapeutix-initiates-first-pivotal-trial-of-implant-for-wet-amd/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-08/lumithera-receives-first-cpt-code-for-retina-based-pbm-therapy/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-03/fda-accepts-tenpoint-s-brimochol-pf-nda-for-presbyopia/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-02/fda-issues-warning-against-unapproved-b-l-copycat-eye-drops/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-15/ior-partners-names-leading-cataract-refractive-surgeon-as-strategic-advisory-board-chairman/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-14/restasis-goes-generic-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-30/palatin-reports-symptom-resolution-phase-3-data-for-ded-eye-drop/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-15/los-angeles-county-optometric-society-calls-for-donations-to-help-wildfire-victims/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-08/glaukos-idose-tr-implant-assigned-permanent-j-code/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-29/aldeyra-reports-positive-topline-data-from-rp-trial-on-adx-2191/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-30/bausch-lomb-to-acquire-xiidra-from-novartis/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-07/samsung-introduces-color-mode-for-cvd-individuals/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-06/new-data-supports-novasight-s-binocular-eye-tracking-device-for-amblyopia-control/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-20/eclipse-life-sciences-launches-phase-2-trial-on-dme-steroid-implant/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-15/daily-contacts-for-healthier-eyes/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-04/implant-treat-macular-degeneration-weekly-glance/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-03/euclid-vision-visionary-optics-launch-optometric-resident-scholarships/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-02/johnson-and-johnson-names-industry-exec-as-president-of-vision-care/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-07/large-scale-study-identifies-key-risk-factors-post-cataract-endophthalmitis/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-31/new-phase-3-data-compares-efficacy-of-lumify-pf-to-lumify-drops-for-ocular-redness-reduction/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-09/ocugen-s-ind-amendment-gets-fda-ok-for-phase-3-rp-gene-therapy-trial/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-09/casexglobal-partners-with-clinical-ai-and-ior-partners-on-ai-based-clinical-trials-for-obs-centers/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-25/vsp-vision-kicks-off-cross-country-mobile-clinic-tour/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-14/noninvasive-imaging-technique-may-improve-ocular-disease-diagnosis-and-treatment/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-10/air-pollutants-linked-to-increased-amd-risk/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-22/therapeutic-contact-lens-market-expected-to-more-than-double-by-2033/ 2026-01-07T22:56:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-05/do-ocular-allergies-negate-impact-of-pediatric-ortho-k/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-21/potential-link-identified-between-glaucoma-and-low-intracranial-pressure/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-14/why-mgd-and-dyslipidemia-may-go-hand-in-hand/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-19/polyactiva-reports-positive-phase-2-data-on-biodegradable-glaucoma-implant/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-14/patients-aren-t-understanding-online-cataract-surgery-resources/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-08/bill-seeks-to-improve-medical-device-access-for-visually-impaired/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-16/atropine-efficacy-may-be-influenced-by-race-eye-color/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-02/okyo-s-urcosimod-demonstrates-long-term-stability-for-ncp/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-09/tinnitus-affect-eyes-weekly-glance/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-21/j-and-j-vision-sight-sciences-add-to-executive-teams/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-19/nanotechnology-targets-blindness-via-gene-therapy/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-24/minnesota-passes-od-scope-of-practice-expansion-legislation/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-25/which-lifestyle-factors-influence-pediatric-dry-eye/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-13/are-glaucoma-obstructive-sleep-apnea-connected/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-26/fda-clears-endogena-s-ind-for-ga-investigational-compound/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-20/kuria-therapeutics-completes-fda-pre-ind-consult-for-ced-candidate/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-01/new-findings-support-brightstar-therapeutics-corneal-allograft-for-lscd/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-15/istar-medical-launches-trial-on-the-use-of-migs-device-with-cataract-surgery/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-26/zenni-optical-now-offers-contact-lens-ordering-of-top-brands/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-07/fda-approves-lupin-s-bromsite-generic-equivalent-for-postop-inflammation-and-pain/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-18/optos-and-toku-partner-to-add-ai-based-bioage-to-uwf-imaging/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-07/do-corticosteroids-cause-cataracts-in-anterior-uveitis/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-31/ophthalmology-tech-forum-to-showcase-groundbreaking-industry-innovations/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-03/staar-surgical-appoints-new-ceo-amid-leadership-changes/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-12/iris-partners-with-aeye-health-for-ai-based-dr-screening/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-11/ocular-waste-recycling-reveals-potential-key-to-stargardt-blindness/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-24/first-of-its-kind-study-examines-ocular-manifestations-in-ms/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-20/ai-captures-new-retinal-biomarker-for-systemic-disease/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-23/could-tamsulosin-be-effective-for-ted-related-eyelid-symptoms/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-15/new-mexico-governor-vetoes-optometric-scope-of-expansion-bill/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-29/rocklatan-rhopressa-moving-weekly-glance/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-09/bausch-lomb-launches-asana-gas-permeable-lenses/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-14/another-fda-approval-weekly-glance/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-01/aldeyra-and-abbvie-agree-to-exclusive-licensing-option-for-reproxalap/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-15/how-does-exercise-impact-iop-levels/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-01/naegis-pharma-secures-financing-to-advance-retinal-disease-candidate/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-29/study-irds-are-on-the-rise-in-the-united-states/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-13/study-assesses-anti-vegf-impact-on-early-dr-treatment/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-20/fda-approves-to-glaukos-epioxa-cxl-ilink-therapy/ 2026-02-16T18:48:59Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-22/arpa-h-launches-eye-transplantation-program/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-10/okyo-pharma-submits-nda-for-neuropathic-corneal-pain-treatment/ 2026-01-26T22:05:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-01/new-genetic-mutation-may-be-root-cause-of-severe-childhood-glaucoma/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-03/ai-system-detects-severe-rop-with-100-accuracy/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-22/clearside-exploring-options-to-advance-suprachoroidal-delivery-platform/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-10-03/glaucoma-medication-market-weekly-glance/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-31/viridian-releases-phase-3-topline-data-on-elegrobart-for-ted/ 2026-04-01T10:56:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-16/dr-contact-lens-digital-ordering-solution-earns-national-ranking/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-05/iveena-submits-ind-to-fda-for-pediatric-myopia-clinical-trial/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-11/lambdavision-raises-usd7m-to-advance-space-based-artificial-retina/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-18/beyeonics-launches-beyeonics-one-ophthalmic-exoscope-with-invisible-light/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-31/lenz-therapeutics-and-corxel-release-positive-phase-3-presbyopia-data-from-china/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-21/topcon-invests-in-medtech-startup-s-microdosing-drug-delivery-system/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-18/study-links-suicide-to-visual-impairment/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-18/experts-weigh-in-on-key-trends-in-anterior-segment-innovations/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-01/chronic-stress-linked-to-increased-amd-risk/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-02/belite-bio-reports-phase-3-topline-data-on-oral-tinlarebant-for-stargardt-disease/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-04/outlook-therapeutics-releases-12-week-data-on-bevacizumab-formulation-for-amd/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-16/ev-tears-point-to-potential-keratoconus-cause/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-30/fda-approves-allergan-s-twice-daily-dosing-drops-for-presbyopia/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-03/leadership-watch-kala-bio-names-new-ceo-aurion-biotech-promotes-execs/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-24/positive-data-supports-dot-spectacle-lenses-for-pediatric-myopia-control/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-28/positive-safety-review-phase-1-study-sbi-100-glaucoma/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-06/alcon-to-launch-new-reusable-toric-lens/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-27/new-report-projects-increased-prevalence-of-myopic-and-visual-impairment-in-the-us-by-2050/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-10/ascrs-names-new-executive-director/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-11/topcon-and-beekeeper-ai-partner-to-develop-ai-solutions-for-eyecare-data/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-21/rain-eye-drops-launches-dispenser-aid-for-single-use-drops/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-15/fda-agrees-to-spa-for-ocular-therapeutix-npdr-registrational-trial/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-10/antidepressant-use-may-lower-amd-risk/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-22/eyexora-launches-with-focus-on-accelerated-ophthalmic-asset-development/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-30/study-patients-stop-wet-amd-therapy-one-year-without-vision-loss/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-10/aura-startup-design-phase-3-trial-bel-sar-early-stage-cm/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-06/new-diagnoses-of-crao-may-share-common-indicator/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-19/could-glp-1-receptor-agonists-reduce-amd-risk/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-23/bausch-lomb-novaliq-release-second-phase-3-data-for-nov03/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-13/cli-research-finds-opticians-are-key-to-better-vision-and-contact-lens-care/ 2026-03-13T18:12:26Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-15/researchers-identify-link-between-scoliosis-and-ocular-health/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-12/investigational-drug-may-block-diabetic-eye-disease/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-04-03/tenpoint-s-yuvezzi-launches-to-the-us-commercial-market/ 2026-04-03T15:11:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-16/lenz-therapeutics-and-graphite-bio-are-merging-to-focus-on-presbyopia/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-19/bostonsight-adds-new-immersive-training-to-fitacademy-program/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-10/eversight-launches-new-preloaded-dmek-endoglide/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-10/opus-genetics-doses-first-patient-in-lynx-3-phentolamine-0-75-study/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-08/alcon-to-purchase-lumithera/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-19/could-a-low-bmi-actually-lead-to-poag/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-05/skipping-nighttime-pillows-may-lower-iop-for-glaucoma-patients/ 2026-03-05T19:42:41Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-02/fda-approves-anda-for-lupin-s-allergic-conjunctivitis-eye-drop/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-01/enrollment-opens-for-clearside-biomedical-s-odyssey-phase-2b-trial-for-wet-amd/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-19/sydnexis-names-long-time-industry-executive-as-new-leader/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-10/potential-treatment-could-manage-uveal-melanoma/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-20/alzheimer-s-significantly-tied-to-vitreous-fluid-biomarkers/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-06/alcon-s-smartcataract-cloud-based-app-now-commercially-available/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-22/lumithera-submits-fda-de-novo-request-for-valeda-light-delivery-system/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-28/aetna-adds-curesight-as-medically-necessary-for-amblyopia/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-22/fda-yenovia-nda-mydcombi-in-office-mydriasis/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-16/iridex-launches-next-gen-platform-of-iridex-lasers/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-03/fda-grants-rmat-designation-to-beacon-therapeutics-xlrp-gene-therapy/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-29/regenxbio-shares-2-year-data-on-one-time-injected-gene-therapy-for-wet-amd/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-14/fda-clears-rayner-s-sophi-phacemulsification-system/ 2026-01-20T12:03:43Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-14/dims-spectacle-lenses-may-mitigate-pediatric-myopia/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-22/new-consensus-guidelines-published-for-suprachoroidal-space-injections/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-11/link-identified-between-ocular-drifts-and-cognitive-processes/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-12/bausch-lomb-launches-preservision-areds-2-formula-mini-soft-gels-with-coq10/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-30/fda-grants-fast-track-designation-for-drug-farm-s-rosah-syndrome-asset/ 2026-02-11T15:30:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-13/naturally-occurring-compound-may-prevent-contact-lens-related-bacterial-complications/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-18/optos-unveils-advanced-silverstone-rgb-uwf-imaging-system/ 2026-01-07T22:56:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-07/fda-grants-onl-therapeutics-ind-for-rrd-ophthalmic-solution/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-19/opthea-concludes-enrollment-concludes-for-pivotal-wet-amd-phase-3-trial/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-03/bausch-lomb-and-ripple-therapeutics-partner-to-develop-sustained-release-implants/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-30/alcon-s-tryptyr-launches-to-the-us-market/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-24/positive-24-month-data-supports-the-elios-system-for-glaucoma-treatment/ 2026-03-24T10:58:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-03/automated-vision-testing-kiosks-face-concerns-amid-national-expansion/ 2026-02-04T17:22:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-14/leadership-watch-new-appointments-at-eoe-owl-and-eyecool/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-04/retinal-differences-identified-in-schizophrenia-patients/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-21/voiant-acquires-ai-based-ophthalmic-image-analysis-startup-voxeleron/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-15/glaucoma-subtype-linked-to-smoking-and-visual-impairment/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-09/gentex-acquires-esight-to-develop-next-gen-electronic-eyewear/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-06/new-iowa-legislation-grants-ods-access-to-anesthesia-injections/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-10/vision-loss-lawsuit-targets-hubble-contacts/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-06/eyedaptic-introduces-ai-powered-smart-glasses-for-amd/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-02/fda-accepts-kala-pharmaceuticals-ind-application-for-pced-treatment/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-11/cequa-s-onset-of-action-trial-demonstrates-rapid-ocular-surface-benefits/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-21/novabay-partners-with-eyeganics-for-otc-organic-eye-drop/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-07/aldeyra-resubmits-reproxalap-nda-for-ded/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-13/hcp-cureblindness-marks-200-000-corneal-transplants/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-29/multiprovider-financing-now-available-for-cofi-s-carecredit-credit-card/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-13/oculis-initiates-phase-2b-relief-trial-on-ocs-02-for-ded/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-06/could-rhngf-treatment-benefit-long-term-nk-corneal-recovery/ 2026-03-06T20:32:57Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-13/report-glaucoma-linked-blindness-has-declined-since-2000/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-02/hubble-launches-new-silicone-hydrogel-daily-contact-lenses/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-04/vsp-vision-now-offers-exclusive-vision-plans-for-aarp-members/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-11/global-iol-injector-maker-debuts-line-of-sustainable-single-use-instruments/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-12/c-light-earns-fda-clearance-for-retinal-eye-movement-monitor/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-31/intravitreal-injections-risk-pcr-weekly-glance/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-02/study-demonstrates-accuracy-of-new-platform-for-comparing-ai-based-dr-screening-systems/ 2026-02-02T12:28:24Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-21/cigna-updates-policy-to-cover-canaloplasty-and-trabeculotomy/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-02/new-diabetic-oral-therapy-targets-early-intervention/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-15/coopervision-white-paper-emphasizes-early-myopia-intervention/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-23/researchers-uncover-new-muscular-data-to-target-eyelid-and-blinking-rates/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-09/staar-surgical-and-alcon-terminate-proposed-merger/ 2026-01-09T13:49:59Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-23/eversight-and-emmecell-biotech-partner-on-advanced-regenerative-ocular-cell-therapy/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-24/how-accurate-are-consumer-reviews-of-otc-eye-care-products/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-06/lumenis-launches-optilift-to-address-lower-lid-laxity-and-impaired-blinking/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-26/viatris-eye-care-division-launches-new-youtube-channel/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-22/aao-report-reaffirms-ongoing-support-for-slt/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-25/nicox-and-glaukos-sign-global-licensing-option-for-glaucoma-and-retinal-candidate/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-12/glaukos-and-radiusxr-partner-with-topcon-on-vf-testing-platform/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-04/optic-disc-edema-may-favor-one-gender/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-17/how-geographically-accessible-are-eye-care-services-for-patients/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-03/rare-side-effects-reported-following-novartis-amd-drug-use/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-14/more-evidence-omega-3-supplements-weekly-glance/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-23/retinal-clinical-trials-underrepresent-minorities/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-19/bascom-palmer-launches-whole-eye-transplant-project/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-11/botox-may-be-the-new-strabismus-surgery-for-pediatric-ace/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-17/regenxbio-to-globally-expand-pivotal-trials-for-wet-amd-gene-therapy/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-05/sight-sciences-reports-new-data-from-gemini-extension-trial-on-omni-surgical-system/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-30/aoa-report-analyzes-ocular-risks-of-glp-1ras/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-20/should-amd-be-classified-as-a-panretinal-disease/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-23/ga-growth-rate-linked-to-imaging-biomarkers/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-27/aoa-launches-educational-prototype-for-eye-health-awareness-campaign/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-18/proposed-utah-bill-restricts-contact-lens-prescribing/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-28/1-800-contacts-launches-digital-eyewear-retail-store/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-17/merck-officially-enters-ophthalmic-space-with-eyebio-acquisition/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-06/haag-streit-launches-corneal-map-for-the-lenstar-900/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-02/researchers-establish-link-between-dr-and-serum-albumin/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-19/dr-risk-may-significantly-increase-with-low-hemoglobin-levels/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-21/jjv-showcases-vision-made-possible-other-key-initiatives-at-optometry-s-meeting-2024/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-27/novartis-ianalumab-earns-fda-breakthrough-therapy-designation-for-sjoegren-s-disease/ 2026-01-27T12:44:49Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-24/how-effective-is-eccentric-viewing-training-for-amd/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-10/phase-3b-data-supports-superior-tear-response-with-tryptyr/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-20/prevalence-of-ocular-events-from-elahere-usage-and-management-strategies/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-30/physical-chemistry-mechanism-may-fight-against-amd/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-22/ocutech-to-launch-limited-release-of-ultrasonic-sensor-device/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-07/kahalari-phase-3-extension-trial-data-published-on-miebo/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-21/how-effective-is-repeat-slt-in-reducing-iop/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-20/alcon-debuts-rebranded-dslt-device-surgical-products-and-new-data/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-20/nanoscope-s-optogenetic-therapy-demonstrates-visual-improvements-for-stargardt/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-14/zeiss-debuts-new-research-data-platform-for-integrated-workflows/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-05/nanoscope-names-former-iveric-bio-ceo-as-chairman-of-the-board/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-17/migraines-could-indicate-higher-likelihood-for-cscr-development/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-30/thea-open-innovation-galimedix-collaborate-for-gal-101-development-and-commercialization/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-01/harrow-launches-vigamox-in-the-us/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-05/fda-accepts-viridian-s-veligrotug-bla-for-ted/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-07/fda-approves-iveric-bio-s-izervay-for-ga/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-10/how-reliable-are-vr-devices-for-visual-field-testing/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-23/topcon-invests-in-okko-health-s-home-vision-monitoring-platform/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-25/phoenix-micron-and-artikode-collaborate-on-ai-based-ophthalmic-imaging/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-31/quantel-medical-introduces-lightweight-handheld-pachymeter/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-10/benefits-cataract-surgery-obvious-weekly-glance/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-05/fda-approves-clobetasol-propionate-solution-for-postop-inflammation-and-pain/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/positive-1-year-data-reported-in-altitude-gene-therapy-trial/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-16/real-world-data-supports-tepezza-for-dysthyroid-optic-neuropathy/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-10/leopard-trial-of-ocs-01-eye-drops-for-cme-enrolls-first-patient/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-09/pediatric-vision-screening-platform-gocheck-kids-names-new-ceo/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-18/positive-topline-data-reported-in-alcon-s-phase-3-comet-trials/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-03/new-2-year-migs-data-supports-tcor-using-the-omni-surgical-system/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-03/viatris-launches-national-consumer-campaign-for-tyrvaya/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-05/vialase-s-ide-trial-treats-first-patient-with-novel-femtosecond-laser-procedure/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-22/are-blue-light-filtering-lenses-actually-effective/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-22/ortho-k-with-bozd-most-effective-for-myopia-control/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-02/positive-6-month-results-reported-in-oasis-extension-trial-for-cls-ax/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-09/eyepoint-concludes-enrollment-for-phase-2-pavia-trial-for-npdr/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-29/fda-approves-pediatric-patient-enrollment-in-rp-lca-gene-therapy-trial/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-17/new-contact-lenses-astigmatism-weekly-glance/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-06/oct-a-determines-dme-treatment-response-to-alternative-therapies/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-20/eschenbach-optik-of-america-launches-video-magnifier-for-low-vision/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-04/zeiss-and-boehringer-ingelheim-partner-on-early-detection-prevention-of-retinal-diseases/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-30/body-posture-may-play-a-major-role-in-iop-fluctuations/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-15/tearrestore-releases-positive-topline-results-from-mgd-study/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-07/aldeyra-to-resubmit-reproxalap-nda-following-positive-phase-3-data/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-10/positive-data-reported-ongoing-phase-1-2-trial-vrdn-ted/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-01/amgen-s-acquisition-of-horizon-is-officially-back-on/ 2026-01-07T22:56:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-31/barti-launches-new-ai-guidelines-for-ehr/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-25/lumibird-launches-omnicad-osd-imaging-platform/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-22/does-visual-impairment-undermine-digital-healthcare-access/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-12/tarsus-announces-positive-phase-2a-topline-data-on-tp-03-for-mgd/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-15/harrow-launches-next-gen-atropine-formulations/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-21/eyes-on-2026-surpasses-attendance-expectations/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-25/alimera-completes-patient-enrollment-for-dme-study-on-iluvien/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-12/spyglass-pharma-reports-long-term-data-on-bimatoprost-iol-system/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-27/b-l-issues-voluntary-recall-of-certain-iols-in-envista-platform/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-18/bausch-lomb-to-purchase-acufocus/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-28/spyglass-pharma-reports-positive-18-month-data-on-glaucoma-sustained-delivery-system/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-25/study-ties-estrogen-and-menopause-to-delayed-glaucoma-diagnosis/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/fda-clears-heidelberg-engineering-s-anterior-segment-diagnostics-platform/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-05/fda-grants-spa-agreement-to-ocuphire-for-phase-3-trial-on-phentolamine-solution/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-28/opregen-phase-1-2a-trial-data-shows-promise-for-ga/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-08/fda-approves-bausch-lomb-s-teneo-excimer-laser-platform/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-28/bausch-lomb-s-envista-envy-iol-secures-canadian-approval/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-07/24-month-data-from-sahara-rct-supports-tearcare-durability-for-ded/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-14/beyeonics-vision-secures-us-patent-for-cataract-surgical-imaging-tech/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-10/first-patient-dosed-in-phase-2-ted-trial/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-08/novabay-launches-oral-supplement-for-dry-eye-health/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-24/can-aflibercept-treat-htlv-1-inflammation/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-08/identifying-the-link-between-pupil-response-and-depression/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-24/okyo-pharma-files-ind-application-for-ded-treatment/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-26/stuart-therapeutics-reports-initial-phase-3-ded-eye-drop-data/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-06/fda-rejects-outlook-therapeutics-third-bla-submission-of-bevacizumab-for-wet-amd/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-03/j-code-for-glaukos-idose-tr-takes-effect/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-01/pantheon-vision-and-eyedeal-medical-to-develop-bioengineered-corneal-implant/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-28/how-effective-are-ipl-and-heat-eye-masks-for-evaporative-ded/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-12/skye-shifting-away-from-eye-care-after-phase-2-glaucoma-study-fails/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-21/ocuvex-therapeutics-to-merge-with-visiox-pharmaceuticals/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-13/too-much-vitamin-d-may-lead-to-amd-development/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-22/eyes-on-dry-eye-raises-over-usd1k-for-sjoegren-s-foundation/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-13/foundation-fighting-blindness-to-host-ird-best-practices-webinar/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-13/reducing-risk-amd-weekly-glance/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-21/initial-fda-inspection-findings-of-recalled-eye-drops-manufacturer-indicate-14-problems/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-22/fda-accepts-lenz-therapeutics-nda-for-presbyopia-eye-drops/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-22/robot-system-for-wet-amd-may-lead-to-fewer-injection-treatments/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-17/meta-analysis-connects-pacg-to-risk-factors/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-30/does-eye-shape-determine-glaucoma-severity/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-05/onlay-transplantation-shows-potential-in-reducing-advanced-kc-risk/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-09/study-majority-of-us-counties-lack-pediatric-eye-care-specialists/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-27/opthea-fails-primary-goal-in-phase-3-wet-amd-on-sozinibercept/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-27/registration-opens-for-eyes-on-myopia-2026/ 2026-03-27T10:45:36Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-05/could-a-cxl-and-customized-prk-combo-provide-better-keratoconus-outcomes/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-24/haag-streit-previews-new-metis-ophthalmic-microscope-system/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-23/smartphone-cameras-and-ai-target-vision-loss-in-rop/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-21/eye-blinks-naturally-keep-tempo-with-music-study-finds/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-29/new-study-reports-increased-rates-of-syphilitic-uveitis/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-15/fda-approves-thea-pharma-iyuzeh-glaucoma/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-29/ziemer-usa-unveils-new-ctak-module-for-galilei-diagnostic-platform/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-02/contact-lens-bandage-material-promotes-corneal-healing/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-02/ocusoft-launches-new-antihistamine-drops-for-ocular-allergy-relief/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-03/extended-mask-wear-linked-with-worsening-dry-eye/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-27/fda-clears-novaliq-s-ind-for-niau-phase-2-trial/ 2026-01-27T18:50:57Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-08/exonate-releases-positive-eye-drop-data-in-phase-1b-2a-trial-data-for-diabetic-eye-disease/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-11/scope-s-optase-hylo-forte-dry-eye-drops-offer-long-lasting-symptom-relief/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-28/notal-vision-s-at-home-oct-for-wet-amd-demonstrates-stable-image-detection/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-12/first-patient-dosed-in-cognition-s-magnify-study-for-ga-secondary-to-dry-amd/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-15/fda-warns-righteye-of-violations-with-vision-system/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-11/opus-genetics-reports-first-in-human-trial-data-on-lca-gene-therapy/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-15/zeiss-launches-disposable-warm-eye-masks/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-14/adverum-biotech-reports-positive-data-from-phase-2-luna-study-for-wet-amd/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-08/fda-approves-eyenovia-s-mydcombi-for-mydriasis/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-12/clinicians-perform-first-fda-approved-encelto-treatment-for-mactel/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-28/aldeyra-reports-positive-data-12-month-reproxalap-trial-ded/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-24/vision-source-launches-member-dividends-initiative-program/ 2026-02-24T20:15:36Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-13/heru-debuts-pretestpro-for-its-wearable-vr-based-testing-platform/ 2026-03-14T00:45:31Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-13/fda-approves-amneal-s-prednisolone-acetate-ophthalmic-suspension/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-25/virtual-field-launches-connectivity-hub-for-instant-vf-ehr-integration/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-20/researchers-develop-smart-contact-lens-for-blood-glucose-monitoring/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-14/gmac-announces-2023-board-members-ongoing-pediatric-myopia-initiative/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-28/olleyes-introduces-remote-ophthalmic-tech-support-for-vr-vf-testing/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-28/skye-bioscience-concludes-enrollment-for-phase-2-glaucoma-oht-trial/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-27/earlier-diabetes-diagnosis-may-lead-to-worsening-dr-progression/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-02/glauconix-rebrands-as-humonix-biosciences-with-new-focus/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-20/corticosteroids-and-cataract-the-link-to-copd-and-asthma-patients/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-29/five-year-data-supports-istent-inject-as-safe-and-effective/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-27/sling-therapeutics-reports-positive-phase-2b-3-data-on-oral-small-molecule-for-ted/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-06/how-effective-is-twice-daily-pilocarpine-hcl-1-25-for-presbyopia/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-13/sun-pharma-reports-positive-phase-4-efficacy-data-on-cequa-after-restasis-for-ded/ 2026-01-14T15:10:08Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-02/do-antibiotics-lead-to-an-amd-diagnosis/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-27/allotex-submits-ide-to-fda-for-collagen-based-corneal-implant/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-10/visionix-partners-with-20-20now-on-tele-optometry/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-03/investigators-suggest-new-biomarker-targeting-vision-loss-prevention/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-17/fda-sends-warning-letter-to-regener-eyes-for-cgmp-violations-unapproved-new-drugs/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-26/could-the-retina-help-detect-early-hearing-loss/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-17/major-opticianary-organizations-announce-merger-at-vision-expo-east/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-31/top-10-glance-stories-of-2024/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-30/coopervision-names-new-leader-of-americas-division/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-16/newton-names-abb-labs-as-strategic-lab-partner/ 2026-01-20T14:22:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-27/sight-sciences-reports-positive-6-month-data-from-trial-on-tearcare-vs-restasis-for-dry-eye/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-26/essilorluxottica-debuts-transitions-powered-ray-ban-frames/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-25/could-having-reaction-eye-drop-weekly-glance/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-08/study-erg-outperforms-structural-testing-for-dr-risk-assessment/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-09/ocular-therapeutix-plans-for-nda-submission-of-axpaxli-for-wet-amd/ 2026-02-17T17:05:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-06/dry-eye-institute-launches-on-demand-and-hybrid-educational-programs/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-07/crispr-gene-editing-may-prevent-early-onset-vision-loss/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-14/genentech-names-interim-leader-as-new-ceo/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-14/regeneron-files-lawsuit-against-potential-eylea-biosimilar/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-23/ocuphire-pharma-just-purchased-opus-genetics/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-07/onpoint-vision-to-begin-phase-1-trial-on-iop-cl-magnifier-for-amd-postop/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-21/phase-3-neurotrophic-keratitis-trial-enrolls-first-patient/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-21/greater-dr-risk-identified-in-african-caribbean-patients/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-02/alcon-officially-acquires-belkin-vision/ 2026-01-07T22:57:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-31/fda-declines-approval-of-outlook-therapeutics-bla-for-wet-amd/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-09/fda-approves-novaliq-s-vevye-for-ded/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-07/bausch-lomb-demos-new-opal-online-ordering-platform/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/aao-and-fundamentalvr-partner-on-vr-ophthalmic-training-initiative/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-09/myze-funded-study-identifies-prolonged-video-game-vision-effect-in-dry-eye/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-09/study-links-dme-to-systemic-microvascular-complications-in-diabetes/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-15/real-world-study-supports-amblyoplay-as-vision-training-tool-for-pediatric-anisometropic-amblyopia/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-26/alcon-launches-unity-vitreoretinal-and-cataract-surgery-systems/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-09/4dmt-cuts-25-of-workforce-and-fast-tracks-wet-amd-gene-therapy-program/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-18/alimera-purchases-us-commercial-rights-to-yutiq/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-18/covid-19-impact-vision-depth-perception/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-12/regeneron-faces-doj-complaint-over-alleged-medicare-overcharge-of-eylea/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-10/topcon-and-microsoft-partner-on-ai-based-healthcare-platform/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-17/smartlens-secures-usd6-1-m-to-support-non-invasive-contact-lens/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-18/zimura-fda-breakthrough-therapy-designation/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-21/visirose-raises-usd3m-to-advance-rb-pdat-therapeutic-toward-regulatory-approval/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-05/research-identifies-key-risk-factors-for-ipv-related-ocular-trauma/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-10/kiora-shifts-clinical-focus-to-rare-retinal-diseases/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-10/eyes-on-glaucoma-2025-highlights-advancements-in-disease-care/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-17/aldeyra-s-reproxalap-faces-fda-concerns/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-24/fda-grants-spa-for-outlook-therapeutics-norse-eight-amd-trial/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-30/alcon-faces-penalty-over-sight-sciences-patent-infringement/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-14/aao-panel-finds-potential-iop-benefits-to-migs-cataract-combined-surgical-approach/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-04/endogena-concludes-enrollment-ahead-of-schedule-for-rp-trial/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-11/fda-approves-zeiss-s-visumax-800-with-new-smile-pro-software/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-28/regeneron-releases-2-year-data-on-aflibercept-8-mg-for-dme/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-26/data-supports-prior-findings-on-red-light-therapy-for-pediatric-myopia-management/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-10/alcon-proposes-higher-bid-for-staar-surgical-acquisition/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-22/registration-now-open-for-eyes-on-dry-eye-2026/ 2026-01-22T12:28:43Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-09/essilorluxottica-s-nuance-audio-pairs-sight-and-sound/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-21/alkeus-receives-two-rare-disease-fda-designations-for-stargardt-candidate/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-23/cdc-advises-immediate-discontinuation-ezricare-artificial-tears/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-13/voluntary-recall-issued-for-over-75k-otc-eyecare-products/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-31/the-vision-council-calls-for-optical-product-exemption-from-new-tariffs/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-29/art-optical-adds-microvault-feature-for-scleral-lens/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-06/aoa-survey-ods-embracing-myopia-management/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-18/ihealthscreen-receives-us-patent-for-ipredict-glaucoma-detection-model/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-14/study-antibiotics-not-needed-for-pediatric-pink-eye/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-19/what-is-the-highest-risk-factor-for-bacterial-keratitis/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-06/study-ded-alters-cornea-heals-post-injury/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-07/women-s-hormone-levels-impact-corneal-fluctuations/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-21/abbvie-names-longtime-executive-as-new-ceo/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-13/retinal-imaging-may-be-able-to-track-human-aging/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-08/orbis-and-heidelberg-engineering-partner-on-virtual-vision-services/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-27/ehr-based-reminders-may-bring-back-no-show-patients/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-09/women-in-eyecare-offers-collaborative-care-for-industry-members/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-25/study-identifies-risk-factors-for-myopic-macular-degeneration-progression/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-16/virtual-vision-health-introduces-new-features-for-virtual-reality-vf-headset/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-11/mgd-patients-may-benefit-more-from-topical-antibiotics/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-27/astellas-receives-permanent-j-code-for-izervay/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-21/data-affirms-tie-between-keratoconus-and-air-pollution/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-14/novasight-reports-long-term-vision-gains-in-curesight-study/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-07/foundation-fighting-blindness-appoints-new-chief-scientific-officer/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-31/astronauts-vision-weakens-on-extended-space-missions/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-25/20-20-20-rule-may-not-actually-help-digital-eye-strain/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-01/ascendis-frazier-spin-off-a-new-global-ophthalmology-company/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-12/research-explores-visual-impact-of-pterygium-in-low-light-conditions/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-20/poor-sleep-duration-may-lead-to-poag/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-27/aao-report-evaluates-validity-of-multifocal-cls-for-myopia/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-06/cholesterol-may-lead-to-earlier-dr-diagnosis/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-10/azura-gets-positive-fda-feedback-on-nda-submission-for-mgd-ointment/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-29/first-patient-dosed-in-atsena-s-phase-1-2-trial-for-xlrs/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-23/eyemd-emr-rebrands-as-optivate-with-expanded-vision/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-09/sight-sciences-releases-12-month-results-from-first-migs-analysis-of-aao-registry-real-world-data/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-28/stem-cell-therapy-trial-for-cornea-regeneration-reports-promising-short-term-data/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-26/hyperopes-may-have-a-lower-risk-for-cataracts/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-27/night-vision-tests-may-help-with-amd-prevention-treatment/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-16/alkeus-releases-positive-data-from-ongoing-phase-3-stargardt-trial/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-20/ocuterra-fails-endpoints-in-phase-2-dr-eye-drop-study/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-03/aramis-biosciences-concludes-enrollment-phase-two-trial-ded-treatment/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-05/investigators-explore-the-use-of-oct-a-for-treating-diabetic-eye-disease/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-20/fda-approves-syfovre-for-ga-treatment/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-30/apellis-to-reduce-workforce-in-support-of-syfovre-growth-prioritize-research-initiatives/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-05/bausch-lomb-launches-blink-nutritears-for-dry-eye/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-13/nearly-50-of-adults-with-keratoconus-still-facing-high-rate-of-progression/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-16/could-rar-determine-cataract-risk/ 2026-02-16T20:30:30Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-25/innovent-biologics-wet-amd-anti-vegf-meets-phase-2-primary-endpoint/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-26/alcon-offers-first-look-at-tryptyr-debuts-new-innovations-for-contact-lens-ordering-app/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-08/prevent-blindness-launches-online-advocacy-resource/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-02/what-to-keep-an-eye-on-in-2025/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-03/fda-accepts-eluminex-s-ind-for-dme-trispecific-fusion-antibody/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-27/asclepix-therapeutics-secures-usd10m-for-neovascular-retinal-disease-clinical-program/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-18/hoya-vision-introduces-binocular-upgrade-of-lifestyle-progressive-lenses/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-09/first-commercial-patients-implanted-ic-8-apthera-iol/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-07/retinal-age-gap-high-risk-patients-end-stage-kidney-disease/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-24/20-20now-and-visionix-partner-on-dr-telehealth-screening/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-20/latest-low-dose-atropine-study-in-myopic-pediatrics-contradicts-prior-research/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-27/potential-connection-identified-between-glaucoma-prs-and-retinal-defects/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-08/adaptive-focus-sunglasses-feature-dynamic-lens-for-presbyopia/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-03/eyecorps-nonprofit-seeks-to-end-preventable-blindness-in-africa/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-28/dr-causation-linked-with-reduced-oxygen-transport-to-retina/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-06/first-patient-dosed-in-phase-3-study-on-needle-and-opioid-free-sedation-for-cataract-surgery/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-05/carl-zeiss-meditec-ag-to-acquire-dorc/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-12/study-lumenis-dmst-manages-lower-lid-laxity-and-blinking-quality/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-12/researchers-call-for-standardized-dr-coding-systems/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-21/bascom-palmer-adopts-beyeonics-one-system-ophthalmic-surgery/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-15/topcon-and-remonihealth-to-advance-ai-based-chronic-eye-disease-monitoring/ 2026-01-15T21:26:20Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-16/aao-nanos-respond-to-study-on-semaglutide-naion-connection/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-06/cell-therapy-dosing-concludes-for-emmecell-s-corneal-edema-trial/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-07/foundation-fighting-blindness-to-host-webinar-on-irds-low-vision/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-28/nidek-launches-phantom-open-field-refraction-system/ 2026-01-28T12:10:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-31/optos-releases-new-uwf-color-image-modality-for-retinal-disease/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-23/tearrestore-launches-neutrawipe-eco-eyelid-cleanser/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-03/diabetic-patients-may-have-worsening-visual-outcomes-after-orbital-cellulitis/ 2026-01-07T22:57:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-30/fda-grants-expanded-clearance-for-luminopia-binocular-amblyopia-therapy/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-02/study-autonomous-ai-for-dr-testing-improves-clinical-productivity/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-12/nidek-s-mirante-scanning-laser-ophthalmoscope-launches-in-the-us/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-17/fda-clears-bvi-s-laser-endoscopic-ophthalmic-system/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-02/glaukos-submits-epioxa-nda-for-keratoconus/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-06/apotex-corp-launches-brimonidine-tartrate-ophthalmic-solution-0-1-us/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-09/fda-accepts-sbla-for-vabysmo-to-treat-rvo/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-07/study-iop-levels-are-dependent-on-the-day-of-the-week/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-27/fda-approves-vabysmo-for-rvo/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-08/independent-analysis-confirms-efficacy-of-naturalvue-mf-for-pediatric-myopia/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-10/grapes-and-eye-health-is-there-a-link/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-15/tenpoint-reports-positive-topline-data-from-phase-3-presbyopia-eye-drop-study/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-19/cdc-reports-new-fatalities-vision-loss-in-eye-drop-recall/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-23/ani-pharmaceuticals-officially-acquires-alimera-sciences/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-17/glenmark-launches-olopatadine-hcl-0-2-to-us-market/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-04/pulsesight-therapeutics-launches-with-focus-on-non-viral-gene-therapy-for-retinal-diseases/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-22/susvimo-phase-3-data-supports-sustained-efficacy-for-dr-dme/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-10/lupin-launches-bromfenac-topical-generic-equivalent-for-postoperative-inflammation-and-ocular-pain/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-30/oxurion-files-for-bankruptcy-following-failed-dme-study/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-30/pseudoexfoliation-glaucoma-is-most-prevalent-among-indigenous-populations-in-the-us/ 2026-01-30T12:16:41Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-13/huminox-biosciences-names-founder-as-new-ceo/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-09/meridian-medical-s-ophthalmic-lasers-launch-in-the-us/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-19/fda-grants-breakthrough-therapy-designation-rmat-to-aurion-s-ced-cell-therapy/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-24/leadership-update-imprimisrx-gets-new-ceo-biotissue-forms-mab/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-20/eyes-on-eyecare-presents-inaugural-eyes-on-retina-event/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-30/study-finds-atropine-has-negative-effects-post-glaucoma-surgery/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-16/verkazia-available-weekly-glance/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-26/clinical-outcomes-support-jjv-s-violet-filtering-iol-for-glaucoma/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-12/eyes-on-eyecare-accelerates-growth-with-new-leadership-appointment/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-12/allovir-and-kalaris-to-form-retinal-disease-focused-company/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-03/nidek-and-hoya-vision-care-launch-global-partnership/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-09/opthea-appoints-new-cfo-other-senior-leadership-positions/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-08/daily-hour-of-screen-time-increases-myopia-risk-by-nearly-25/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-22/topcon-officially-debuts-the-institute-for-digital-health/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-29/dopavision-reports-topline-data-in-photobiomodulation-myopia-trial/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-19/new-alliance-seeks-a-shift-in-healthcare-via-ai-based-oculomics/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-27/eyecare-partners-adds-daniel-miller-md-phd-to-executive-team/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-08/real-world-survey-on-naion-diagnostics-reveals-no-standardization/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-07/aoaexcel-endorses-visionhq-s-in-office-patient-membership-plans/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-03/nanoscope-releases-key-efficacy-data-from-phase-2b-trial-for-rp/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-05/haag-streit-launches-metis-900-surgical-control-center/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-14/fda-approves-celltrion-s-eylea-bisoimilar/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-20/aviceda-submits-ind-for-avd-104-to-treat-ga-secondary-to-amd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-30/j-and-j-expands-us-rollout-of-tecnis-odyssey-iol/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-16/johnson-and-johnson-vision-announces-new-regional-leaders/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-08/apple-adds-new-myopia-focused-health-features-to-devices/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-03/what-to-know-about-akorn-pharma-s-bankruptcy/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-24/new-light-filtering-eyeglasses-may-reduce-migraines/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-08/registration-opens-for-the-american-retina-forum-with-eyes-on-eyecare-2026/ 2026-02-02T16:54:50Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-16/okyo-pharma-reports-favorable-phase-2-data-for-ncp-asset/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-30/forsight-robotics-raises-usd125m-to-advance-robotic-ophthalmic-surgical-platform/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-14/is-ranibizumab-be-more-effective-for-rop-than-laser-therapy/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-29/amring-names-new-coo-forms-us-medical-advisory-board/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-19/brightstar-therapeutics-secures-financing-for-groundbreaking-corneal-disease-treatment/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-30/is-weekly-or-daily-atropine-more-effective-for-pediatric-myopia-management/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-09/clearside-biomedical-positive-results-oasis-trial-wet-amd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-27/fda-accepts-oxular-s-ind-for-dme-treatment/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-07 /could-3d-eye-scans-determine-kidney-health/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-05/analysis-identifies-risk-factors-for-mnv-exudative-amd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-30/preterm-born-adults-may-be-more-at-risk-for-strabismus/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-03/coopervision-adds-synergeyes-specialty-contact-lens-portfolio/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-16/essilorluxottica-demos-advanced-eyewear-with-hearing-technology/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-28/short-term-sunlight-exposure-impacts-pediatric-myopia-development/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-03/stress-leads-to-iop-increase-in-glaucoma-patients/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-02/how-effective-is-nanodropper-in-reducing-topical-medication-waste/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-24/alcon-launches-voyager-dslt-in-the-us/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-03/researchers-identify-long-term-risk-factors-of-vf-progression-in-glaucoma/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-24/lenz-raises-millions-in-financing-for-advancement-of-presbyopia-trials/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-11/updates-from-aaopt-2023-day-1/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-25/registration-opens-for-eyes-on-glaucoma-2024/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-03/gene-therapeutic-approach-has-potential-to-treat-various-eye-diseases/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-12/researchers-identify-genetic-overlap-between-cscr-and-amd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-31/aoaexcel-to-host-financial-wellness-workshop-for-optometrists/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-30/smoking-among-factors-linked-to-retinal-vessel-trait-changes/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-10/first-patient-enrolled-pivotal-phase-3-trial-nyxol-presbyopia/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-10/eyepoint-releases-positive-6-month-data-from-phase-2-dme-trial/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-12/leadership-watch-haag-stret-heidelberg-and-samsara-name-new-executives/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-08/oculis-reports-positive-topline-data-for-phase-3-trial-of-ocs-01-eye-drops/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-03/brim-biotechnology-enrolls-first-patient-in-des-trial/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-21/eyefinity-introduces-integrated-pm-and-ehr-platform/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-14/eyebio-presents-positive-data-on-restoret-from-amarone-trial-for-dme-and-wet-amd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-01/twice-daily-betamethasone-eye-drops-reduces-postop-pain-and-inflammation/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-18/provectus-launches-visirose-to-commercialize-rb-pdat-for-severe-infectious-keratitis/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-25/united-states-ophthalmologist-workforce-is-declining/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-02/how-does-peripheral-defocus-impact-pediatric-myopia-development/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-01/new-therapeutic-may-benefit-dme-in-the-long-term/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-18/ogs-unveils-2023-world-sight-day-challenge/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-01/visionary-optics-launches-europa-tangent-scleral-lens/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-05/fda-tentatively-approves-gland-pharma-s-brimonidine-tartrate-0-025-generic/ 2026-03-10T11:18:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-10/bausch-lomb-receives-fda-premarket-approval-for-stablevisc-ovd/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/updates-from-aaopt-2023-day-2/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-13/apellis-names-retinal-specialist-as-chief-medical-retina-advisor/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-30/gmac-launches-free-myopia-awareness-toolkit-for-ecps/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-20/wayne-state-receives-usd2-1m-grant-for-diabetes-eyesight-damage-study/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-13/aviceda-raises-usd207m-to-support-phase-3-testing-of-avd-104-for-ga/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-31/character-biosciences-raises-usd93m-to-advance-genetics-based-amd-therapeutics/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-07/new-research-supports-efficacy-of-ai-in-home-oct-monitoring/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-14/low-cost-tech-could-lead-to-at-home-oct-systems/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-20/how-successful-are-pediatric-glaucoma-procedures/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-09/norlase-earns-fda-clearance-for-echo-green-pattern-laser/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-10/lenz-therapeutics-reports-positive-phase-3-data-for-presbyopia-eye-drops/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-11/orbital-and-preseptal-cellulitis-are-on-the-rise-in-the-us/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-11/first-patient-dosed-in-oculis-phase-3-trial-of-ocs-01-for-dme/ 2026-01-07T22:57:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-21/cost-effective-hiv-drug-may-improve-vision-in-dme-patients/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-14/opthea-releases-phase-2b-trial-results-of-opt-302-and-lucentis-for-wet-amd/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-26/lenz-therapeutics-merges-with-graphite-bio/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-25/oculus-launches-easyfield-vr-headset-in-the-us/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-10/clearside-biomedical-reports-positive-topline-phase-2b-data-on-clx-ax-for-wet-amd/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-15/fda-clears-ai-diagnostic-screening-dr/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-16/retinai-and-boehringer-ingelheim-partner-for-ai-based-ga-treatment/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-08/registration-opens-for-eyes-on-dry-eye-2024/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-11/low-dose-atropine-shows-benefits-for-pediatric-myopia-progression/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-03/bausch-lomb-adds-new-executives-to-leadership-team/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-15/mediwhale-raises-usd12m-in-funding-for-ai-based-retinal-scanning-tech/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-23/could-an-eye-drop-compound-replace-injections/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-14/10-year-analysis-examines-sex-disparities-among-cataract-surgeons/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-18/csc-may-get-a-protected-boost-from-spironolactone/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-20/myopia-management-navigator-targets-global-advancements-in-care/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-27/johnson-and-johnson-vision-earns-fda-clearance-for-elita-femtosecond-laser/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-26/zeiss-earns-fda-510k-clearance-for-the-visulas-yag-laser/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-18/new-digital-image-capture-system-available-for-baxter-s-panoptic-plus-ophthalmoscope/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-16/retina-themed-pyramid-game-to-feature-all-star-ecp-lineup/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-23/fda-extends-recall-to-delsam-pharma-s-artificial-eye-ointment/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-09/essilor-adds-new-progressive-lens-to-varilux-series/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-05/could-rare-genetic-variants-be-the-cause-for-amd/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-19/kodiak-sciences-concludes-enrollment-for-phase-3-dr-on-tarcocimab/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-19/registration-now-open-for-eyes-on-cataract-and-refractive-2025/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-21/lighthouse-guild-selects-accessibility-innovator-as-new-leader/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-05/lawsuit-filed-against-vsp-alleging-optometric-market-power-abuse/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-27/social-determinants-of-health-tied-to-vision-loss/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-12/galimedix-kicks-off-phase-1-study-on-oral-therapy-for-ocular-neurodegenerative-diseases/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-03/myopia-may-delay-dr-development-and-progression/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-05/alcon-officially-purchases-lumithera/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-09/disparity-in-pediatric-ophthalmology-care-is-on-the-rise/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-16/pilocarpine-and-night-driving-don-t-mix-well/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-09/tarsus-fda-acceptance-nda-tp-03/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-11/digitaloptometrics-partners-with-eyoto-to-expand-telehealth-platform/ 2026-03-14T00:46:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-16/revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/ 2026-03-16T11:03:08Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-23/complement-therapeutics-ga-gene-therapy-ind-receives-fda-clearance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-20/international-panel-proposes-new-criteria-diagnosing-optic-neuritis/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-25/fda-approves-tarsus-s-xdemvy-for-demodex-blepharitis/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-13/coopervision-launches-initiative-to-address-myopia-management-access-disparities/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-08/cheaper-version-lucentis-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-16/fda-grants-ide-approval-for-avisi-s-glaucoma-treatment-device/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-12/new-treatments-dry-eye-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-03/eyes-on-retina-2024-features-hot-topics-and-global-attendees/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-17/illinois-passes-vision-plan-protection-legislation/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-23/study-identifies-10-year-postop-outcomes-of-canaloplasty-for-oag/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-12/dilation-reversal-drops-available-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-19/aoa-responds-to-florida-s-not-a-doctor-legislation/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-19/anti-cancer-drug-use-may-lead-to-neuro-ophthalmic-issues/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-20/national-study-assesses-risk-of-uveitis-after-covid-vaccination/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-11/new-phase-3-data-supports-eylea-hd-for-macular-edema-following-rvo/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-18/eye-drop-treat-mgd-horizon-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-20/does-aspirin-reduce-the-risk-for-dr-development/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-14/fda-accepts-revised-snda-of-izervay-for-ga/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-29/iris-registry-identifies-key-factors-for-post-cataract-iop-spikes/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-11/here-s-why-you-shouldn-t-miss-eoe-s-first-ever-in-person-meeting/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-05/ametek-purchases-lkc-technologies/ 2026-02-06T19:06:39Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-17/bruder-healthcare-is-now-the-exclusive-licensor-of-ded-relief-drink/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-05/nidek-s-np-t-preloaded-toric-iol-injection-system-makes-global-debut/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-02/amneal-receives-fda-approval-for-restasis-generic/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-05/study-links-scleral-lens-and-increased-iop-to-keratoconus/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-12/positive-4-year-data-reported-from-phase-3-champ-study-for-pediatric-myopia/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-11/study-envista-aspire-iol-delivers-expanded-intermediate-vision-without-sacrificing-distance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-06/bausch-lomb-launches-biotrue-hydration-boost-cl-rehydrating-drops/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-14/newly-launched-ocular-gene-therapy-company-targets-blinding-retinal-diseases/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-17/fda-grants-anda-approval-for-brimonidine-tartrate-and-timolol-maleate-0-2-or-0-5/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-24/gene-therapy-restores-vision-loss-in-primates/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-21/preservative-freedom-coalition-is-targeting-ocular-surface-awareness/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-20/amgen-purchasing-horizon-therapeutics/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-24/fda-accepts-nda-submission-for-glaukos-s-epioxa/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-13/fda-approves-updated-label-for-izervay-to-treat-ga/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-26/evoq-launches-fda-registered-dark-adaptation-testing-device-for-irds/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-31/glaucoma-patients-may-be-more-likely-to-develop-dementia/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-23/leadership-watch-qlaris-vsp-ffb-and-sightglass-share-updates/ 2026-03-25T15:27:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-02/aldeyra-to-resubmit-nda-for-reproxalap-ded-treatment/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-07/nidek-introduces-the-rs-1-glauvus-oct-system/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-02/bausch-lomb-officially-acquires-xiidra-from-novartis/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-24/study-urges-alternative-tracking-for-wet-amd-poor-responders/ 2026-03-24T19:08:12Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-05/amring-pharmaceuticals-is-now-nordic-pharma/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-30/generic-version-of-durezol-launches-in-us/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-25/cms-assigns-syfovre-a-permanent-j-code/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-20/harrow-unveils-new-direct-to-prescriber-cash-pay-program-for-branded-products/ 2026-03-06T17:14:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-17/fda-approves-anda-for-lupin-s-bromfenac-ophthalmic-solution-0-09/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-19/glaukos-epioxa-now-commercially-available-in-the-us/ 2026-03-23T18:13:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-11/coopervision-announces-myopia-management-updates-and-plans/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-10/bvi-reports-first-us-implantations-of-finevision-hp-trifocal-iol/ 2026-02-11T11:58:53Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-22/fda-approves-genentech-s-susvimo-for-dr/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-22/renew-prescription-online-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-12/fda-grants-510-k-clearance-to-topcon-s-robotic-maestro2-for-octa/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-31/high-myopes-may-be-associated-with-non-glaucomatous-optic-atrophy/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-06/potential-pattern-identified-between-alcohol-and-glaucoma/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-13/mitochondrial-homeostasis-therapy-shows-potential-as-glaucoma-treatment/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-21/are-eye-drops-the-new-injections-for-rvo/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-26/aviceda-reports-topline-data-from-siglec-trial-for-ga/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-14/fda-grants-rmat-designation-for-atsena-s-lac1-gene-therapy/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-13/topcon-healthcare-launches-new-customer-care-portal/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-22/increased-likelihood-of-keratoconus-noted-among-autistic-patients/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-28/fda-grants-510-k-clearance-to-norlase-s-lynx-pattern-scanning-lio/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-31/apellis-releases-update-on-review-of-syfovre-retinal-vasculitis-cases/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-11/iron-overload-may-increase-glaucoma-risk/ 2026-02-11T21:22:31Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-17/fda-rejects-chiesi-group-s-nda-for-lhon-oral-drug/ 2026-03-17T16:13:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-03/hello-2022-weekly-glance/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-27/veo-ophthalmics-and-perivision-launch-visionone-ai-vf-platform-in-the-us/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-29/boehringer-partners-with-re-vana-on-extended-release-ophthalmic-therapeutics/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-05/johnson-and-johnson-unveils-tecnis-odyssey-presbyopia-correcting-iol/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-02/montana-passes-od-scope-expansion-for-laser-procedures/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-07/aao-and-rpb-announce-award-recipients-for-iris-registry-research/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-29/lilly-to-purchase-adverum-biotechnologies/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-30/iridex-enrolls-first-patient-in-micropulse-tlt-glaucoma-study/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-10/opthea-names-senior-leaders-ahead-of-phase-3-wet-amd-data-readout/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-28/second-annual-optometry-innovation-awards-showcase-top-3-winners/ 2026-01-07T22:58:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-26/ocusoft-launches-retaine-omega-forte-for-dry-eye/ 2026-01-26T20:11:32Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-13/first-ever-corneal-health-summit-kicks-off-in-april/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-03/longtime-declining-global-trachoma-rate-now-on-the-rise/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-01/fda-clears-first-ever-fully-autonomous-ai-portable-dr-screening/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-13/ocular-therapeutix-releases-12-month-topline-data-from-phase-1-wet-amd-trial/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-04-01/biogen-is-purchasing-apellis/ 2026-04-01T19:58:36Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-05/research-investigates-teprotumumab-effect-on-ocular-alignment-in-ted/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-06/migs-rising-popularity-is-shifting-glaucoma-candidate-demographics/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-14/pykus-concludes-study-enrollment-for-post-rd-surgery-retinal-sealant/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-27/voluntary-recall-issued-for-eye-ointments-due-to-lack-of-sterility/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-19/research-identifies-link-between-ded-and-chronic-pain/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-12/fda-grants-501-k-clearance-for-the-first-synthetic-non-degradable-tissue-sub-for-ophthalmic-surgery/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-07/exclusive-license-agreement-ocuphire-develop-commercialize-nyxol/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-17/eyesbio-expands-financing-for-advanced-development-of-restoret/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-17/ocular-therapeutix-releases-positive-npdr-phase-1-data-plans-for-wet-amd-repeat-dosing-study/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-22/amgen-purchase-of-horizon-delayed-after-ftc-lawsuit/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-16/belite-bio-concludes-enrollment-for-phase-3-ga-trial-on-oral-tinlarebant/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-04/first-patient-enrolled-in-azura-s-phase-3-mgd-trial-for-azr-md-001/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-18/clearside-biomedical-releases-plans-for-wet-amd-odyssey-trial/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-09/fda-accepts-outlook-therapeutics-bevacizumab-bla-for-wet-amd/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-10/majority-of-glaucoma-patients-have-no-record-of-gonioscopy/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-12/flacs-versus-phaco-which-is-more-advantageous/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-02/kala-s-phase-2b-pced-trial-fails-to-meet-primary-goal/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-30/regeneron-receives-fda-crl-delaying-eylea-hd-sbla-approval/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-26/leadership-update-spyglass-lumata-health-and-horizon-surgical-report-changes/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-19/lumenis-unveils-updates-to-digital-duet-slt-yag-platform/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-22/infantsee-program-to-host-pop-up-workshops-for-young-ods/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-15/dr-reddy-s-olopatadine-hcl-0-7-launches-as-first-to-market-generic/ 2026-01-15T19:17:28Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-30/aoa-advises-on-eye-safety-guidelines-amid-air-quality-alerts/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-16/study-finds-low-dose-aspirin-ineffective-for-amd/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-24/topcon-invests-in-sanro-health/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-07/do-omega-3s-and-dha-actually-reduce-amd-risk/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-01/new-data-finds-increased-prevalence-of-refractive-surgery-among-cataract-patients/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-10/oculus-smartfield-perimeter-launches-into-space/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-23/bausch-lomb-acquires-trukera-medical/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-01/nicox-selects-biotech-exec-for-ceo-as-clinical-focus-shifts/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-02/fgh-science-launches-lidrevive-pro-lash-and-eyelid-shampoo-for-ocular-surface-health/ 2026-03-05T11:51:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-28/fda-scrutiny-of-unapproved-cxl-trials-reveals-critical-lapses-in-patient-safety-and-regulatory-adherence/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-26/is-lotilaner-for-demodex-effective-at-1-year/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-08/bausch-lomb-launches-second-annual-glaucoma-awareness-campaign/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-01/happy-new-year/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/exhibit-hall-highlights-from-aao-day-3/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-29/novel-in-office-suprachoroidal-surgical-approach-targets-retina-detachment/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-18/abbvie-and-ripple-therapeutics-to-develop-glaucoma-intracameral-implant/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-06/first-corneal-tissue-transplants-successfully-performed-in-african-country/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-16/real-world-data-confirms-long-term-efficacy-of-omni-surgical-system-for-poag/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-14/beta-zone-ppa-may-be-major-glaucoma-disease-marker-for-black-patients/ 2026-01-14T22:41:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-12/tenpoint-therapeutics-launches-with-focus-on-regenerative-medicine-for-degenerative-ocular-diseases/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-19/botox-injections-may-actually-help-treat-ded/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-03/study-reaffirms-omega-3s-lack-benefits-for-ded/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-10/alcon-launches-first-fully-personalized-lasik-treatment/ 2026-01-08T19:01:21Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-19/vti-reports-data-from-defocus-curve-study-with-mature-presbyopes/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-26/bruder-healthcare-bolsters-dry-eye-portfolio-with-allergy-test/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-18/which-is-more-effective-for-astigmatism-toric-iols-or-fsak/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-29/smart-contact-lenses-target-uv-protection-and-temperature-change/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-26/prevent-blindness-kicks-off-rop-awareness-week-with-new-program/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-25/nanoscope-updates-regulatory-status-of-rp-optogenetic-therapy/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-12/clinicians-are-under-utilizing-this-ai-based-dr-screening-system/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-03/bruder-to-rebrand-and-distribute-retaine-mgd-eye-drop-in-the-us/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-22/kodiak-is-restarting-its-tarcocimab-clinical-program-for-three-retinal-disease-indications/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-03/early-glaucoma-med-adherence-predicts-long-term-patterns/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-11/can-non-iop-factors-determine-glaucoma-progression/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-14/fda-approves-bausch-lomb-s-en-vista-envy-iol/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-10/bostonsight-introduces-scleral-lens-fitting-consultation-program/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-19/harrow-purchases-north-american-commercial-rights-to-santen-s-ophthalmic-brands/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-09/reduced-kidney-function-may-impact-amd-progression/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-05/how-accurate-are-at-home-vision-tests-for-wet-amd/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-26/are-blue-light-filtering-iols-beneficial-for-amd/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-18/bausch-lomb-launches-envista-aspire-iol-in-the-us/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-13/harrow-partners-with-asembia-for-expanded-branded-ophthalmic-product-access/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-27/oculogyx-introduces-ai-platform-to-boost-clinical-practice-efficiency/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-24/new-class-of-therapeutics-may-treat-retinal-diseases/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-20/keeler-usa-long-grove-pharmaceuticals-to-distribute-ak-fluor-amidst-us-shortage/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-11/increased-risks-wearing-mask-vitrectomy/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-08/avisi-reports-positive-6-month-data-on-visiplate-aqueous-shunt-for-glaucoma/ 2026-02-26T18:41:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-15/new-light-study-data-assesses-longer-term-slt-for-glaucoma-and-oht/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-21/haag-streit-usa-launches-metis-3d-digital-heads-up-module/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-04/new-and-improved-eyes-on-career-fair-to-launch-in-january/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-02/anatomical-brain-changes-noted-in-patients-with-restored-vision/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-10/j-and-j-s-new-ird-global-registry-targets-real-world-data-accessibility/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-14/reason-not-smoke-weekly-glance/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-29/california-legislators-kill-od-bill-seeking-increased-scope-of-practice-again/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-03/alcon-voluntarily-recalls-systane-lubricant-eye-drops-ultra-pf/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-10/why-do-macular-holes-spontaneously-close/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-17/visionix-unveils-next-gen-auto-lensmeter-and-verification-system/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-28/omega-3s-could-be-key-in-preventing-amd-alzheimer-s-vision-loss/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-06/serious-risks-drops-treat-presbyopia-weekly-glance/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-15/fda-grants-atsena-rare-pediatric-disease-designation-for-xlrs-gene-therapy/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-07/cofi-raises-usd3-5-million-for-multi-party-payment-platform-expansion-of-elective-surgeries/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-09/blood-type-may-determine-retinal-structures/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-26/annexon-releases-topline-data-for-phase-2-ga-study/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-19/oasis-launches-soft-plug-extended-duration-180-t-tapered-plug/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-04/4dmt-releases-60-week-phase-2-analysis-on-wet-amd-gene-therapy/ 2026-02-10T12:17:20Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-24/gmac-launches-myopia-awareness-summer-campaign/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-22/researchers-test-chatgpt-on-retinal-disease-clinical-guidelines/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-03/fda-rejects-aldeyra-s-reproxalap-nda-for-a-second-time/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-15/b-l-launches-zenlens-chroma-hoa-scleral-contact-lenses/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-23/opthea-selects-global-retinal-leaders-for-medical-advisory-board/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-19/zeiss-showcases-expanded-ophthalmic-portfolio-of-digital-tools/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-08/fda-approves-kiora-to-start-phase-2-study-of-kio-101/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-19/latest-industry-updates-know-weekly-glance/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-24/registration-opens-for-eyes-on-dry-eye-2025/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-10/nanoscope-to-submit-optogenetic-therapy-bla-for-rp/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-06/aviceda-doses-first-patient-with-avd-104-in-phase-2-study-for-ga/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-17/notal-vision-receives-fda-de-novo-clearance-for-scanly-home-oct/ 2026-01-07T22:58:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-14/positive-data-supports-use-of-non-invasive-contact-lens-for-iop-monitoring/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-26/blinkjoy-launches-rechargeable-heat-mask-for-dry-eyes/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-24/short-term-data-reported-case-series-sing-imt-amd/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-24/dme-risk-may-decrease-with-use-of-glp-1-agonists-and-fenofibrates/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-21/gensight-biologics-reports-4-year-efficacy-and-safety-data-on-lumevoq-for-lhon/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-19/oct-a-reveals-retinal-findings-after-parkinson-s-disease-diagnosis/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-13/how-effective-is-ortho-k-in-slowing-al-growth-for-pediatric-myopia/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-06/researchers-update-the-areds-simplified-severity-scale/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-22/coffee-and-tea-may-be-beneficial-for-your-macula/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-11/brim-biotechnology-submits-ind-for-neurotrophic-keratitis-study/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-22/fda-clears-selagine-s-immunoglobulin-ded-drops-for-phase-2-trial/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-10/teclens-study-treats-first-patient-for-noninvasive-refractive-vision-correction/ 2026-03-10T11:19:06Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-11/wet-amd-progression-decreases-with-dietary-zeaxanthin/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-06/luminopia-raises-usd16m-to-support-amblyopia-binocular-digital-therapeutic/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-13/nanodropper-now-operating-as-mu-medical-a-precision-eyecare-platform/ 2026-01-13T20:53:31Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-07/comorbidities-decrease-glaucoma-med-adherence-over-time/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-09/investigators-develop-new-strategy-for-glaucoma-cell-replacement-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-07/is-there-a-link-between-peripheral-neuropathy-and-ded-risk/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-19/air-pollution-exposure-leading-to-more-ocular-disease-cases-among-adults/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-27/fda-warns-against-use-of-unapproved-amniotic-fluid-eye-drops/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-22/ftc-warns-ecps-of-legal-action-for-potential-contact-lens-rule-violations/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-07/research-suggests-retinal-health-is-dependent-on-eye-color-genes/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-10/warmer-regions-linked-to-serious-vision-issues-in-older-adults/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-20/top-10-glance-stories-of-2023/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-26/fda-adds-new-warning-to-tepezza-label/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-18/zeiss-showcases-clarus-700-with-icga-for-uwf-imaging/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-10/formosa-and-aimmax-submit-joint-nda-for-ocular-pain-and-inflammation/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-16/fda-clears-ocugen-for-phase-2-3-trial-on-stargardt-gene-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-07/adverum-biotechnologies-raises-usd127-5-million-for-gene-therapy-pipeline/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-13/fda-issues-warning-letters-to-8-companies-over-unapproved-eye-products/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-11/vevye-is-officially-available-in-the-us/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-22/latinos-en-optometry-officially-launches/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-19/fda-approves-expanded-age-indication-for-staar-s-evo-evo-visian-icls/ 2026-02-23T12:12:18Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-01/earlier-onset-amd-linked-to-high-bmi-other-risk-factors/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-15/orcam-introduces-ai-powered-device-for-low-vision-and-visual-impairment/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-19/copy-glasses-prescription-weekly-glance/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-18/fda-accepts-regeneron-s-eylea-hd-sbla-for-priority-review/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-26/eyecare-partners-names-new-ceo/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-08/sightglass-unveils-18-month-data-on-dot-spectacle-lenses-for-myopia/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-22/dompe-receives-fda-priority-voucher-for-naion-intranasal-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-14/could-rnfl-changes-and-vessel-density-detect-pseudoexfoliation-glaucoma/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-19/fda-expands-tepezza-indication-for-ted-patients/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-01/preventing-certain-light-exposure-may-decrease-ird-risk/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-17/glaukos-reports-phase-3-topline-data-on-epioxa-for-keratoconus/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-22/core-launches-environmental-focused-eyewear-education-website/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-03/research-finds-limited-benefits-of-outdoor-exposure-for-premyopic-children/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-19/coave-therapeutics-debuts-lead-scs-gene-therapy-for-retinal-vascular-diseases/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-04/haag-streit-usa-names-new-ceo/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-18/caeregen-awarded-usd1-4-m-grant-to-advance-regenerative-therapeutic-for-retinal-diseases/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-01/harrow-to-purchase-melt-pharmaceuticals/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-12/south-dakota-governor-signs-optometric-scope-of-expansion-bill/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-11/nationwide-survey-links-regular-drinking-with-poag/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-09/travoprost-implant-shows-robust-iop-lowering-in-phase-3-study/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-29/topcon-healthcare-names-new-ceo-and-president/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-03/cli-publishes-full-report-on-generational-contact-lens-and-eyewear-preferences/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-04/researchers-develop-clinical-decision-tool-for-ga-treatment/ 2026-02-05T12:09:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-18/study-identifies-link-between-anterior-chamber-angle-status-and-lebcs-in-poag/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/clinical-perspective-from-aao-day-2/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-22/dryeye-rescue-adds-new-hybrid-digital-display/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-09/cognition-therapeutics-data-phase-2-trial-ga-dry-amd/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-06/sandoz-completes-acquisition-of-coherus-s-ranibizumab-biosimilar/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-18/registration-now-open-for-eyes-on-glaucoma-2025/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/zeiss-launches-prospara-cloud-based-software-solution/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-16/beacon-therapeutics-reports-positive-24-month-phase-2-xlrp-gene-therapy-data/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-08/can-an-eye-disease-drug-fight-covid-19/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-06/aeye-health-broadens-epic-emr-integration-for-ai-eye-screening/ 2026-02-06T12:39:28Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-21/why-arent-new-glasses-working-weekly-glance/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-12/novartis-halts-clinical-development-of-ga-gene-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-18/fda-clears-opus-genetics-ind-for-best1-ird-gene-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-30/cms-assigns-permanent-j-code-for-neurotech-s-encelto-cell-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-14/nova-eye-medical-earns-us-market-clearance-for-canaloplasty-device/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-25/xdemvy-official-launches-in-the-us/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-28/immunosuppressives-diminish-slt-iop-reduction/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-15/how-safe-are-ipsc-based-rpe-strip-transplants-for-patients-with-rpe-degeneration/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-19/inmode-investors-asked-to-join-class-action-lawsuit/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-03/luminopia-s-amblyopia-treatment-earns-anthem-insurance-coverage/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/pediatric-sickle-cell-disease-study-reports-surprising-ophthalmic-findings/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-29/topcon-and-orbis-partner-to-expand-dr-screenings-in-sub-saharan-africa/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-09/bausch-lomb-and-grf-launch-glaucoma-awareness-campaign/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-05/modifiable-risk-factors-dementia-weekly-glance/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-06/canadian-ophthalmologist-receives-2024-ascrs-foundation-chang-crandall-humanitarian-award/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-26/ocuphire-releases-topline-data-from-phase-2-trial-for-dr/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-04/alternative-postop-treatment-comparable-to-standard-drops/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-14/study-dr-dme-patients-most-likely-to-miss-follow-up-care/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-28/class-action-lawsuit-filed-against-ezricare-over-artificial-tears/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-14/novartis-is-reportedly-starting-to-sell-its-ophthalmology-assets/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-16/registration-for-eyes-on-2025-is-now-open/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-12/polyactiva-and-raresight-to-advance-long-acting-therapies-for-pediatric-irds/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-17/assessing-parent-child-corneal-astigmatism-relationship/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-27/oculis-completes-enrollment-for-post-cataract-surgery-phase-3-trial/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-01/astellas-pharma-acquires-iveric-bio/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-22/researchers-identify-risk-factors-for-unplanned-or-visits-post-cataract-surgery/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-05/nordic-pharma-acquires-visant-medical-with-plans-for-dry-eye-product-launch/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-20/lutein-shows-potential-as-myopia-management-supplement/ 2026-02-20T12:19:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-11/pilot-study-compares-at-home-vs-in-clinic-glaucoma-monitoring-systems/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-30/sugar-hypothesis-of-diabetic-cataracts-may-be-a-myth/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-15/ftc-approves-final-consent-order-following-lawsuit-against-amgen-s-horizon-acquisition/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-06/shamir-launches-advanced-digital-electro-optic-measurement-system/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-14/positive-data-phase-trial-ted-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-13/fda-grants-fast-track-designation-to-aavantgarde-s-stargardt-gene-therapy/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-29/refractive-tech-startup-teclens-gets-j-and-j-investment/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-23/alcon-officially-acquires-aerie/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-19/ocular-implants-market-projected-to-reach-over-24-billion-by-2032/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-18/2023-in-review-fda-approvals-rundown/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-18/a-look-at-2024-ophthalmic-launches/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-30/norlase-raises-usd11-million-for-echo-pattern-laser-funding/ 2026-01-07T22:58:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-09/genentech-is-reintroducing-susvimo-implant-for-wet-amd-in-the-us/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-07/childhood-bmi-may-determine-risk-for-poag-development/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-02/what-to-keep-an-eye-on-in-2026/ 2026-01-12T22:20:24Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-11/leadership-watch-vialase-j-and-j-and-myze-announce-executive-additions/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-26/4dmt-reports-positive-interim-data-from-phase-1-2-wet-amd-trial/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-22/adverum-releases-positive-phase-2-data-on-wet-amd-gene-therapy/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-26/aao-adds-erg-to-preferred-practice-guidelines-for-dr/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-01/nicox-reports-favorable-iop-lowering-for-oag-in-phase-3-eye-drop-trial/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-18/atsena-and-nippon-shinyaku-to-collaborate-on-lca1-gene-therapy-in-us/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-21/diagnostic-tools-identify-early-retinal-neovascular-dysfunction-in-diabetes-patients/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-04/study-questions-ortho-k-effectiveness-over-time/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-23/blinking-may-actually-benefit-your-visual-acuity/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-03/lifestyle-habits-may-benefit-cognitive-impairment-in-glaucoma/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-06/tarsus-names-elizabeth-yeu-md-as-new-chief-medical-officer/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-26/repurposed-drugs-resistant-bacterial-eye-infections-weekly-glance/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-16/medicare-reimbursement-rates-glaucoma-procedures-decline/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-05/lifestyle-behaviors-play-major-role-in-preventing-genetic-risk-for-advanced-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-26/leadership-watch-emmecell-abo-outlook-and-heidelberg-make-changes/ 2026-01-26T16:11:01Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-06/genentech-reports-5-year-results-on-susvimo-for-wet-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-16/alcon-introduces-innovator-program-identifies-contact-lens-market-needs/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-14/are-zepto-ppc-and-ccc-comparable-in-phaco-cataract-surgery/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-20/vsp-vision-launches-student-loan-repayment-program/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-09/myopia-profile-debuts-ai-virtual-assistant-for-disease-management/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-31/health-issues-looking-eyes-weekly-glance/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-24/thermal-imaging-device-detects-ded-via-eye-temperature-monitoring/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-05/ascrs-names-vance-thompson-md-as-president/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-09/iris-registry-data-analysis-predicts-goniotomy-success-rates/ 2026-03-09T19:59:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-02/harrow-launches-three-ophthalmic-medicines-in-us/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-31/areds-supplements-may-slow-late-stage-dry-amd-progression/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-18/digitaloptometrics-previews-first-ever-advanced-autonomous-slit-lamp/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-23 /alzheimer-s-drug-may-reduce-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-28/seco-2026-highlights-ai-and-technology-advancements/ 2026-02-28T20:31:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/does-semaglutide-for-weight-loss-worsen-diabetic-eye-disease/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-16/study-identifies-key-variables-for-keratoconus-progression-risk/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-23/fda-grants-501-k-clearance-for-new-world-medical-s-kdb-glide/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-11/fda-accepts-nda-for-sydnexis-s-low-dose-atropine-for-pediatric-myopia/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-23/scientists-establish-ah-protein-database-for-vision-loss-research/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-15/fda-approves-bvi-medical-s-finevision-hp-trifocal-iol/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-15/glaucoma-research-foundation-receives-usd5m-gift-to-launch-initiative/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-04/bausch-lomb-launches-two-new-eye-drops-to-blink-portfolio/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-05/contamination-issues-reported-at-recalled-eye-products-manufacturer/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-27/eyenovia-launches-clobetasol-propionate-suspension-in-us/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-28/eating-behaviors-affect-eye-health-weekly-glance/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-19/ametek-reichert-signs-exclusive-us-partnership-for-ocular-surface-technology/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-03/pantheon-vision-reports-positive-pre-clinical-fda-meeting-on-bioengineered-corneal-implants/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-04/cellusion-receives-odd-for-bullous-keratopathy-regenerative-compound/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-11/survey-identifies-myopia-management-in-over-60-of-clinical-practices/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-16/beacon-therapeutics-to-evaluate-patented-aav-gene-therapy-for-retinal-diseases/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-15/mediprint-reports-positive-phase-2-data-on-3d-printed-drug-eluting-cl-for-glaucoma/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-04/fda-grants-odd-to-huidagene-s-ird-gene-therapy/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-03/glaucoma-research-foundation-releases-audiobook-for-visually-impaired/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-21/wave-lens-designer-software-integrates-with-topcon-myah/ 2026-01-21T12:18:38Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-07/congress-approves-physician-level-pay-scale-for-va-optometrists/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-08/leadership-watch-prevent-blindness-sightglass-and-meibum-scientific-share-updates/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-20/theianova-doses-first-patient-in-fih-trial-on-regenerative-eye-drop-for-keratoconus/ 2026-01-20T19:43:57Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-12/pediatric-amblyopia-may-indicate-more-adult-health-issues/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-09/how-will-reciprocal-tariffs-impact-the-optical-industry/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-26/alzheimer-s-biomarker-linked-to-putative-retinal-gliosis/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-13/interim-data-supports-long-term-use-of-bionic-eye-in-rp-patients/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-09/study-biotissue-s-cam-improves-recovery-following-corneal-cxl/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-22/aao-weighs-in-on-congress-passing-medicare-physician-payment-adjustment/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-20/leadership-watch-okyo-orbis-and-bvi-medical-name-new-ceos/ 2026-01-20T12:04:22Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-19/visiox-pharma-acquires-us-rights-to-omlonti/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-01/fda-approves-ml6710i-photodynamic-laser-bausch-lomb-s-pdt/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-22/retinai-launches-ai-based-platform-for-clinical-decision-workflows/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-27/case-reports-indicate-positive-outcomes-of-cam-for-osd-management/ 2026-02-27T11:11:27Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-27/fda-approves-ocuphire-and-viatris-s-ryzumvi-for-rm/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-25/samsung-bioepis-byooviz-is-now-interchangeable-with-lucentis/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-24/ihealthscreen-submits-ai-based-amd-screening-tool-to-fda-for-510-k-clearance/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-08/fda-approves-eylea-biosimilar-for-serious-retinal-diseases/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-04/fda-clears-harrow-s-ind-to-initiate-phase-3-trial-on-triesence/ 2026-03-04T16:30:38Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-14/retinalyze-debuts-new-advanced-glaucoma-progression-ai-for-disease-tracking/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-08/spyglass-pharma-releases-6-month-data-from-first-in-human-trial-for-glaucoma/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-06/experts-question-red-light-therapy-for-pediatric-myopia/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-17/aura-biosciences-reports-positive-data-from-bel-sar-trial-on-choroidal-melanoma/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-03/is-ptk-effective-for-recurrent-corneal-erosions/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-14/azura-reports-positive-data-from-phase-2-trial-on-azr-md-001-for-mgd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-14/do-you-need-to-treat-subretinal-fluid-in-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-19/aao-and-fundamentalvr-partner-to-launch-vr-education-program/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-30/myze-launches-preservative-free-daily-wipes-for-lid-hygiene/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-15/glaukos-campaign-targets-keratoconus-prevention-among-young-adults/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-05/optomed-usa-launches-next-gen-handheld-fundus-camera/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-31/opthea-terminates-wet-amd-program-for-sozinibercept/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-26/iyuzeh-launches-in-the-united-states/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-04/researchers-develop-fluorescent-gel-device-for-cataract-surgery/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-18/first-patient-dosed-phase-1-study-ced-treatment/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-22/healthycell-launches-new-ultra-absorbable-gel-supplements-for-retina-health/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-09/nanotechnology-grown-3d-retinal-tissue-could-one-day-treat-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-24/fda-approves-amneal-s-bimatoprost-0-01-generic/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-01/vizz-presbyopia-eye-drops-launch-in-the-us/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-05/long-term-study-supports-tissuetuck-technique-following-pterygium-surgery/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-16/keratitis-risk-increases-with-use-of-lung-cancer-drug/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-29/nanoparticles-may-be-a-game-changer-for-corneal-transplants/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-10/researchers-identify-link-between-e-cigs-and-uveitis/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-07/positive-topline-data-reported-in-eyepoint-s-phase-2-wet-amd-trial/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-01/registration-opens-for-eyes-on-glaucoma/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-18/fda-accepts-aldeyra-s-resubmitted-reproxalap-nda/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-25/istent-inject-with-cataract-surgery-may-reduce-glaucoma-meds/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-01/happy-new-year-2026/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-15/surface-ophthalmics-appoints-new-leader-with-plans-for-dry-eye-advancements/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-11/view-optometry-launches-to-support-independent-practices/ 2026-02-13T16:59:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-13/sonoma-pharmaceuticals-and-emc-pharma-to-co-market-expanded-eye-care-product-line/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-03/aurion-biotech-releases-topline-phase-1-2-data-on-allogenic-cell-therapy-for-ced/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-09/favorable-safety-data-supports-alkeus-oral-gildeuretinol-for-dry-amd/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-16/enrollment-concludes-for-invirsa-s-first-in-human-ded-study/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-21/does-sleep-apnea-increase-high-iop-risk/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-06/nationwide-recall-issued-for-two-more-eye-drop-products/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-10/fda-grants-rare-pediatric-disease-designation-for-vigeneron-s-rp-gene-therapy/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-12/could-melatonin-reduce-the-risk-for-amd-development/ 2026-01-07T22:58:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-21/ophthalmology-workforce-lacks-diversity-new-analysis-reports/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-19/patients-with-glaucoma-amd-may-have-increased-risk-for-systemic-conditions/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-07/hormones-may-play-key-role-in-dr-risk-among-diabetes-patients/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-06/myopia-profile-to-launch-first-ever-myopia-action-month/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-04/signaling-system-identified-zebrafish-retina-regeneration/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-09/oculis-completes-patient-recruitment-for-stage-1-of-phase-3-diamond-study-for-ocs-01-in-dme/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-02/bvi-completes-enrollment-for-ide-study-on-hydrophobic-trifocal-iol/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-29/is-secondhand-smoking-tied-to-pediatric-myopia/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-12/researchers-develop-new-oct-metric-for-detecting-glaucoma/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-12/how-effective-are-autologous-serum-tears-for-sjoegren-s-syndrome-at-50-concentration/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-09/aviceda-releases-phase-2b-topline-data-on-avd-104-for-ga/ 2026-01-09T19:17:30Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-16/new-octa-cpt-code-goes-into-effect/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-10/researchers-identify-impact-of-alzheimer-s-disease-on-the-retina/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-12/real-world-efficacy-of-dot-lenses-evaluated-for-pediatric-myopia/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-25/how-does-amblyopia-affect-amd/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-14/ocugen-announces-positive-preliminary-results-phase-1-2-trial-of-ocu400/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-22/fda-grants-sanofi-fast-track-designation-for-ga-gene-therapy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-12/hilco-vision-launches-ndemex-revitalizing-eye-serum/ 2026-03-12T11:08:46Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-20/fda-approves-initiation-of-first-inflammasome-inhibitor-trial-for-ga/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-27/rayner-to-introduce-ai-designed-spiral-iol/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-05/orasis-pharmaceuticals-submits-nda-csf-1-treatment-presbyopia/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-17/fecd-solution-targets-rescuing-corneal-cells/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-08/orasis-secures-financing-to-support-us-commercial-launch-of-qlosi/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-17/kiora-pharma-secures-ird-grant-for-late-stage-rp-trial/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-20/adhd-medication-may-lead-to-corneal-cell-changes-in-pediatric-patients/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-04/provectus-and-miamiu-sign-global-licensing-agreement-for-eye-infection-therapy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-25/systemic-factors-tied-to-retinal-microvascular-parameters-in-diabetic-patients/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-25/potential-connection-low-fat-diets-glaucoma/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-08/how-effective-is-propranolol-for-severe-rop/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-06/fda-approves-formycon-and-bioeq-s-lucentis-biosimilar/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-31/vascular-changes-emerge-in-later-mactel-stages/ 2026-03-31T20:44:35Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-17/is-low-bp-associated-with-gcc-thinning-in-glaucoma/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-17/fda-clears-heidelberg-engineering-s-spectralis-octa-module-with-shift-technology/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-03/nicox-reports-positive-phase-3-data-on-ncx-470-glaucoma-eye-drop/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-23/study-identifies-cancer-causing-chemicals-in-popular-contact-lenses/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-31/fda-grants-orphan-drug-designation-to-signablok-s-rop-therapy/ 2026-04-01T19:49:49Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-30/fda-clears-tourmaline-bio-s-ind-for-ted/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-21/researchers-tie-dr-to-cardiovascular-disease/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-15/novel-spiral-shaped-lens-targets-multifocal-capabilities/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-21/sightpath-medical-purchases-accusite-surgical/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-12/research-identifies-elevated-risk-factors-following-rvo/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-04/ftc-refunds-over-usd1m-to-bait-and-switch-lasikplus-consumers/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-08/aldeyra-reports-positive-phase-3-data-on-reproxalap-for-ded/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-03/the-vision-council-reports-q2-2024-optical-market-trends/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-12/study-ties-magnesium-to-reduced-rvo-risk/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-14/gene-therapy-may-restore-cone-function-in-color-blindness/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-27/kids-better-blinking-adults-digital-device-weekly-glance/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-23/research-identifies-link-between-menopause-and-oag/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-12/konan-medical-launches-objectivefield-visual-field-analyzer/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-07/fda-accepts-vyluma-s-nda-for-nvk002-for-pediatric-myopia/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-20/investigators-identify-new-oct-based-biomarker-for-presbyopic-accommodation/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-17/fda-accepts-nda-grants-priority-review-for-zimura/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-03/nordic-pharma-launches-lacrifill-canicular-gel-dry-eye-therapy-in-the-us/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-17/nicox-reports-positive-pre-nda-fda-meeting-for-iop-lowering-drop/ 2026-02-17T20:52:49Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-13/fda-extends-neurotech-s-bla-pdufa-date-for-mactel-therapy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-04/rayner-launches-ai-based-ophthalmic-patient-education-platform/ 2026-02-04T19:47:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-12/okyo-pharma-seeks-fast-track-designation-for-ncp-candidate/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-24/jjv-launches-acuvue-oasys-max-1-mf-contact-lens-for-astigmatism/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-15/iantrek-launches-alloflow-uveo-in-the-us/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-16/fda-clears-splicebio-s-ind-of-gene-therapy-for-stargardt-trial/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-18/fda-grants-orphan-drug-designation-for-atsena-s-xlrs-gene-therapy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-18/harrow-purchases-us-commercialization-rights-to-samsung-bioepis-biosimilar-portfolio/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-12/lumithera-valeda-system-extension-trial-data-expands-dry-amd-vision-improvements/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-08/new-cli-data-shows-generational-variance-in-contact-lens-wear/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-28/corneat-everpatch-for-ophthalmic-surgery-launches-in-the-us/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-16/nih-study-finds-gap-in-medicaid-vision-coverage-among-adults/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-12/allegro-ophthalmics-earns-fda-approval-for-intermediate-dry-amd-trial-design/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-29/googleai-chatbots-pass-ophthalmology-board-exams/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-13/thea-open-innovation-link-biologics-partner-on-ded-drug/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-02/retinal-complications-linked-to-covid-19-diagnosis/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-28/cannabis-implicated-in-ocular-inflammatory-disease-development/ 2026-01-28T22:02:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-19/horizon-releases-phase-2-trial-results-dazodalibep-sjoegren-s-syndrome/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-24/revopsis-receives-nei-grant-for-advancing-retinal-vascular-disease-candidate/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-26/global-myopia-awareness-coalition-adds-international-members/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-05/researchers-eye-tissue-3d-bioprinting/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-12/measuring-onh-vascular-density-may-diagnose-sleep-disorder/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-17/your-rundown-on-2024-fda-approvals/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-09/fda-grants-huidagene-s-hgoo4-rare-pediatric-disease-designation-to-treat-ird/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-04/retinal-imaging-may-avoid-stargardt-s-disease-misdiagnosis/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-09/topcon-invests-in-senseye-s-ocular-biomarker-based-mental-health-platform/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-05/new-dry-eye-treatments-horizon-weekly-glance/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-26/cencora-to-buy-eyesouth-partners-retina-division-in-usd1b-deal/ 2026-03-26T18:13:44Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-13/va-optometrists-secure-physician-level-pay-parity/ 2026-01-21T16:47:18Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-05/oculus-adds-dual-testing-to-easyfield-vr-perimetry-device/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-07/ani-pharmaceuticals-receives-fda-approval-for-purified-cortrophin-gel-pfs/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-17/rayner-acquires-developer-of-sophi-phaco-system/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-09/hoya-reports-6-month-data-on-miyosmart-iq-spectacle-lenses-for-pediatric-myopia/ 2026-02-09T20:19:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-30/harrow-ior-partners-expand-national-product-supply-agreement/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-08/researchers-identify-new-drug-combo-for-bacterial-keratitis/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-20/positive-24-month-data-released-for-phase-3-trials-on-syfovre/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-07/iapb-welcomes-johnson-and-johnson-vision-as-eye-health-advocacy-member/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-27/ior-partners-releases-results-from-ophthalmic-based-surgery-safety-study/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-07/contact-lenses-allergies-available-yet-weekly-glance/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-15/drinking-water-help-dry-eyes/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-01/new-technology-targets-photoreceptor-cells-to-create-a-novel-color/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-24/harrow-transfers-ndas-and-launches-5-ophthalmic-products/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-04/is-rop-risk-influenced-by-prenatal-maternal-factors/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-23/neurolens-with-contoured-prism-tech-demonstrates-greater-symptom-relief-for-binocular-vision-anomalies/ 2026-02-25T14:15:02Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-01/how-effective-are-glp-1-agonists-in-protecting-against-glaucoma/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-28/study-connects-hdl-levels-to-amd-development/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-25/alcon-to-acquire-lensar-and-its-next-gen-flacs-portfolio/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-08/carl-zeiss-meditec-ag-ceo-to-step-down/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-09/first-of-its-kind-surgery-removes-spinal-tumor-via-eye-socket/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-14/new-data-on-eylea-hd-supports-prolonged-dosing-for-wet-amd/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-12/pandorum-tech-raises-usd18m-to-expand-operations-for-bioengineered-cornea/ 2026-02-12T21:27:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-02/scope-health-debuts-optase-cloud-based-meibographer-and-digital-solution/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-05/new-research-supports-od-performed-capsulotomy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-11/how-effective-are-blue-light-filtering-iols-in-reducing-macular-atrophy/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-05/should-botox-be-considered-for-pediatric-esotropia/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-04/unique-anterior-stromal-puncture-device-targets-rces/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-30/exercise-linked-to-reduced-risk-for-cataract-development/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-11/new-retinal-neuron-subset-may-impact-vision/ 2026-01-07T22:59:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-09/seabelife-and-unither-to-formulate-and-develop-retinal-degenerative-disorder-formulation/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-08/potential-connection-ties-amd-to-higher-cvd-risk/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-27/new-oasys-town-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-11/genentech-s-vabysmo-pfs-earns-fda-approval-for-retinal-diseases/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-23/eyes-on-glaucoma-draws-more-than-2-400-eyecare-professionals/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-17/pediatric-keratoconus-may-be-more-detectable-with-anterior-segment-oct/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-23/repeat-cases-of-toxoplasmosis-favor-one-gender/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-16/bausch-lomb-names-new-returning-ceo/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-11/glaukos-reports-positive-clinical-data-phase-2a-ded-trial/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-05/samsara-vision-promotes-industry-veteran-to-coo/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-08/apellis-submit-phase-3-data-fda-pegcetacoplan-nda/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-09/nicox-enrolls-first-patient-in-phase-3b-glaucoma-trial-for-ncx-470/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-17/contact-lens-institute-offers-sneak-peek-at-new-report-identifying-cross-generational-lens-trends/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-14/virtual-vision-health-launches-visual-acuity-testing-for-vr-device/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-15/fda-oks-aavantgarde-s-ind-for-stargardt-gene-therapy-trial/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-16/orbis-and-fundamentalvr-rollout-vr-cataract-surgery-training/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-23/patients-uncontrolled-with-cyclosporine-a/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-04/vantage-purchases-ophthalmic-surgical-solutions/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-16/researchers-develop-infrared-light-sensing-contacts-for-humans/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-10/semaglutide-for-diabetes-tied-to-increased-naion-risk/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-24/phoms-may-be-prevalent-among-patients-with-intracranial-hypertension/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-03/researchers-identify-critical-drawbacks-for-uninsured-dr-patients/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-01/gene-therapy-stargardt-disease-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-22/nanoscope-reports-trial-data-on-mco-010-for-stargardt-disease/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-19/neuralink-s-blindsight-implant-receives-fda-breakthrough-device-designation/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-31/being-active-may-relieve-ded-symptoms/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-12/ophthalmology-tech-forum-2024-breaks-new-ground-in-innovations/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-01/balance-ophthalmics-earns-de-novo-classification-for-fsyx-iop-device/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-22/potential-link-identified-between-myopia-and-reading-in-the-dark/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-19/top-10-glance-stories-of-2025/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-23/essilorluxottica-purchases-retinai/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-02/why-low-blood-sugar-worsens-diabetic-eye-disease/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-26/long-term-corneal-endothelial-changes-noted-after-covid/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-02/personalized-occlusion-medical-device-targets-ded-treatment/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-09/pantheon-vision-raises-usd2-5m-to-develop-bioengineered-corneal-implant/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-04/biotissue-launches-cam360-amniograft-regenerative-therapy/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-10/do-personality-traits-play-a-role-in-ded-development/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-17/new-data-supports-hal-spectacle-lenses-for-myopia/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-30/lineage-cell-therapeutics-launches-new-ced-cell-therapy-program/ 2026-03-30T11:11:23Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-20/icymi-real-world-data-support-izervay-s-long-term-benefits/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-08/which-factors-are-most-influential-in-fuchs-visual-function/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-04/research-investigates-ai-as-a-bcva-estimator-in-dme/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-02/ocusciences-receives-fda-clearance-for-retinal-health-assessment-tool/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-28/significant-increase-noted-in-mental-health-disorders-among-macular-disease-patients/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-10/positive-long-term-data-reported-in-phase-3-trials-of-vabysmo-for-rvo/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-26/digitaloptometrics-launches-real-time-patient-translation-service/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-26/osheru-raises-usd4-7m-to-advance-blepharoplasty-surgical-device/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-17/wave-eye-care-launches-as-new-specialty-contact-lens-division/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-12/fda-grants-fast-track-designation-to-kpi-012-for-pced/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-24/analysis-global-dr-cases-on-the-rise-sparking-urgent-need-for-intervention/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-08/eyeyon-medical-secures-ide-approval-for-study-on-first-artificial-endothelial-layer/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-23/csi-dry-eye-software-selects-new-ceo/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-31/fda-clears-huidagene-for-ind-multi-national-ird-trial/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-13/here-s-what-to-know-about-aao-s-new-aop-membership-group/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-04/does-patching-after-age-4-benefit-unilateral-congenital-cataract-patients/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-04/lumithera-receives-nih-grant-for-dry-amd-extension-trial/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-29/fda-sends-warning-letters-to-4-eye-drop-manufacturers-distributors/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-07/positive-results-myopia-control-study-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-05/orbis-digital-course-trains-healthcare-workers-on-glaucoma-identification/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-15/study-examines-dme-pdr-risk-with-popular-diabetes-drugs/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-05/salvat-initiates-pediatric-study-for-post-surgery-inflammation-and-pain/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-05/alcon-debuts-new-contact-lens-ordering-app/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-23/virtualens-launches-monovision-simulation-for-vr-iol-simulator/ 2026-03-23T18:13:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-19/cli-reports-new-findings-on-consumer-digital-habits-for-contact-lens/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-28/amd-cardiovascular-disease-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-12/fda-clears-belkin-vision-s-eagle-device-for-slt/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-16/first-of-its-kind-robotic-cataract-procedure-makes-debut-at-ascrs/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-06/moking-ted-treatment-could-be-worst-case-scenario/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-25/long-term-data-finds-acoltremon-0-003-increases-tear-production-in-ded/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-09/study-finds-glaucoma-patients-are-increasingly-lost-to-follow-up/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-19/pixium-vision-is-looking-for-buyers/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-27/adhd-medications-may-lead-to-increased-glaucoma-risk/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-20/opthea-names-arshad-m-khanani-md-ma-fasrs-as-chief-medical-advisor/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-23/visual-sensitivity-loss-may-predict-dementia-years-before-diagnosis/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-12/teclens-raises-usd9-3m-in-funding-for-non-invasive-refractive-tech/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-04/iveric-bio-submits-nda-ga-treatment/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-21/alcon-unveils-total30-for-astigmatism-expanded-parameters/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-06/revival-retina-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-14/eversight-and-lightoptech-partner-on-ophthalmic-imaging-advancements/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-13/how-could-new-tariffs-impact-the-optical-industry/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-27/could-tki-use-cause-rvo-development/ 2026-03-27T20:56:14Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-14/new-contact-len-institute-research-reveals-untapped-contact-lens-demand/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-10/researchers-identify-two-new-methods-for-vf-testing/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-03/harrow-health-changes-corporate-name/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-19/ortho-k-and-atropine-combo-may-slow-pediatric-myopia/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-23/bruder-introduces-air-activated-moist-heat-eye-mask/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-01/topcon-acquires-intelligent-retinal-imaging-systems/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-25/research-argues-in-favor-of-exercise-for-healthier-retinal-vasculature-among-pediatrics/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-30/managing-ocular-emergencies-as-an-on-call-optometrist/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-07/opus-genetics-and-fda-agree-on-spa-for-phase-3-npdr-gene-therapy-trial/ 2026-02-13T20:28:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-18/ai-model-identifies-at-risk-pediatric-patients-for-rop/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-21/fda-grants-opus-genetics-rare-pediatric-disease-designation-for-lca-gene-therapy/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-06/fda-approves-neurotech-s-encelto-cell-therapy-for-mactel/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-06/harrow-announces-in-office-availability-fortisite-formulations/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-10/viridian-reports-positive-topline-data-from-phase-3-ted-trial/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-04-25/culprits-behind-photophobia-weekly-glance/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-06/heidelberg-showcases-fully-digital-surgical-visualization-platform/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-17/pixium-vision-releases-48-month-study-data-for-severe-atrophic-amd/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-05/could-ophthalmic-spray-replace-drops-for-pediatric-pupil-dilation/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-24/north-american-pharma-companies-partner-on-newborn-ophthalmic-drug-shortage/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-30/hoya-reports-8-year-data-on-dims-spectacle-lenses-for-pediatric-myopia/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-20/prevent-blindness-launches-diabetes-and-the-eye-advisory-committee/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-14/updates-from-aaopt-2023-day-3/ 2026-01-07T22:59:37Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-05/advanced-amd-linked-to-imbalanced-gut-microbiome/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-26/study-correlates-visual-impairment-with-sleep-disruptions/ 2026-02-26T23:03:28Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-26/revopsis-raises-usd16-5m-to-advance-namd-tri-specific-therapy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-04/atropine-0-05-for-myopia-shows-promise-in-5-year-lamp-study/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-05/harrow-launches-iheezo-for-ocular-surface-anesthesia/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-09/genomic-risk-factor-linked-to-amd/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-05/september-marks-global-launch-of-myopia-action-month/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-13/ace-vision-adds-new-cmo-medical-advisory-board-members-and-websites/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-11/young-dual-use-smokers-face-more-severe-ocular-symptoms/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-16/gensight-biologics-releases-1-year-data-from-phase-1-2-trial-of-rp-treatment/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-19/fda-grants-altris-ims-platform-510-k-clearance/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-07/long-term-effects-of-overminus-lens-may-include-myopic-shift/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-15/new-data-supports-hoya-s-dims-lenses-for-myopic-prevention-among-preschool-aged-pediatrics/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-10/harrow-s-iheezo-to-be-available-via-apexus-340-prime-vendor-program/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-13/need-rub-contacts-clean-weekly-glance/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-13/fda-approves-zeiss-mel-90-excimer-laser/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-04/does-socioeconomic-status-impact-pediatric-amblyopia-rates/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-22/oculis-positive-phase-2-data-ocs-02-acute-anterior-uveitis/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-06/opus-genetics-reports-positive-pediatric-data-from-lca5-gene-therapy-study/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-14/eyes-on-eyecare-s-first-annual-pathways-dry-eye-series-surpasses-expectations/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-27/do-seasonal-variations-impact-myopia-treatment-efficacy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-05/fda-approves-genentech-s-susvimo-for-dme/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-15/how-safe-is-contact-lens-wear-among-pediatrics/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-09/cdc-identifies-source-of-multistate-bacteria-outbreak-due-to-artificial-tears/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-30/national-trial-to-test-preventative-atropine-drops-for-pediatric-myopia/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-08/alcon-is-buying-belkin-vision-and-its-contact-less-slt-glaucoma-device/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-17/bausch-lomb-launches-ortho-k-lens-fitting-system/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-27/new-tvc-survey-reveals-tariff-and-inflation-impact-on-ecps/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-03/fda-clears-novoxel-s-tixel-device-for-evaporative-dry-eye-due-to-mgd/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-01/enrollment-concludes-for-vialase-s-pivotal-poag-laser-trial/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-01/inaugural-insight-by-eyes-on-eyecare-kicks-off-this-april/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-13/cms-approves-iheezo-for-transitional-pass-through-reimbursement-status/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-22/ibisvision-to-introduce-remote-vision-testing-platform/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-16/west-virginia-bill-to-change-newborn-blindness-prevention-law/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-25/peer-reviewed-study-supports-euclid-ortho-k-lenses-for-pediatric-myopia/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-15/aoa-to-host-town-hall-webinar-on-vision-plan-concerns/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-31/fda-warns-against-use-of-27-eye-drops-from-major-brands/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-20/novabay-launches-avenova-allograft-in-the-us/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/centricity-vision-launches-zeptolink-iol-positioning-system/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-19/splicebio-and-spark-therapeutics-partner-on-ird-gene-therapy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-24/glaukos-reports-positive-iop-lowering-clinical-data-on-idose-platform/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-25/spryte-medical-earns-fda-breakthrough-device-designation-for-noct-tech/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-10/arpa-h-invests-in-four-research-teams-for-eye-transplant-project/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-19/azura-releases-positive-data-from-phase-2-trial-of-azr-md-001-for-cld-mgd/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-01/researchers-develop-eye-friendly-laser-to-detect-tbi/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-05/atia-vision-presents-first-in-human-clinical-data-from-novel-iol/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-25/bausch-lomb-reports-statistically-significant-data-on-novel-dry-eye-supplement/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-08/esight-showcases-wearable-assistive-device-for-central-vision-loss/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-21/ocuphire-pharma-ousts-ceo-names-interim-leader/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-14/is-low-intensity-red-light-effective-for-myopia/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-17/phase-3-enrollment-concludes-for-oculis-dme-eye-drop-program/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-14/positive-52-week-data-supports-4dmt-s-wet-amd-gene-therapy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-05/adverum-receives-fda-rmat-designation-for-wet-amd-gene-therapy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-16/allotex-names-new-ceo-to-lead-commercialization-of-allogeneic-corneal-tissue-technology/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-29/contact-lens-institute-and-the-vision-council-unveil-new-report-on-contact-lens-culture/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-26/fda-extends-review-period-for-eylea-hd-expanded-labeling/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-22/fda-grants-nacuity-pharmaceuticals-fast-track-designation-for-rp-tablets/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-28/coburn-releases-new-hpe-990-lens-edger-for-in-office-system-use/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-05/rayner-completes-enrollment-for-us-study-on-first-ever-spiralized-iol/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-13/ocubio-introduces-personalized-autologous-serum-eye-drops/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-30/extensive-prc-study-offers-new-data-on-rare-retinal-diseases/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-06/study-identifies-vitamin-d-benefits-for-dry-eye/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-23/harrow-completes-acquisition-exclusive-us-rights-5-ophthalmic-products/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-13/are-adolescents-receiving-enough-vision-testing/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-20/data-suggest-pch-eye-drops-significantly-relieve-ded-symptoms/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-10/rxsight-launches-newest-light-adjustable-lens/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-26/eyenovia-and-senju-to-develop-chronic-dry-eye-drop-device-combo/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-21/tearrestore-launches-eyelid-serum-for-digital-eye-strain/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-14/how-does-sleep-quality-rate-among-dry-eye-patients/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-08/scope-health-brings-eyelid-health-to-forefront-with-new-pf-optase-life-eye-cream/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-01/ocuphire-reports-favorable-phase-3-data-on-ryzumvi/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-21/gene-therapy-trial-for-x-linked-rp-doses-first-patient/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-24/which-social-determinants-of-health-are-tied-to-dry-eye/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-03/regeneron-wins-eylea-patent-case/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-28/study-links-pandemic-induced-psychosocial-functions-to-visual-impairment/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-18/fda-clears-topcon-s-omnia-auto-kerato-refracto-tonometer/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-28/hoya-vision-care-launches-expanded-power-range-for-miyosmart-lenses-for-high-pediatric-myopia/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-17/viridian-reports-positive-phase-3-data-on-veligrotug-for-chronic-ted/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-17/promising-early-data-supports-rp-gene-therapy-testing/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-19/olleyes-launches-vr-based-hearing-platform-for-ecps/ 2026-02-28T18:35:18Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-18/pantheon-vision-closes-on-usd1-8m-to-advance-bioengineered-corneal-implants/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-02/versea-ophthalmics-relaunches-as-defeye-inc/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-25/bausch-lomb-names-leading-ophthalmologist-as-strategic-medical-advisor/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-04/eyepoint-doses-first-patient-in-second-phase-3-trial-of-duravyu-for-wet-amd/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-12/arctic-vision-acquires-mdco-technology-s-ophthalmic-device-business/ 2026-02-12T12:27:21Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-23/viridian-reports-long-term-durability-data-secures-fda-designation-for-ted-therapy/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-08/canine-trial-offers-pathway-to-gene-therapy-for-rp-in-humans/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-28/aldeyra-s-nda-for-reproxalap-requires-more-studies-fda-says/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-22/ftc-sends-claim-forms-in-lasikplus-provider-settlement-to-consumers/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-24/virtual-workshop-series-to-offer-dry-eye-practice-success/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-26/washu-receives-usd20m-to-fund-development-of-portable-oct-system/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-29/world-council-of-optometry-partners-with-coopervision-on-myopia-management-resource/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-25/aoa-excel-endorses-barti-software-in-first-ever-eyecare-ehr-investment/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-11/can-acupuncture-reduce-ded-post-surgery/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-11/visual-field-rebrands-as-carrot-with-broader-visual-diagnostics-focus/ 2026-03-12T15:08:10Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-20/apotex-to-receive-canadian-licensing-rights-for-harrow-s-five-branded-ophthalmic-products/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-28/aldeyra-nda-primary-vitreoretinal-lymphoma-treatment/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-09/vigeneron-rebrands-as-veongen-therapeutics-with-new-fda-designation/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-24/survey-identifies-burnout-among-cataract-surgeons/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-16/new-ai-company-optain-targets-retinal-imaging/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-29/cdc-reports-rare-cluster-of-ocular-syphilis-in-the-us/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-23/glasses-prevent-myopia-progression-weekly-glance/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-19/horizon-releases-additional-tepezza-phase-4-data-for-ted/ 2026-01-07T22:59:56Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-11/azalea-vision-performs-first-on-eye-test-of-smart-contact-lens/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-17/ior-partners-launches-md-od-surgery-partnership-model/ 2026-03-19T19:22:10Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-31/researchers-explore-10-year-outcomes-after-rrd-repair/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-20/revitalvision-makes-us-debut-with-digital-vision-enhancement-technology/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-22/artificial-vision-system-offers-groundbreaking-results-for-blindness/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-21/optometric-task-force-releases-new-report-on-dr-management/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-27/unitedhealthcare-adds-online-option-for-vision-prescription-renewals/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-02/asrs-names-new-2024-2025-president/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-16/novartis-selling-ophthalmology-franchise/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-10/orcam-adds-augmented-ai-to-myeye-device-for-low-vision/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-31/sight-sciences-wins-patent-lawsuits-against-alcon-and-ivantis/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-19/is-there-a-link-between-demodex-and-post-cataract-surgery/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-16/aoa-to-fight-florida-senate-s-not-a-doctor-bill/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-09/annual-anti-vegf-injection-costs-are-on-the-rise/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-07/ocuphire-releases-post-hoc-phase-2-data-on-dr-oral-supplement/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-26/one-dilation-drop-instead-two-weekly-glance/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-17/m-and-s-bruder-ocular-surface-analyzer-launches-in-the-us/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-29/slt-vs-drops-which-is-more-effective-for-iop-reduction/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-18/vital-dyes-may-identify-sjoegren-s-related-ded/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-26/fda-authorizes-marketing-of-essilor-stellest-eyeglass-lenses-for-myopia/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-21/researchers-link-keratoconus-to-climate-related-variable/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-05/topcon-launches-is-6500-ophthalmic-instrument-stand/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-31/researchers-uncover-promising-fda-approved-compound-that-may-benefit-pediatric-lca/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-09/ai-and-smartphone-imaging-may-detect-pediatric-eye-diseases/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-04/happy-4th-of-july/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-17/eyenovia-acquires-us-rights-to-formosa-s-app13007/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-25/do-lifestyle-habits-influence-glaucoma-risk/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-26/could-waist-size-determine-dr-risk/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-22/cholesterol-medication-may-also-reduce-dr-risk/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-03/hello-2023-weekly-glance/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-05/sydnexis-reports-phase-3-topline-data-on-syd-101-eye-drop-for-pediatric-myopia/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-27/eye-safety-tips-you-need-to-know-ahead-of-the-solar-eclipse/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-05/fda-grants-authorization-to-lumithera-s-valeda-system-for-dry-amd/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-21/fda-clears-neolight-s-icon-go-portable-ophthalmic-retinal-imaging-system/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-11/lilly-gains-exclusive-global-rights-to-meiragtx-s-ophthalmic-genetic-therapies/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-22/coopervision-recalls-biofinity-sphere-cls-in-singapore/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-17/new-covid-19-subvariant-exhibits-key-ocular-symptoms-in-pediatric-patients/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-04/happy-4th-of-july-2025/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-27/glaukos-submits-nda-for-idose-tr/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-06/harrow-reports-52-week-data-from-phase-3-vevye-extension-study/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-22/fda-declines-regeneron-s-eylea-hd-sbla-for-extended-dosing/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-31/younger-mds-weigh-in-on-slt-vs-eye-drops-for-poag/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-24/saliogen-therapeutics-s-gene-coding-therapy-targets-stargardt-disease/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-29/advancing-the-understanding-of-geographic-atrophy/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-07/fda-accepts-aldeyra-s-nda-for-reproxalap-for-ded/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-28/alcon-purchases-majority-stake-in-aurion-biotech/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-27/atopic-dermatitis-linked-to-increased-risk-for-amd/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/study-reexamines-sutureless-cam-for-ded-with-short-term-treatment/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-07/fda-clears-first-edof-contact-lens-for-presbyopia/ 2026-01-12T12:09:07Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-05/ocular-therapeutix-to-cut-13-of-workforce/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-20/first-patient-enrolled-in-study-on-ga-secondary-to-amd/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-18/new-world-medical-earns-fda-clearance-for-via360-surgical-system/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-13/eyenovia-releases-positive-data-optejet-glaucoma-treatment/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-19/ocular-therapeutix-announces-executive-chairman-as-new-ceo/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-02/thea-acquires-exclusive-rights-to-kiora-s-ird-therapy/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-13/fda-approves-sandoz-s-eylea-biosimilar-for-wet-amd/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-28/eyenovia-proposes-merger-with-betaliq-to-form-glaucoma-company/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-11/vision-impairment-linked-dementia-cases/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-24/sun-ophthalmics-announces-philrx-partnership/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-04/viridian-submits-bla-for-veligrotug-to-treat-ted/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-24/amaros-secures-series-a-financing-for-ai-ophthalmic-evidence-platform/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-03/first-real-world-data-shows-early-promise-of-high-dose-aflibercept-for-wet-amd/ 2026-02-03T19:14:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-11/neurolens-debuts-official-rebrand-as-newton/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-13/fda-approves-rayner-s-rayone-emv-toric-iol/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-26/registration-opens-for-corneal-health-summit-2026/ 2026-03-20T19:11:00Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-19/asoa-names-ascrs-leader-as-new-executive-director/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-03-28/ded-depression-weekly-glance/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-15/fda-grants-breakthrough-device-designation-to-sightglass-vision-s-dot-spectacle-lenses/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-22/bioage-labs-expands-into-dme-clinical-program-for-oral-inhibitor-asset/ 2026-01-22T19:50:19Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-18/tearoptix-secures-funding-for-presbyopia-mf-lens-tech/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-04/first-patient-treated-with-calibreye-system-in-ide-glaucoma-study/ 2026-02-05T15:11:27Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-19/hoya-vision-care-launches-the-id-mystyle-3-and-id-workstyle-3-lenses/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-26/barti-raises-usd12m-to-support-expansion-of-ai-based-eyecare-ehr/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-05/ace-vision-group-appoints-former-b-l-executive-as-cso/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-04-01/study-cv-risk-score-identifies-future-eye-disease-risk/ 2026-04-01T19:57:55Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-28/assessing-the-visual-impact-of-reabsorption-of-peds-on-ga-patients/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-07/unvaccinated-uveitis-patients-prove-more-at-risk-for-covid-19-infection/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-31/could-oral-contraceptives-lead-to-retinal-thinning/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-25/graybug-vision-and-mireca-terminate-ird-partnership/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-06/is-there-a-cognitive-benefit-to-cataract-surgery/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-08/fda-accepts-nda-for-glaukos-s-idose-tr/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-14/new-world-medical-launches-upgraded-streamline-surgical-system/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-26/how-necessary-are-1-week-postop-visits/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-09/bausch-lomb-releases-preservision-areds-2-mini-soft-gels-ocusorb/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-03/sight-sciences-iridex-confirm-macs-withdrawal-of-final-lcds-on-migs/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-21/bausch-lomb-launches-pf-lumify-redness-reliever-drops/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-26/study-names-new-risk-factors-for-pcr-during-cataract-surgery/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-21/study-repeated-stress-accelerates-aging-eye/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-08/earlier-ppv-may-benefit-vitrectomy-among-pdr-patients/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-06/palatin-fails-to-meet-primary-endpoints-in-pivotal-phase-3-ded-study/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-15/oculis-releases-positive-phase-3-data-from-optimize-1-trial-for-post-op-inflammation-and-pain/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-21/amber-ophthalmic-enrolls-first-patient-in-pced-study/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-08/dance-eyes-weekly-glance/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-08/global-collaboration-to-develop-immunoglobulin-eye-drops-for-ded/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-18/your-rundown-2025-approvals-and-launches/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-29/suicide-rates-highest-for-females-physicians-meta-analysis-reports/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-18/j-and-j-reports-significant-phase-2-data-in-nipocalimab-for-sjoegren-s-disease/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-26/contact-lens-of-the-americas-specialist-symposium-2024-to-make-us-debut/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-23/regenxbio-reports-positive-interim-data-in-gene-therapy-trial-for-wet-amd/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-31/prototype-designed-to-prevent-contact-lens-induced-dry-eye/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-05/fda-grants-rmat-designation-to-4dmt-for-dme-gene-therapy/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-18/registration-opens-for-eyes-on-2024/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-17/plenoptika-debuts-mobile-refraction-platform-for-portable-ar-device/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-23/international-task-force-develops-multimodal-imaging-criteria-for-choroiditis/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-11/fda-grants-fast-track-designation-to-feliqs-rop-prevention-candidate/ 2026-01-07T23:00:09Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-15/the-vision-council-launches-online-regulatory-monitoring-service-for-optical-industry/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-23/visus-completes-enrollment-for-phase-3-trial-of-brimochol-pf-for-presbyopia/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-04/kiora-s-kio-104-receives-us-patent-for-expanded-protection-of-inflammatory-retinal-diseases/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-18/aldeyra-resubmits-reproxalap-nda-for-dry-eye-again/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-22/scope-health-purchases-eyetamins-supplements/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-07/iantrek-names-former-trukera-medical-leader-as-new-ceo/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-19/better-way-treat-demodex-weekly-glance/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-12/regeneron-settles-with-sandoz-over-eylea-biosimilar-patent-infringement-lawsuit/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-02/ocuphire-pharma-names-new-ceo/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-27/covid-causing-virus-may-damage-vision-via-blood-retinal-barrier/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-28/could-vitamins-slow-amd-growth/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-12/ectasia-progression-may-diminish-with-epi-off-cxl/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-10/fda-approves-eylea-for-rop-in-preterm-infants/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-15/anti-vegf-therapy-may-maintain-va-for-namd-in-the-long-term/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-13/new-prediction-model-proposed-for-eyelid-sebaceous-carcinoma/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/topcon-healthcare-introduces-tempo-perimeter/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-16/euclid-and-visionary-optics-to-host-nationwide-specialty-contact-lens-forums/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-19/aoa-town-hall-addresses-vision-plan-policy-concerns-and-future-advocacy-initiatives/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-09/avant-technologies-and-ainnova-to-advance-low-cost-retinal-camera-with-ai-software/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-30/kodiak-reports-positive-phase-3-data-on-tarcocimab-for-dr/ 2026-04-01T15:27:25Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-04/optoai-releases-ai-powered-assistant-for-optometrists/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-04/newly-launched-tern-therapeutics-acquires-ex-regenxbio-gene-therapies/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-11/could-optic-disc-phenotypes-make-targeted-patient-care-a-reality/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-15/myopia-profile-unveils-revamped-educational-website/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-18/alcon-and-lensar-terminate-proposed-merger-after-ftc-pressure/ 2026-03-18T19:17:05Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-17/glaukos-partners-with-radius-xr-on-wearable-diagnostic-system/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-01/precise-bio-performs-first-transplant-with-3d-printed-cornea-implant/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-06/myze-launches-daily-lid-and-lash-anti-microbial-cleanser/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-19/fda-accepts-nda-amendment-pdufa-pegcetacoplan-ga/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-13 /here-s-why-uveal-melanoma-treatment-shouldn-t-be-delayed/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-06/glaukos-and-celanese-to-collaborate-on-glaucoma-treatment/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-06/four-year-data-continues-to-support-dot-spectacle-lenses-for-myopia/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-21/could-high-hdl-levels-lead-to-lower-dr-risk/ 2026-01-21T22:29:11Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-26/melt-reports-favorable-phase-3-data-on-preop-procedural-sedation-tablet/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-25/first-autofocus-glasses-offer-lightweight-vision-correction/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-20/oct-a-may-be-noninvasive-option-for-detecting-kidney-changes/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-06/aoa-s-blink-land-game-targets-eye-friendly-screen-habits/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-03/visgnex-announces-positive-data-for-gene-therapy-dry-amd-candidate/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-19/essilor-introduces-cellview-retinal-camera-with-widefield-fundus-imaging/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-14/newton-acquires-founders-optical-lab/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-24/physically-active-kids-less-likely-to-develop-myopia/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-07/rgc-thickness-may-be-early-retinal-indicator-with-oral-hcq/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-04/three-year-data-supports-extended-treatment-of-syfovre-for-ga/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-22/epion-therapeutics-receives-us-patent-for-cxl-based-light-therapy-device/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-09/canadian-association-of-optometrists-joins-gmac-s-fight-against-myopia/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-20/does-oct-a-improve-dr-detection/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-30/viridian-completes-patient-enrollment-for-thrive-2-chronic-ted-trial/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-14/nacuity-moves-forward-with-trial-of-intravitreal-implant-for-cataract-progression-delay/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-13/how-impactful-is-access-to-outdoor-green-space-on-myopia-progression/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-08/study-links-pediatric-inhalers-to-increased-cataract-risk/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-04/gene-therapy-restores-genetic-disease-vision-loss/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-17/contact-lenses-may-shed-microplastics-research-finds/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-29/study-details-rare-visual-condition-of-facial-distortion-vision/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-20/study-smoking-an-unlikely-risk-factor-for-glaucoma/ 2026-03-20T18:49:03Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-24/obesity-linked-macular-degeneration-development/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-02-21/cataract-surgery-lose-weekly-glance/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-10/acelyrin-announces-phase-2-data-and-phase-3-design-for-ted-therapy/ 2026-02-13T20:47:21Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-11/spyglass-pharma-raises-usd75m-to-advance-sustained-release-drug-delivery-platform/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-09/ciliatech-reports-positive-36-month-follow-up-on-glaucoma-surgical-implant/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-21/investigators-identify-ossn-drops-as-potential-demodex-therapy/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-03/qlaris-bio-raises-usd24m-in-financing-for-iop-lowering-glaucoma-candidate/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-08/lumibird-medical-launches-tango-reflex-neo-yag-slt-laser/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-19/opthea-to-lay-off-80-of-workforce-amid-executive-cuts/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-12/sight-sciences-reports-real-world-data-on-leading-migs-devices-including-omni-surgical-system/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-09/outdoor-exposure-leads-to-less-myopic-shift-among-children/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-05/outlook-therapeutics-resubmits-wet-amd-bla-for-bevacizumab/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-17/2020-now-and-visionix-usa-debut-new-tele-optometry-program/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-22/chatgpt-gets-tested-on-ophthalmologic-subspecialty-accuracy/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-10/positive-data-reported-for-phase-4-study-on-tepezza-for-ted/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-01/vision-expo-east-2024-to-feature-expansive-ce-opportunities/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-14/registration-opens-for-eyes-on-retina-2025/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-21/fda-approves-biocon-biologics-interchangeable-biosimilar-for-eylea/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-02/outlook-therapeutics-receives-second-fda-crl-over-wet-amd-bla/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-16/do-optometrists-benefit-from-pe-acquisitions/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-19/harrow-officially-acquires-melt-pharmaceuticals/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-18/direct-to-consumer-contact-lens-brand-launches/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-15/sandoz-releases-positive-data-on-biosimilar-aflibercept-for-wet-amd/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-06/eyes-on-2024-highlights-eyecare-s-biggest-innovations/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-11/contact-lens-institute-publishes-new-cl-culture-report/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-03/zeiss-updates-cirrus-6000-oct-technology/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-03/favorable-preliminary-data-reported-for-kio-301-in-rp-treatment/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-05-09/sleep-dry-eye-checklist-weekly-glance/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-20/oculogenex-s-amd-gene-therapy-to-undergo-testing-in-space/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-12/enrollment-concludes-for-alimera-s-synchronicity-study-on-yutiq/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-11/positive-topline-data-released-for-telios-pharma-s-ded-treatment/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-05/liquid-cornea-human-trials-target-corneal-blindness/ 2026-02-13T16:10:52Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-18/vitamins-contact-lenses-weekly-glance/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-24/neurophth-doses-first-patient-in-lhon-gene-therapy-trial/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-01 /mireca-medicines-granted-usd1-m-for-inherited-retinal-disease-advancements/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-23/helpmesee-expanding-simulation-based-surgical-training-to-two-new-locations/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-16/haag-streit-introduces-3d-imaging-for-imaging-module-910/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-16/remote-consult-protocol-seeks-to-rapidly-diagnose-retinal-artery-occlusions/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-01/okyo-pharma-to-launch-real-world-trial-on-ok-101-ncp/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-12/extended-phase-3-study-reports-3-year-durability-of-eylea-hd-for-wet-amd/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-28/does-gender-impact-the-risk-for-myopia-development/ 2026-01-07T23:00:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-12/formosa-and-eyenovia-to-co-develop-clobetasol-propionate-solution-for-ded/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-27/pangaea-data-s-ai-platform-receives-topcon-investment/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-20/eyenovia-s-phase-3-pediatric-myopia-trial-fails-primary-goal/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-26/alan-kabat-od-faao-joins-eyes-on-eyecare-as-associate-director-of-medical-communications/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-17/deep-optics-showcases-adaptive-focus-sunglasses/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-06/american-college-of-eye-technicians-offers-fast-track-training-program/ 2026-02-06T19:05:19Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-13/new-6-month-data-evaluates-azr-md-001-for-mgd/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-29/cliara-receives-us-patent-for-contact-lens-measurement-device/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-18/fda-approves-orasis-s-qlosi-for-presbyopia/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-13/clinical-review-calls-for-upper-eyelid-imaging-in-meibomian-gland-evaluations/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-17/study-artificial-tears-disrupt-ocular-surface-inflammation-cycle/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-07/orasis-s-qlosi-for-presbyopia-launches-in-the-us/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-30/what-to-rule-out-before-diagnosing-ded/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-01/prevalence-of-dr-is-increasing-among-diabetics-minorities/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-26/bausch-lomb-launches-lumify-eye-illuminations/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-10/macula-changes-identified-among-sleep-apnea-patients/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-20/zenni-optical-unveils-the-vr-vision-screener/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-03/csi-dry-eye-software-releases-new-version-of-ai-based-program/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-16/pivotal-study-validates-scanly-home-oct-device-for-namd-management/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-04/visus-releases-topline-data-from-phase-3-trial-of-brimochol-pf/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-26/researchers-develop-smart-iol-for-diagnosing-alzheimer-s/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-13/samsung-biopeis-and-regeneron-settle-eylea-biosimilar-us-patent-dispute/ 2026-02-17T12:32:51Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-23/iveric-bio-nda-submission-zimura/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-03/pilot-study-evaluates-scleral-lens-device-and-cyclosporine-for-ded-drug-delivery/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-07/vision-expo-shifting-to-single-annual-event-in-2026/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-12/fda-approves-allotex-s-ide-for-us-study-of-tissue-based-solution-for-presbyopia/ 2026-01-12T12:08:38Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-25/acute-angle-closure-glaucoma-may-benefit-from-phaco/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-03/rayner-acquires-anikavisc-ophthalmic-viscosurgical-device/ 2026-03-03T19:16:34Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-25/is-the-mediterranean-diet-actually-effective-for-ocular-health/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-15/pivotal-study-showcases-envista-envy-iol-s-full-range-of-vision/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-11/viridian-reports-positive-data-from-ongoing-trial-of-vrdn-001-for-chronic-ted/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-29/fda-approves-glaukos-idose-tr-for-repeat-treatment-labeling/ 2026-01-29T11:59:29Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-01/deep-learning-based-software-establishes-new-mgd-imaging-analysis/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-30/therapeutic-may-resolve-zika-virus-related-ocular-infections/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-22/idetective-campaign-targets-early-keratoconus-diagnosis/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-04/regener-eyes-launches-new-preservative-free-bottles-with-backflow-prevention/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-26/research-examines-ties-between-dme-and-systemic-meds/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-01/iveric-bio-reports-new-data-in-ga-trial-on-acp/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-24/haag-streit-launches-new-corneal-ectasia-display-for-eyestar-900/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-08/tracey-technologies-launches-upgraded-aberrometer/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-07/surprising-protective-role-of-estrogen-may-lower-glaucoma-risk-in-women/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-09/presbyopic-pilots-may-benefit-from-novel-laser-vision-correction-tech/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-07-11/patients-wet-amd-lifelong-anti-vegf-injections-weekly-glance/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-20/glaucoma-development-associated-with-osteoarthritis-drug/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-25/adverum-reports-extended-4-year-findings-on-wet-amd-gene-therapy/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-10/tearcare-fda-approval-weekly-glance/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-27/first-patient-dosed-in-rnai-therapeutic-trial-for-dry-wet-amd/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-01/core-director-dr-lyndon-jones-to-step-down-amid-scope-expansion/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-29/are-corneal-dystrophies-linked-to-mental-health-conditions/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-03/viatris-acquires-oyster-point-pharma-famy-life-sciences/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-27/fda-rejects-sydnexis-nda-for-low-dose-atropine-drop/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-01/aldeyra-positive-primary-vitreoretinal-lymphoma-pre-nda-fda/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-28/first-patient-transplanted-with-ipsc-derived-ce-cell-substitute/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-07/first-patients-enrolled-in-ocular-therapeutix-phase-3-wet-amd-study/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-29/merck-to-acquire-eyebiotech-in-deal-worth-up-to-usd3b/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-12/complement-therapeutics-secures-fast-track-designation-for-lead-ga-therapy/ 2026-01-12T19:21:30Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-30/research-compares-rnfl-and-gcipl-in-pxg-poag-patients/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-21/fda-accepts-orasis-nda-for-csf-1-to-treat-presbyopia/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-06/iridex-releases-part-2-of-micropulse-evidence-based-guideline-series/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-23/therini-bio-raises-nearly-usd40m-to-study-dme-and-alzheimer-s-immunotherapeutics/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-20/ocumetra-showcases-all-in-one-myopia-management-software/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-19/bausch-lomb-and-novaliq-receive-fda-approval-for-miebo-to-treat-ded/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-15/hoya-vision-launches-spectacle-lenses-for-pediatric-myopia-protection/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-29/zenni-optical-launches-vr-based-prescription-lenses/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-30/dyno-therapeutics-launches-new-aav-capsid-for-eye-gene-therapy/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-20/coopervision-sole-provider-synergeyes-scleral-lens-design-system/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-17/positive-data-glaukos-idose-tr-exchange-trial/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-23/visionix-introduces-vx-610-automated-fundus-camera/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-31/prima-system-for-dry-amd-receives-fda-breakthrough-device-designation/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-08/age-gender-play-a-role-in-rate-of-myopia-progression/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-10/eyelid-irrigating-retractor-achieves-ocular-lavage-for-allergic-conjunctivitis/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-16/topline-data-reported-for-reproxalap-in-phase-3-trial-on-allergic-conjunctivitis/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-23/investigators-develop-three-new-al-progression-trajectories/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-18/csi-dry-eye-software-releases-update-for-ai-based-clinical-platform/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-01/specific-weight-loss-medications-may-also-benefit-ocular-outcomes/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-14/nanoscope-begins-rolling-bla-submission-for-rp-gene-agnostic-therapy/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-10/fda-oks-palatin-s-phase-3-ded-trials-on-melanocortin-agonist/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-07/positive-results-reported-for-first-in-human-study-of-flight/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-24/b-l-s-envista-iols-return-to-market-after-voluntary-recall/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-10/genentech-reports-positive-data-in-phase-3-trials-of-vabysmo-for-rvo/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-04/fda-clears-essilorluxottica-s-nuanceaudio-for-us-market/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-24/dorc-receives-fda-odd-for-trypan-blue-and-bbg/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-13/fda-510-k-clearance-bausch-lomb-biotrue-contact-lens-rehydrating-drops/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-23/nanotechnology-approach-targets-namd-with-protein-like-polymers/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-06/arkansas-passes-legislation-regulating-vision-benefit-managers/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-04/investigators-receive-usd6-4m-nei-grant-for-amd-oral-candidate/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-20/water-free-cyclosporine-shows-potential-for-ded-treatment/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-14/interim-data-announced-for-ocular-therapeutix-phase-1-trial-on-wet-amd/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-09-26/links-covid-vaccine-eye-weekly-glance/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-17/physical-activity-tied-to-decreased-glaucoma-progression/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-09/could-computer-aided-ortho-k-fitting-surpass-standard-methods/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-18/newton-formerly-neurolens-launches-with-new-sequel-lens-technology/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-21/researchers-identify-new-biomarker-for-early-ms-diagnosis/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-20/invirsa-secures-usd7-7-million-in-funding-to-advance-ocular-candidate/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-01/positive-12-month-data-reported-in-coave-s-ongoing-rp-phase-1-2-trial/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-05/revisiting-ocular-antibiotic-resistance-with-the-armor-study/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-26/oculus-introduces-myopia-software-to-pentacam-axl-wave/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-22/university-of-purdue-receives-usd6-7m-grant-to-advance-development-of-smart-contacts/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-02/topcon-and-retispec-partner-on-ocular-ai-diagnostic-tool-for-alzheimer-s/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-05/the-vision-council-reports-q3-2024-optical-market-consumer-trends/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-02/opus-genetics-reports-positive-phase-3-data-for-phentolamine-0-75/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-11/qlaris-bio-developing-fixed-dose-latanoprost-and-qls-111-eye-drop-for-glaucoma/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-04/viatris-and-locus-biosciences-to-develop-antibacterial-therapies-for-ophthalmic-infections/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-20/lawsuits-follow-nationwide-recall-of-eye-drop-products/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-28/alcon-program-guides-clinical-practices-on-advanced-technology/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-21/fda-issues-new-warnings-and-guidance-on-otc-eye-drops/ 2026-01-07T23:00:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-24/ollin-biosciences-debuts-with-next-gen-ophthalmic-pipeline/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-24/new-research-uncovers-how-diabetes-delays-wound-healing-in-the-eye/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-07/fda-grants-breakthrough-therapy-designation-to-oculis-privosegtor-for-optic-neuritis/ 2026-01-08T14:46:13Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-09/study-proposes-new-severity-scale-for-diabetic-macular-ischemia/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-06/fda-grants-breakthrough-device-designation-to-cvd-retinal-imaging-platform/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-23/nightly-atropine-may-lead-to-lower-incidence-of-myopia/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-07/oculis-advances-neuro-ophthalmic-asset-after-positive-fda-feedback/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-21/harrow-acquire-us-rights-5-ophthalmic-products-novartis/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-08/opzira-launches-with-lumithera-diagnostic-product-line/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-25/seonix-bio-debuts-clinical-polygenic-risk-score-testing-for-glaucoma/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-22/death-toll-rises-in-artificial-tears-recall/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-04/global-myopia-awareness-coalition-names-2024-board-of-directors/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-21/coopervision-report-highlights-growing-prevalence-of-digital-eye-strain/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-30/drug-farm-receives-fda-ind-clearance-for-rosah-syndrome-candidate/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-01/video-games-may-have-a-surprising-visual-benefit/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-22/topcon-launches-dry-eye-imager-with-robotic-intelligence/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-19/harrow-purchases-us-canadian-commercial-rights-to-novaliq-s-vevye/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-08/vivavision-reports-significant-iop-reduction-in-phase-2-study/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-21/lower-amd-risk-tied-to-long-term-metformin-use/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-02/bascom-palmer-receives-nih-grant-for-csvd-detection-via-the-eye/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-30/nanoscope-reports-3-year-vision-improvements-for-rp-optogenetic-therapy/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-12/bausch-lomb-launches-miebo-in-the-us/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-14/regeneron-releases-2-year-pulsar-trial-data-on-aflibercept-8-mg-for-wet-amd/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-22/registration-opens-for-eyes-on-retina-2024/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-26/positive-6-month-data-reported-in-phase-1-2-trial-for-lca1/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-06-20/new-custom-contacts-market-weekly-glance/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-06/cdc-updates-ecps-on-ezricare-artificial-tears-discontinuation/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-12/fda-approves-tecnis-puresee-iol-for-cataract-patients/ 2026-03-17T18:46:47Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-18/essilorluxottica-is-purchasing-a-majority-stake-in-heidelberg-engineering/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-05/oct-imaging-detects-retinal-volume-parameters/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-11/sahara-crossover-trial-reports-significant-continued-advantages-of-tearcare-for-ded/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-11/alcon-launches-total30-mf-contact-lenses-for-presbyopia/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-11/oculis-reports-positive-phase-2b-topline-data-on-licaminlimab-for-ded/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-31/proposed-bill-bans-contact-lens-prescription-robocalls/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-24/fda-clears-oertli-s-faros-anterior-cataract-surgery-system/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-30/opthea-names-new-us-based-leadership/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-11/researchers-explore-new-method-for-calculating-iol-power-in-congenital-cataracts/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-28/florida-ods-kill-yet-another-not-a-doctor-bill/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-12-07/ocuphire-submits-nda-fda-nyxol/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-13/new-5-year-syfovre-data-indicates-extended-delay-of-ga-progression/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-13/researchers-detect-first-dry-eye-specific-genetic-locus/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-23/ftc-supports-proposed-fda-interchangeable-biosimilar-drug-guidance/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-23/bausch-lomb-may-be-acquiring-inflammx-therapeutics/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-08/euclid-vision-launches-new-sihy-daily-disposable-lens-for-myopia/ 2026-01-15T15:00:49Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-02/could-diabetes-medication-reduce-rvo-risk/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-08/pathologic-myopia-has-a-new-grading-scale/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-09/west-virginia-od-bill-to-permit-use-of-ophthalmic-lasers/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-07/physically-active-kids-linked-lower-risk-allergic-conjunctivitis/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-10/ppc-surpasses-manual-capsulorhexis-for-white-cataracts-treatment/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-13/ded-severity-increases-with-certain-systemic-drug-use/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-03/women-in-ophthalmology-survey-identifies-barriers/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-05/4dmt-releases-positive-interim-data-on-phase-2-amd-gene-therapy-trial/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-30/current-trajectory-of-global-eyecare-access-unlikely-to-meet-2030-goal/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-01/are-prostaglandins-really-the-most-effective-glaucoma-therapy/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-27/retinal-thickness-may-predict-parkinson-s-progression/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-25/kiora-granted-us-patents-covering-local-ocular-delivery-for-kio-100-compounds/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-26/verana-health-launches-real-world-data-ted-module/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-23/fda-grants-priority-review-for-chisei-s-lhon-therapeutic/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-08-01/new-options-cataract-surgery/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-14/is-there-a-risk-for-niu-following-covid-19-vaccination/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-13/astellas-and-4dmt-enter-into-licensing-deal/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-12-10/scope-health-and-cevr-partner-to-develop-commercialize-ded-and-osd-tech/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-20/glaukos-acquires-global-rights-to-stuart-therapeutics-neuroprotection-glaucoma-asset/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-24/safety-and-efficacy-data-supports-vista-1-step-vitrectomy-probe/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-06/positive-data-reported-in-qlaris-bio-s-phase-2-poag-and-oht-trials/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-09/sight-sciences-launches-new-ergo-series-for-omni-surgical-system/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-06/distinct-features-identified-in-pediatric-ocular-melanoma/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-03/high-risk-poag-patients-less-likely-to-undergo-migs/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-30/new-dot-lens-data-finds-75-pediatric-myopia-management-efficacy-after-12-months/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-06/ocuphire-doses-first-patient-in-phase-3-presbyopia-study-on-phentolamine-solution/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-18/viridian-to-initiate-two-phase-3-studies-for-chronic-ted/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-03-01/coopervision-launches-myday-energys-contact-lenses-in-us/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-27/critical-link-identified-between-iron-and-ocular-toxoplasmosis/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-07-02/how-prevalent-are-hyper-reflective-foci-in-dme/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-30/two-year-data-on-omni-surgical-system-shows-promise-for-poag-patients/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-01/fda-clears-skyline-therapeutics-ind-for-namd-gene-therapy/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-09-24/despite-missing-primary-outcomes-alkea-s-phase-3-ga-trial-shows-promise/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-30/cli-report-reveals-new-insights-into-contact-lens-patient-behavior-trends/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-28/versea-ophthalmics-and-celularity-partner-on-us-distribution-of-two-ocular-products/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-20/fda-oks-clinical-trial-on-atia-vision-s-novel-iol-for-cataract-patients/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-08-16/new-keratoconus-staging-system-incorporates-oct/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-12/fda-approves-alembic-pharma-s-loteprednol-etabonate-and-tobramycin-ophthalmic-suspension/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-09/horizon-reports-published-data-from-phase-3-study-on-uplizna/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-07-08/eyenovia-rebrands-as-hyperion-defi-inc-with-new-focus/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-15/newsight-reality-debuts-next-gen-ar-based-transparent-optical-module/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-19/fda-accepts-aldeyra-s-reproxalap-ded-nda-resubmission/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-28/how-effective-is-red-light-therapy-for-pre-myopic-patients/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-11/two-eye-diseases-may-lead-amd-development/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-10-28/ciliatech-to-open-us-subsidiary-supporting-clinical-advancement-of-novel-glaucoma-device/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-20/fda-issues-company-response-letter-to-astellas-for-izervay-supplemental-nda/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-05-29/fda-approves-alcon-s-tryptyr-acoltremon-ophthalmic-solution-0-003-for-ded/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-29/eyecare-partners-launches-accelerated-ophthalmic-training-fellowship/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-18/bmi-alternative-may-better-predict-cataract-risk/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-17/linking-smoking-intensity-optic-nerve-vessel-density-glaucoma/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-01-14/bausch-lomb-adds-to-glaucoma-and-ga-pipeline-with-two-deals/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-03-17/tenpoint-therapeutics-names-veteran-executive-as-first-cco/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-10-29/six-year-data-supports-kahook-dual-blade-for-glaucoma/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-07-28/fda-gives-ok-to-first-handheld-corneal-esthesiometer/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-05-31/how-does-smoking-impact-onh-vessel-density-in-poag/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-01-17/how-quickly-refer-patient-retinal-artery-occlusion-weekly-glance/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-09/xipere-earns-category-1-cpt-code-from-ama/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-13/lower-endophthalmitis-rates-associated-with-high-volume-of-cataract-surgeons/ 2026-01-07T23:01:16Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-03/harrow-prepares-to-launch-widespread-market-access-for-vevye/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-05/fda-grants-rmat-designation-to-nanscope-for-stargardt-gene-therapy/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-02-06/endogena-therapeutics-earns-fast-track-designation-for-rp-treatment/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2022-11-29/aldeyra-submits-nda-reproxalap-ded/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-10-18/positive-data-released-for-aviceda-s-phase-2-3-ga-trial/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-19/first-annual-eyes-on-retina-exceeds-attendance-expectations/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-05-11/chatgpt-scores-46-on-ophthalmology-board-certification-practice-test/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-10/opthea-to-cut-workforce-by-an-estimated-65/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-08-25/iantrek-raises-usd42m-for-launch-of-uveoscleral-pathway-glaucoma-tech/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-08/myra-vision-initiates-fih-trial-on-calibreye-system-for-iop-reduction/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-28/is-teprotumumab-or-decompression-more-impactful-for-proptosis/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-09-28/how-to-medically-manage-anterior-segment-disease/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-10/does-silicone-oil-cause-macular-edema-post-rrd-surgery/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-01-07/study-identifies-key-risk-factors-for-punctate-inner-choroidopathy-patients/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-04-13/fda-clears-aviceda-s-ind-application-for-ga-candidate/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-09-04/virtualens-launches-with-vr-based-iol-simulator/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-27/alcon-debuts-new-digital-platform-for-clinics-and-surgery-centers/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-11-27/diabetes-mellitus-subtypes-may-lead-to-increased-retinal-thinning/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-12-22/oculis-launches-phase-3-optimize-trial-for-post-cataract-inflammation-and-pain/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-12/regeneron-reports-extended-dosing-data-on-eylea-hd-for-wet-amd-and-dme/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-17/optos-launches-next-gen-uwf-imaging-system-with-sd-oct/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-06-17/dry-eye-foundation-to-host-dc-advocacy-days-in-july/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-01-24/does-ded-severity-impact-efficacy-varenicline-nasal-spray/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-02-13/digital-retinal-imaging-tool-may-detect-dementia/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-26/eyedaptic-launches-latest-version-of-ai-based-smart-glasses-for-amd/ 2026-03-26T13:26:33Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-12-17/rinsada-expands-irrigating-eyelid-retractor-distribution-to-canada/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-03-22/study-finds-nanodropper-adaptor-demonstrates-efficacy-and-safety-as-glaucoma-treatment/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-21/does-an-inflammatory-diet-play-a-role-in-amd-development/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-01-24/dso-procedure-demonstrates-long-term-durability/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-06-14/foundation-fighting-blindness-grants-opus-genetics-usd1-7m-to-fund-ird-programs/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-06-27/myra-vision-secures-usd25m-for-advancement-of-novel-glaucoma-treatment/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-11-20/essilor-stellest-2-0-lenses-demonstrate-superior-efficacy-in-slowing-myopia-progression/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2025-04-10/fda-grants-anda-approval-to-olopatadine-hydrochloride-for-ocular-allergy-relief/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-02-12/beacon-therapeutics-releases-positive-12-month-data-from-phase-2-xlrp-trial/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-12/fda-oks-ocugen-s-rp-expanded-access-program-in-adult-patients/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-08-14/lupin-reports-positive-phase-3-program-for-lucentis-biosimilar/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2023-11-10/modmed-launches-single-screen-soap-notes-for-ema/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-03-04/smart-contact-lens-performs-real-time-iop-monitoring/ 2026-03-04T20:58:28Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-23/coopervision-and-aoa-launch-the-myopia-collective/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2026-02-10/seasonal-variations-play-major-role-in-csc-development/ 2026-02-12T12:09:42Z yearly 0.75 https://glance.eyesoneyecare.com/stories/2024-04-22/ocuphire-enrolls-first-patient-in-lynx-2-phase-3-study-for-phentolamine/ 2026-01-07T23:01:48Z yearly 0.75 https://glance.eyesoneyecare.com/organizations/spyglass-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/olleyes/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vision-council/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bruno-vision-care/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/genentech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/syncona/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sun-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cognition-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aoa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/novasight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visionix/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/fera-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/carrot/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/myopia-profile/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyebiotech-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocubio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/famy-life-sciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aimmax-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/beyeonics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rpb/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/view-optometry/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/be-my-eyes/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocusciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/celularity/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/anltera-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/virtual-vision-health/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ascendis-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cloudbreak-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vista-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/qlaris-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/hcp-cureblindness/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocuvex-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/intelligent-retinal-imaging-systems/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dopavision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eclipse-life-sciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/brill-engines/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rinsada/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/horizon-surgical-systems/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/celanese/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/retispec/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/atsena-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/unity-biotech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/character-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/csi-dry-eye-software/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sun-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/newton/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/wave-eye-care/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/esight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/grifols/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/kuria-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/senju-pharmaceutical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vme/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nidek/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/modulight-corp/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/casexglobal/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyedaptic/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nei/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/association-for-pediatric-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cellusion/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/baxter-international/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/outlook-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/national-federation-of-opticianry-schools/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mu-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lensar/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/voiant/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/luxa-biotechnology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/neurolens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/asrs/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iveric-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/orbis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/glaucoma-research-foundation/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tear-restore/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/belite-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aviceda-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/emmetrope-ophthalmics-emmecell/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/skyline-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/feliqs/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/innovent-biologics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/merck/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/thea-open-innovation/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/allegro-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/shifamed/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/amber-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/plenoptika/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/formosa-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aura-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oculogenex-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/seonix-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/graybug-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/abeona-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visibly/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vialase/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/belkin-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/brightstar-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sling-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/amring-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/biocon-biologics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocumetra/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iveena-delivery-systems/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/atia-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ace-vision-group/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ollin-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lsl-pharma-group/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oculus-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iapb/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visus-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/samsung-bioepis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rain-eye-drops/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visionary-optics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/alembic-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/novoxel/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visirose/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optometry-divas/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ezricare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/johnson-and-johnson/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mod-med/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/regenx-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/medicel-ag/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/okyo-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/barti/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/celltrion/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nicox/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sightpath-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/allotex/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/inflammx-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ray-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/saliogen-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sight-sciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optos/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/hubble-contacts/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/frontera-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eluminex-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/apellis-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nacuity-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/neuralink/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dyno-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/naegis-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/scope-health-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/arvo/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/altris-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ior-partners/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lumithera/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/kodiak-sciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/alumis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aegis-ventures/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/biogen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pulsesight-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/retinalyze/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyeganics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/verana-health/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/regeneron/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/palatin-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/beacon-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oculogyx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/exonate/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/moria-surgical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sgn-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/novaliq/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/precise-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visible-genomics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/virtualens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/amgen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/chiesi-group/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/olix-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nordic-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lilly / monthly 0.75 https://glance.eyesoneyecare.com/organizations/eversight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/unither-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/brim-biotechnology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dr-contact-lens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/adverum-biotechnologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/immunogen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/myra-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ametek / monthly 0.75 https://glance.eyesoneyecare.com/organizations/heidelberg-engineering/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vigeneron/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/raresight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ophthalmic-world-leaders-owl/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/amaros/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/opticians-association-of-america/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/huidagene-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cassini-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sandoz/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/microsurgical-technologies-mst/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/20-20now/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/amneal-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/retinai/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/veongen-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nanoscope-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/alimera/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/phoenix-micron/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/yuyu-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/coave-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/world-council-of-optometry/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/samsara-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/azalea-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/apple/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/healthycell/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/new-world-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/avulux/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cofi/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tenpoint-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ivantis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oasis-medical-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mireca-medicines/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lambdavision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visiox-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aao-ophthalmology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/topcon-healthcare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mediwhale/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/inflammasome-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vivavision-biotech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/blinkjoy/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/proqr-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lumata-health/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyeyon-medical-ltd/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/infantsee/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/endogena-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/zhongmou-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyecheq/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tear-film-ocular-surface-society/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pykus-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optometry-giving-sight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/galimediex-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/boehringer-ingelheim/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/global-pharma-healthcare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vsp-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocutrx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/leo/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/long-grove-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/difgen-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mount-sinai/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pantheon-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/opthea-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/euclid-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/american-medical-association/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyemd-emr/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/caeregen-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rayner/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/prevent-blindness/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyefficient / monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyecool-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/meivertor/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bluerock-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/advancing-eyecare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/provectus-biopharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eye2gene/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/fdc-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/olympic-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/4dmt/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/art-optical-contact-lens-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/orcam-tech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/the-contact-lens-institute/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/neurophth-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ascrs/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/polyactiva/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iris / monthly 0.75 https://glance.eyesoneyecare.com/organizations/vantage-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocusoft/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/avisi-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/byers-eye/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pandorum-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyefinity/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lkc-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pine-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aavantgarde-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/norlase/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eschenbach-optik-of-america/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/balance-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bayer-ag/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/foundation-fighting-blindness/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/annexion-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/novartis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/acufocus/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bio-tissue/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/opus-genetics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bioage-labs/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/coherus-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lineage-cell-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/american-glaucoma-society/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/signablok/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bionic-vision-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/neolight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/acet/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/c-light-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/viatris/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/corneat-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/fundamentalvr/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/radius-xr-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lighthouse-guild/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nextgen-healthcare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bvi-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/american-academy-of-optometry/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ai-optics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optomed-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/zenni-optical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oertli-instrumente/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/evoq-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sightglass-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/biostem-tech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aapos/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iridex/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/marco-lombart/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/spark-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sanofi-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/luvo-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vital-tears/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/shamir/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oxular-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/beekeeper-ai/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyenuk/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/veo-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sagent-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyepoint-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tourmaline-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/theianova/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/inmode/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/orasis-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/caplin-steriles-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/epion-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/istar-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aesculatech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/fgh-science/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/allovir-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/abbvie/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rxsight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/hanall-biopharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/alkeus-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/emc-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visioneering-technologies-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optivate/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/azura-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/trefoil-tpx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ripple-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/horizon-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/trukera-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/avista-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/kiora-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/m-and-s-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/laboratoires-thea/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/allysta-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/onl-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/spryte-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lumibird-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/right-eye/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/glaukos/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oxurion/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/osheru/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/digitaloptometrics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/north-american-neuro-ophthalmology-society/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/staar-surgical-/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dry-reddys-lab/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/elios-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cliara/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/opzira-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/arctic-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/unitedhealthcare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/staar-surgical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/accusite-surgical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/jcyte/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/meridian-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aramis-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/surface-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/astellas-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/brill-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/centre-for-ocular-research-and-education/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/newsight-reality/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/quantel-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/teclens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyexora/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/humonix/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/skye-bioscience/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocugen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/visant-medical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/forge-biologics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/gensight-biologics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bausch-lomb-envista/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/myze/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/neurotech-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/delsam-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pixium-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/smartlens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/alcon-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/kala-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lumeniscom/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oyster-point-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dompe/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tarsus-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/icare-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/reichert/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vision-source/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/essilorluxottica/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/heru/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/johnson-johnson-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/allergan-an-abbvie-company/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/revolutionehr/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lasikplus/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/carl-zeiss-meditec/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyes-on-eyecare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vision-expo/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/johnson-johnson-surgical-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/synergeyes/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/asoa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ziemer-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/formycon-ag/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/imprimis-rx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ihealthscreen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/oculis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bausch-lomb/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/virtual-field/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocutech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bostonsight/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyecare-partners/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocuterra-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mediprint-ophthalmics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ora-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/novabay-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ibis-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/clinical-ai/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/optase/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/apotex-corp/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aldeyra-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bascom-palmer-eye-institute/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lenz-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/revitalvision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eiyan-lens/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pangaea-data/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/selagine/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/coburn-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/melt-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/centricity-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/drug-farm/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sightlife-international/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nona-biosciences/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/acelyrin-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/sonoma-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/go-check-kids/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/revopsis-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/openai/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/bruder-healthcare/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nanodropper/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aerie-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/eyenovia/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/thea-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lightoptech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/haag-streit-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/hyperion-defi-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vsy-biotechnology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/focus-vitamins/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/clearside-biomedical/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/meibum-scientific/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/pharmedica/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/gland-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/gmac/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/forsight-robotics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lumenis-be/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iuvo-bioscience/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/onpoint-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tracey-techologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/salvat/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/akorn-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/https://stuarttherapeutics.com// monthly 0.75 https://glance.eyesoneyecare.com/organizations/toku-eyes/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/regener-eyes/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/santen/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aurion-biotech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/glenmark-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/zhaoke-ophthalmology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/asclepix-tx/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/splicebio / monthly 0.75 https://glance.eyesoneyecare.com/organizations/sydnexis/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vantage-surgical-solutions/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/artikode-intelligence/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/therini-bio/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/avant-technologies/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/invirsa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/complement-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocuphire-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/mylan-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/helpmesee/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/apellis-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/kalaris-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dryeye-rescue/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/zeiss-medical-technology/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dorc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/iantrek-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/nova-eye/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/notal-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dry-eye-institute/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ciliatech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tern-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/keeler-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/cooper-vision/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/konan-medical-usa/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ainnova-tech/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ascidian-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/vyluma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/octane/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/seabelife/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ani-pharmaceuticals/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/telios-pharma/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/interventional-mindset/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/deepoptics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/gore/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/identifeye-health/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/ocular-therapeutix/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/lupin-limited/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/hoya-vision-care/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/capsida-biotherapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/dry-eye-society-of-the-americas/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/tearoptix/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/gentex/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/luminopia/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/rebion-/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/northwell-health/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/defeye-inc/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/viridian-therapeutics/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/harrow/ monthly 0.75 https://glance.eyesoneyecare.com/organizations/aeye-health/ monthly 0.75